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Abstract
Overproduction of intestinal lipoproteins contribute to postprandial 
hypertriacylglycerolaemia. Understanding the mechanisms that modulate chylomicron 
(CM) production in health and disease may lead to prevention and improvement of 
treatments for atherosclerosis. It is well known that following the hydrolysis of 
dietary triacylglycerol (TAG) in the intestine, glycerol is taken up by the luminal side 
of absorptive cells. However, it has recently been shown that in humans, 
endogenously derived glycerol tracer (administered intravenously) also appears to be 
incorporated into exogenous (dietary derived) lipoprotein particles. This was 
investigated further utilising stable isotopic techniques in human volunteers and by an 
in vitro model utilising the Caco2 cell line. Phospholipids (PL) synthesis was also 
measured in the Caco2 cells.
Five healthy subjects (age 50-65, BM I21-24) were fed identical high fat meals every 
2 hours for 11 hours. During this time, two different tracers, one administered 
intravenously (^Hs-glycerol) and another given orally (^^Cg-glycerol) as part of a high 
fat meal were used to measure the incorporation of endogenous and exogenous 
glycerol into CM or very low density lipoproteins (VLDL).
^Hs-glycerol was detected in VLDL and CM derived TAG, confirming endogenous 
glycerol could be incorporated into TAG derived from enterocytes. ^^Cg-glycerol was 
found to be predominantly associated with CM. There was no significant difference 
in the proportion of oral or intravenous tracer used for TAG synthesis. VLDLl
production rate (PR) was significantly higher than VLDL2 PR; CMl PR was 
significantly higher than CM2 PR.
The incorporation of ^^Cs-labelled glycerol into TAG and PL by Caco2 cells was 
measured by the addition of a trace quantity of labelled ^^Cg-glycerol to either the 
apical or basolateral side of cells. As different culture conditions might affect 
lipoprotein synthesis and secretion, the effect of culturing in different media 
concentrations of glucose and insulin was also investigated.
Incubation with labelled ^^Cg-glycerol on either the apical or the basolateral surface of 
the cells resulted in the detection of glycerol enriched TAG and PL in the basolateral 
media and the cells themselves. Because the enrichment of basolateral media TAG 
and PL was higher than that in the cells, the presence of unlabelled cellular storage 
pools was proposed. Insulin had no effect on the synthesis and secretion or cellular 
enrichment of TAG and PL, but reduced enrichment of TAG and PL in the media. 
This suggests that insulin increased the incorporation of newly synthesised (labelled) 
TAG and PL into the cellular storage pool and reduced the amount in the export pool.
This study clearly demonstrates that both exogenous and endogenous glycerol can be 
used to synthesise TAG in enterocytes in both an in vivo and in an in vitro model. 
The study also confirms the presence of intracellular storage pools of TAG in 
enterocytes and that enterocytes can regulate CM synthesis and secretion using these 
pools. Endogenous substrates may have an important role in the overproduction of 
CM and further studies are needed to understand their role in postprandial 
hypertriacylglycerolaemia.
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Chapter 1 Introduction
1.1 Chemical characteristics of lipids
Lipids are a diverse group of molecules that primarily contain carbon and hydrogen 
atoms linked together by non-polar covalent bonds (Germann & Stanfield. 2005). 
The major lipids in human plasma and in the diet are triacylglycerols (or triglycerides, 
TAG), which consist of three individual fatty acids, each linked to a molecule of 
glycerol by an ester bond (Frayn 2010). Other major forms of lipids are the 
phospholipids (PL) and cholesterol. PLs are lipids that contain a phosphate group, 
and are major constituents of cell membranes and essential metabolites in the human 
body (Bender 2008). Cholesterol is important for membrane structure and the 
synthesis of hormones and bile salts. Fatty acids are carboxylic acids with a 
hydrocarbon-chain, which are either saturated (no double bonds) or unsaturated (one 
or more double bonds). Long chain fatty acids are not water soluble and require 
albumin for circulation in the blood (Gurr et al.2002).
1.2 Morphological features of the small intestine
The small intestine consists of the duodenum (approximately the first 20 cm), jejunum 
(2 m) and ileum (final 2.5-3 m).
1.2.1 Villi, microvilli and brush border
The surface of the small intestine has layers of smooth muscle running lengthways 
and around its circumference. The inner surface is covered by finger-like projections, 
termed villi; each villus is 0.5-1 mm long. There are 20-40 villi per mm^, which gives 
a total absorptive surface area of about 300 m^. Each of these villi contains many 
more folds, called microvilli; thousands of microvilli form a structure called the brush
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border, giving a brush-like appearance under the electron microscope. The presence 
of the microvilli increases the absorptive surface area by about a further 30-fold 
(Frayn 2010) (Figure 1). Within each villus, there is a dense network of capillaries 
surrounding a channel called the lacteal, a branch of the lymphatic system; the venous 
blood vessels leaving intestinal mucosa merge and ultimately form the hepatic portal 
vein (Frayn 2010). The lymphatic system joins the bloodstream at the thoracic duct 
(Bender 2008).
Microvilli (forming brush border)
Enterocytes
Basolateral
membrane
Goblet cells
Villus
[ Lacteal 
(lymphatic system)
Lymphatic drainage 
Venous drainage
Arterial blood supply
>0.5- 1mm
Figure 1 Structure of a villus of the small intestine.
One of the absorptive cells (enterocytes) on the surface is enlarged to demonstrate the 
microvilli of the brush-border membrane (Modified from Bender 2008; Frayn 2010).
1.2.2 Cell types in the epithelium of the small intestine
The intestinal epithelium consists of four main differentiated cell types: enterocytes, 
goblet, enteroendocrine and Paneth cells (Barker et al. 2008; Sancho et al. 2003). 
Among these cells, the enterocytes and goblet cells represent the two major 
phenotypes in the proportion of 90 % and 10 %, respectively (Walter et al. 1996).
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Enterocytes, or intestinal absorptive cells, are highly specialized, polarized absorptive 
cells responsible for the transepithelial transfer of nutrients from the luminal side of 
the intestine to the bloodstream, and play a dynamic role in lipid and glucose 
metabolism (Massey-Harroehe 2000). The entire intestinal epithelium is renewed 
every 3-4 days in the mouse and 5-6 days in humans; therefore, the life cycle of an 
individual epithelial cell spans less than a week (Marshman et al. 2002; Hernandez 
Vallejo et al. 2009). The main cell types in the epithelium of the small intestine are 
shown in Table 1.
Table 1 Major cell types in the epithelium of the small intestine
Cell type______________________________ Function______________________
Enterocytes Responsible for absorbing and transporting nutrients across the
(absorptive cells) epithelium (Massey-Harroehe 2000).___________________________
^  1  ^ „ Secrete protective mucins and trefoil proteins that are required for theGoblet cells ^  i • r . . . A, . movement and effective expulsion of gut contents, provide
(mucus secre mg pj-Qtection against shear stress and chemical damage (Van Der Flier &
______ Clevers, 2009; Karam 1999)._________________________________
Enteroendocrine Control gut physiology by secreting a variety of hormones including
cells (hormone- serotonin, substance P and secretin (Schonhoff et al.2004; Barker et
secreting cells) al.2008)._________________________________________________
Secrete bactericidal defensin peptides and lysozymes, which play an
p , P important role in the control of the microbial environment of the
ane ce s small intestine (Porter et al. 2002; Barker et al.2008; Van Der Flier
_________________& Clevers, 2009).__________________________________________
1.3 Intestinal digestion and absorption of dietary lipids
Humans spend most of their time in the absorptive state. Typically, 90-95% of fat in 
the diet is provided by TAG (90-100 grams per day on the Western diet), with smaller 
contributions from phospholipids, cholesterol and other lipids (e.g., fat-soluble 
vitamins) (Iqbal & Hussain. 2009).
1.3.1 Digestion and absorption of dietary lipids
Along with the stomach, the small intestine is the major site of digestion and 
absorption of nutrients. This complex process involves both physicochemical and 
enzymatic processing.
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Lipid digestion and absorption largely depends on the émulsification of dietary lipids 
into micelles (4-6 nm in diameter). The émulsification of lipids is primarily due to the 
action of emulsifying agents known as bile salts, amphipathic molecules secreted 
from the gall bladder. When bile salts come into contact with a fat globule, their 
hydrophobic sides (non-polar portion) face inward (toward the hydrophobic droplet), 
and their hydrophilic sides (polar portion) face outwards to the aqueous intestinal 
contents, as shown in Figure 2 (Germann & Stanfield. 2005). This enables 
solubilisation.
Fat globule (nonpolar)
Water (polar)
Bile salts 
(amphipathic)
y iK, ’
Fat droplet Phospholipids
(nonpolar) - W \
2— Triglyceride 
W ater (polar)
Figure 2 Emulsification of a fat globule by bile salts (Germann & Stanfield. 2005).
Pancreatic lipase catalyses the hydrolysis of fatty acids from position 1 and position 3 
of TAG resulting in the production of fatty acids and 2-monoacylglycerol (2-MAG). 
Further hydrolysis of the 1-or 2-MAG results in the formation of glycerol and fatty 
acids (Iqbal & Hussain. 2009). MAG and PL are also amphipathic molecules and aid 
the émulsification process (Frayn 2010). The efficient hydrolysis of TAG is achieved 
as after a fatty meal, pancreatic lipase is secreted in a 100-fold excess compared to its
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needs (Caspary et al. 1992; Carey et al. 1983). Dietary PLs are hydrolyzed by 
activated pancreatic phospholipase A] yielding lysophospholipids and fatty acids. 
Cholesteryl esters are hydrolyzed by cholesterol esterase to liberate cholesterol and 
fatty acids (Gurr et al. 2002). Thus, mixed micelles are formed, which consists of bile 
salts, fatty acids, MAG and free cholesterol. These micelles are able to move readily 
through the aqueous intestinal contents and thus bring the hydrolysis products to the 
surface of the absorptive cells where they are absorbed (Frayn 2010).
Once within enterocytes, fatty acids, glycerol and MAG are re-esterified to form TAG; 
cholesterol is esterified to cholesteryl esters. Newly esterified TAG, cholesteryl esters 
and lipid-soluble vitamins are packaged with proteins synthesized in the enterocytes 
to form chylomierons (CM) (Frayn 2010).
Lipid digestion and absorption in the small intestine is summarized in Figure 3.
Bile
Bile sa lts  ------ -----------------
TAG
FA Micelles
Pancreatic  lipase m a g  Solubilization
PL FA,MAG,Glycerol
Re-esterlflcatlon ^
TAG
Hydrolysis Glycerol
(Lumen)
CHO,CE,| 
PL, apoB I
(Lumen) CM
(E nterocytes)
CM
(Blood) <-----
(Lymph)
Figure 3 Lipid digestion and absorption in the small intestine (Modified from Ros. 2000).
Abbreviations: TAG, triacylglycerols; apo, apolipoprotein; FA,fatty acid; MAG, 
monoacylglycerol; CM, chylomicron; CHO, cholesterol; CE, cholesteryl ester; PL, 
phospholipids.
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1.3.2 TAG synthesis pathway in enterocytes
Within the enterocytes, MAG lipase can lead to further hydrolysis of MAG to 
glycerol and fatty acids (Chon et al. 2007). TAG synthesis requires fatty acids and 
glycerol which are transformed into fatty acyl-CoA and glycerol-3-phosphate (G3P) 
respectively to be used as substrates for the synthesis of TAG.
There are two main pathways of TAG synthesis in small intestine in humans: the 
MAG synthesis pathway and the G3P synthesis pathway (Trotter & Storch. 1993a). 
The MAG and G3P pathways share a common final step, the conversion of 
diacylglycerol (DAG) to TAG, a reaction catalyzed by diacylglycerol acyltransferase 
(DGAT) (Figure 4).
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Long chain acyl-CoA sj-nthetase
fTa+CoA fa-CoA
( 1 )
2-nionoacylglycerol
MGAT 
Mono acylgly c e rol 
acyltransferase
fa-CoA
CoA
Diacylglycerol
Glucose ( 2 ) Glycerol
GPAT 
Glycerol 3 phosphate 
acyltransferase
Glycerol 3 phosphate
— — fa CoA
CoA
Lysophosphatidate
fa CoA 
CoA
Phosphatidate
DGAT
Diacylglycerol
acyltransferase
fa CoA
Diacylglycerol
fa CoA
CoA
1 erCT P: p ho sp ho c holim c jti dj-lyltransferase
PAP
Phosphatidate
phosphohydrolase
Triacylglycerol Phospholipids 
(e.g. phosphatidylcholine)
Figure 4 Pathway of TAG synthesis in the small intestine (1) MAG pathway; (2) G3P 
pathway (Modified from Trotter & Storch. 1993a).
Abbreviations: ffa, free fatty acid; fa-CoA, fatty acyl-Coenzyme A; MGAT, 
monoacylglycerol acyltransferase; DGAT,diacylglycerol acyltransferase;GPAT,glycerol-3- 
phosphate acyltransferase; PAP, phosphatidate phosphohydrolase.
1.3.2.1 Monoacylglycerol (MAG) pathway of TAG synthesis
The MAG pathway is primarily associated with the smooth endoplasmic reticulum 
(SER) (Lehner & Kuksis. 1996). This pathway begins with the acylation of MAG 
with a fatty acyl-CoA by monoacylglycerol acyltransferase (MGAT), generating 
DAG, followed by further acylation by DGAT to form TAG (Shi & Cheng. 2009).
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1.3.2.2 Glycerol-3-Phosphate (G3P) pathway of TAG synthesis
A second pathway to TAG synthesis is the G3P pathway, which is largely confined to 
the rough endoplasmic reticulum (RER) membranes (Lehner & Kuksis. 1996). In 
mice and in humans, the G3P pathway begins with the acylation of G3P with a fatty 
acyl-CoA by G3P acyltransferase (GPAT) (Cao et al. 2006), resulting in the 
production of lysophosphatidic acid (LPA), which is considered to be the rate-limiting 
step in TAG synthesis (Wendel et al. 2009), followed by further acylation and 
dephosphorylation to yield DAG. The last step is the conversion of DAG to TAG, 
catalyzed by DGAT, is the same step as in the MAG pathway.
Under normal conditions of lipid absorption in humans and rats, the MAG pathway 
accounts for approximately 80 % of TAG incorporated into CM; while the G3P 
pathway contributes about 20 % of CM TAG (Breckenridge & Kuksis. 1975; Kayden 
et al. 1967; Phan & Tso. 2001). When 2-MAG and fatty acids levels are low, the G3P 
pathway becomes a major route for the synthesis of TAG. Therefore the G3P 
pathway predominates during inter-prandial periods and fasting states in the small 
intestine (Small 1991; Thomson et al. 1993).
1.3.2.3 Diacylglycerol (DAG) pools
Although both pathways merge at the point of DAG synthesis, it is not known 
whether the DAG pools obtained fi'om the two pathways are separately located within 
the cell and therefore differentially incorporated into lipoprotein particles. There is 
evidence to suggest DAG fi'om each pathway enters separate intracellular pools, 
whereby DAG produced fi'om MAG is only acylated to form TAG and the DAG 
synthesized fiom G3P can either progress to TAG via a subsequent acylation step or 
can be utilized to form a phospholipid (Mansbach & Charles. 2009). These different
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metabolic fates for DAG suggest that the two pathways are physically separated on 
the enterocytes ER membrane (Mansbach & Charles. 2009; Storch et al. 2008).
1.3.2.4 Cytosolic TAG pool in enterocytes
Animals and human studies have suggested the presence of different cytosolic pools 
of TAG in enterocytes.
A series of in vivo experiments using radiolabelled trioleoylglycerol or oleate which 
was constantly infused intraduodenally into rats demonstrated that the TAG that 
appeared in the lymph had a specific activity that was greater than the specific activity 
of the TAG in the ER (Mansbach & Siddiqi. 2010). It was also shown that intestinal 
TAG synthesized from circulating fatty acids was not selected as a precursor of CM 
TAG (Mansbach & Siddiqi. 2010). Therefore these authors proposed that there may 
be at least two intracellular pools of TAG in enterocytes which are not in equilibrium. 
One pool is quickly transported from the intestine as CM TAG while the other is a 
storage pool (Mansbach & Parthasarathy. 1982; Mansbach & Dowell. 1992; 
Mansbach & Nevin. 1998). Sequential meal studies in humans showed that CM 
secreted after a second meal carried the main constituent of the first meal (Fielding et 
al. 1996; Jackson et al. 2002). This suggests that following a meal, TAG may be 
retained within the enterocytes. Further, Robertson and co-workers demonstrated that 
after fat ingestion, TAG was retained within enterocytes and glucose as the second 
meal could stimulate its secretion in the form of CM (Robertson et al. 2003). A more 
recent study directly visualized the presence of a dynamic, cytoplasmic TAG pool in 
mouse enterocytes of the small intestine during dietary fat absorption by coherent 
anti-Stokes Raman scattering (CARS) imaging (Zhu et al. 2009). This study provided
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evidence to show enterocytes are able to store TAG and raised the possibility of these 
pools regulating postprandial blood TAG concentrations.
The small intestine obtains lipids from two sources: ‘exogenous’ or dietary, which are 
substrates which come from the intestinal lumen following a dietary fat, and 
‘endogenous’, which are substrates taken-up by the basolateral surface of the 
enterocytes, primarily from the blood circulation.
Following their entry into enterocytes, dietary derived fatty acid and MAG are mainly 
re-synthesized to TAG by the MAG pathway; some glycerol and fatty acids are re­
synthesized to TAG by the G3P pathway in humans and in rats (Porter et al. 2007; 
Trevaskis et al. 2006). Dietary TAG formed by this pathway typically enters the ER 
lumen and is assembled into primordial CM and then transported to the Golgi, 
exocytosed from the enterocytes and taken-up into the intestinal lymphatic system; 
this pool of lipids is referred to as the lymph lipid precursor pool (Porter et al. 2007; 
Trevaskis et al. 2006; Trevaskis et al. 2011). Alternatively, TAG can be stored in a 
cytosolic pool. This lipid pool comprises mostly excess TAG formed by the G3P 
pathway, which is derived from basolaterally soureed endogenous lipids taken-up 
from the intestinal bloodstream in the form of either fatty acids (medium chain fatty 
acids: below 12-14 carbons) or CM remnants (Porter et al. 2007; Trevaskis et al. 
2011). These cytosolic lipids are subject to hydrolysis by intestinally expressed 
pancreatic lipase (Mahan et al. 2001). The hydrolyzed products formed, may be 
transported back to the ER and can be re-circulated into TAG assembly pathways or 
may be either incorporated into PL or oxidized within the enterocytes (Zhu et al. 2009; 
Porter et al. 2007).
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Figure 5 illustrates the cytosolie TAG pools within the enterocytes.
Apical
membrane ENTEROCYTE
Cytosolic 
lipids
E x o g e n o u s
(MAG&FA)
Basolateral
membrane
— ^  N Blood
t Circulation
Endogenous 
Basolateral lip idS’CM'
CM retnnants & fA }
FA
CM
\ FA
j CM 
FA
Lymph pool lipids
Intestinal
lymph
Figure 5 Illustration of the cytosolic TAG pools within the enterocytes (Modified from 
Trevaskis et al. 2011).
There are hypothesized to be at least two separate intracellular lipid pools present in 
enterocytes, one pool consists primarily of lipids derived from exogenous (e.g., dietary) 
sources. Lipids from this pool are predominantly transported to the systemic circulation via 
the mesenteric lymph; this pool is referred to lymph lipid precursor pool. The second pool of 
lipids (cytosolic storage pool) is located within the cytosol and comprises mostly endogenous 
lipids that enter the enterocytes via basolateral uptake from the intestinal blood. The lipids 
from the cytosolic pool can be re-circulated into TAG assembly pathways or may be either 
incorporated into PL or oxidized within the enterocytes. Abbreviations: FA, fatty acids; 
MAG, monoacylglycerol; CM, chylomicron; PL, phospholipid.
1.3.2.5 PL and PL metabolism in the small intestine
1.3.2.5.1 PL digestion
The normal dietary intake of PL is 2-8 grams per day, which represents 1-10 % of 
total daily fat intake (Cohn et al. 2010). The most common PL in food is 
phosphatidylcholine (PC) (i.e., lecithin). PC is derived not only from the diet but also 
from the bile. Other PLs, such as phosphatidylethanolamine (PE), phosphatidylserine 
(PS) and phosphatidylinositol (PI) are present in much smaller amounts (Cohn et 
al.2010; Cohn et al.2008). Sphingomyelin (SM), a phosphorus-containing lipid (more
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accurately classified as a sphingolipid) is ingested at a level of 0.3-0.4 grams per day 
(Cohn et al. 2010).
Dietary PC is almost completely absorbed (>90%) by the human intestine (Zierenberg 
& Grundy. 1982; Cohn et al. 2010). Other PLs, such as PE, PS and PI are also 
ingested (Cohn et al. 2008).
Pancreatic phospholipase A] (PEA]) hydrolyzes PL to yield fatty acids and 1- 
lysophospholipids (Carlier et al. 1991). The products are then incorporated into CM 
and transported into the circulation (Nilsson & Duan. 2006; Cohn et al. 2010; Field et 
al. 1994). A proportion of dietary PL is incorporated into HDL by the intestine 
(Krimbou et al. 2005; Magun et al. 1988; Wang et al. 2001).
1.3.2.5.2 PL synthesis pathway
In the last step of the G3P synthesis pathway in the small intestine, DAG is converted 
to TAG. DAG is also used as a substrate for the synthesis of PL, such as PC and PE 
(Shi & Cheng. 2009; Trotter & Storch. 1993a; Figure 6); this reaction is catalyzed by 
CTP: phosphocholine cytidylyltransferase (CT), which is thought to be the rate- 
limiting enzyme for “de novo” PL synthesis (Trotter & Storch. 1993a; Trotter & 
Storch. 1993b).
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Figure 6 Pathway of PL estérification in the intestine (Modified from Trotter & Storch. 
1993a).
Abbreviations: fa-CoA, fatty acyl-Coenzyme A; DGAT, diacylglycerol acyltransferase; 
GPAT, glycerol-3-phosphate acyltransferase; PAP, phosphatidate phosphohydrolase; CT, 
CTP: phosphocholine cytidylyltransferase; PC, phosphatidylcholine; PE, 
phosphatidylethanolamine.
1.3.2.5.3 PL metabolism
PLs play a vital role in lipoprotein absorption and secretion (Trotter & Storch. 1991; 
Trotter et al. 1996). It has been demonstrated that the metabolism of lipids appears to 
be regulated by the site from which luminal (apical) or bloodstream (basolateral) fatty 
acids are absorbed. Studies in rats and human jejunal biopsy samples showed fatty 
acids absorbed from the intestinal lumen were preferentially incorporated into TAG, 
whereas those absorbed from the bloodstream (basolateral side) were used primarily 
for incorporation into PL or oxidised (Gangl & Ockner.1975; Gangl & Renner. 1978). 
Studies in an in vitro human intestinal cell line (Caco2) have confirmed and further 
shown that there is greater incorporation of fatty acids to TAG relative to PL for
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apically derived as opposed to basolaterally loaded fatty acids (Trotter & Storch. 1991; 
Trotter et al. 1996). Studies in Caco2 cell line also found the enzymes DGAT and CT 
which are rate-limiting at the DAG branch point of the G3P pathway, may play 
important roles in regulating the metabolic fate of fatty acids (Trotter & Storch. 
1993a). The change in DGAT and CT activity coincided with the change in TAG: PC 
ratio observed during Caco2 cell differentiation, suggesting a regulatory role of the 
DAG branch point of the G3P synthesis pathway (Trotter & Storch. 1993a).
1.4 Overview of the pathways of lipoprotein metabolism
1.4.1 Chemical characteristics of lipoproteins and apolipoproteins
The transport of both TAG and cholesterol requires specialized macromolecular 
structures known as lipoproteins. Lipoproteins have a hydrophobic core containing 
TAG and cholesteryl ester, and an outer surface monolayer of phospholipids and free 
cholesterol (Figure 7).
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Figure 7 A typical structure of lipoproteins.
The hydrophobic core consists of cholesteryl ester and triacylglyceorl. The relatively 
hydrophilic surface is composed of free cholesterol and phospholipids (Frayn 2010).
34
Based on their density, lipoproteins are classified as CM, very low density lipoprotein 
(VLDL), intermediate density lipoprotein (IDL), low density lipoprotein (LDL) and 
high density lipoprotein (HDL). CM and VLDL particles are relatively rich in TAG 
and are often grouped as the triacylglycerol-rich-lipoproteins (TRL), which are 
mainly involved in the delivery of TAG to tissues (Gurr 2002).
Each lipoprotein particle is associated with different apolipoproteins (Table 2), which 
stabilize the lipid particles and maintain their structural integrity and also play an 
essential role of ‘identifying’ the lipoprotein and directing its metabolism in a specific 
way (Gurr 2002).
Table 2 Characteristics of the major lipoproteins
Lipoprotein Density(g/ml)
Diameter
(nm) Major lipids
Major
apolipoprotein
%TAG
composition
%PL
composition
CM <0.950 80-1000 Dietary TAG B48,A-I,A-IV,C,E 90 4
VLDL 0.950-1.006 30-80 EndogenousTAG B100,C,E 65 13
LDL 1.019-1.063 20-25 Cholesterol and CE BlOO 10 23
HDL 1.063-1.210 9-15 CE and PL A-I,A-II ,C,E 2 30
Abbreviations: TAG, triacylglycerol; PL, phospholipids; CM, chylomicron; CE, cholesteryl 
ester ; VLDL, very low density lipoproteins; IDL, intermediate density lipoproteins; LDL, 
low density lipoproteins; HDL, high density lipoproteins (Frayn 2010).
1.4.2 CM metabolism -  the exogenous pathway
CMs are the largest, least dense of the lipoproteins. They consists of a core of TAG 
and cholesteryl ester, with a surface of unesterified cholesterol and PLs, 
apolipoproteinB 48 (apoB 48), apolipoprotein A-I (apoA-I) and apolipoprotein A-IV 
(apo A-IV) (Van Greevenbroek & De Bruin. 1998). ApoB48 is the major structural 
component of CM, and is necessary for the synthesis and secretion of this intestinal 
lipoprotein (Glickman et al. 1986).
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The metabolism of CM is often referred to as the exogenous pathway of lipoprotein 
metabolism as it transports dietary lipids (Figure 8). CMs are assembled with apoB48 
in the small intestine and secreted into the lymph. In the circulation, CMs undergo 
hydrolysis by lipoprotein lipase (LPL) located on the surface of capillary walls of 
tissues which releases fatty acids for uptake by muscle and adipose tissue. Lipase 
action is activated by apolipoprotein CII (apo CII), one of the apolipoproteins present 
on the surface of CM particles. During this process, apoA-I and apo A-IV are 
transferred to HDL, and TAG is transferred to HDL in exchange for cholesteryl ester 
via the action of cholesteryl ester transfer protein (CETP). As the CM particle shrinks, 
apo Cn is also transferred to HDL (Frayn 2010). Successive rounds of hydrolysis 
eventually lead to the production of a smaller CM remnant particle that is taken-up by 
receptors in the liver.
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Figure 8 The exogenous pathway of lipoprotein metabolism.
CMs are assembled with apoB48 in the small intestine and transport TAG to other tissues. 
The particles pass through several cycles of hydrolysis by LPL in capillary beds, reducing in 
size each time to produce CM remnants which are taken up by specific receptors in the liver. 
Abbreviations: Apo, apolipoprotein; TAG, triacylglycerol; FA, fatty acids; LPL, lipoprotein 
lipase; CM, chylomicron.
1.4.2.1 CM assembly
The assembly of CM in intestinal enterocytes involves two steps: the first step 
involves the synthesis of apoB48 in the RER and its movement as a membrane 
component to the SER where co-translational lipidation of apoB48 to form a 
‘primordial lipoprotein’ take place. This protects the protein from early intracellular 
degradation and results in the formation of a primordial intracellular lipoprotein 
(Mahmood Hussain et al. 1996). In the second step, the primordial lipoprotein fuses 
with TAG lipid droplets (a process referred to as core expansion) controlled by
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microsomal TAG transfer protein (MTP) (Cartwright et al. 2000). The developing 
CM must be transported from the ER to the Golgi using a specialized vesicular 
compartment called the prechylomicron transport vesicle (PCTV) before its 
basolateral secretion, which is proposed to be a rate-limiting step (Cartwright & 
Higgins. 2001). After final processing in the Golgi, the mature CM is secreted via the 
basolateral membrane. ApoB48 is formed by post-translational truncation of 
apolipoproteinB 100 (apoBlOO) in enterocytes (Mardani et al. 2011).
1.4.3 VLDL metabolism -  the endogenous pathway
VLDL particles have a surface coat of PL and unesterified cholesterol. The content of 
apo E and C quickly increases in the plasma, by transfer from other lipoproteins, 
mainly HDL (Frayn 2010). Each VLDL particle contains one molecule of apoBlOO. 
ApoBlOO is a very large complex protein. It is the essential apolipoprotein present in 
VLDL, IDL and LDL with one molecule present on each particle (Ginsberg & Fisher. 
2009).
The endogenous pathway of lipoprotein metabolism distributes TAG from the liver to 
other tissues thereby distributing energy in the form of lipids in the non-fed state. 
TAG in VLDL particles, secreted by the liver serves as a substrate for LPL. The 
particles also contain cholesteryl ester. The hydrolysis of TAG is facilitated by 
apoCll and inhibited by apolipoprotein Clll (apo Clll) as apoCll is an essential 
activator of LPL whereas apoClll inhibits LPL (Frayn 2010). VLDL undergoes a 
sequential hydrolysis to form IDL and LDL. LDL can be taken up by LDL receptors 
in most tissues (Figure 9).
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Figure 9 The endogenous pathway of lipoprotein metabolism.
VLDL is assembled with apoBlOO in the liver and is secreted into the blood. TAG is 
hydrolysis by LPL. VLDL undergoes hydrolysis to fonn IDL and LDL. LDL can be taken up 
by LDL receptors. Abbreviations: Apo, apolipoprotein; TAG, triacylglycerol; FA, fatty acids; 
LPL, lipoprotein lipase; VLDL, very low density lipoproteins; IDL, intermediate density 
lipoproteins; LDL, low density lipoproteins.
1.4.3.1 VLDL assembly
A two-step model for the assembly of VLDL has been proposed. In the first step, 
apoBlOO is eo-translationally lipidated by MTP in the RER to form primordial pre- 
VLDL particles (Boren et al. 1992; Rustaeus et al. 1998).
The second step involves the formation of the mature, TAG-rich VLDL. Pre-VLDL 
is converted to a TAG -poor VLDL partiele by additional lipidation; the TAG -poor 
VLDL particle can either be secreted from the cell as VLDL] or further lipidated to 
form a mature, TAG-rich VLDL (i.e. VLDLi ) (Stillemark et al. 2000; Stillemark- 
Billton et al. 2005). The late step of VLDL formation occurs in the Golgi apparatus
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(Stillemark et al. 2000; Gusarova et al. 2007). Rate-limiting steps in VLDL assembly 
include the movement of apoBlOO to the RER lumen and the formation of TAG-rieh 
particles (Tran et al. 2002).
1.5 Glycerol and glycerol transport in the small intestine
1.5.1 Characteristics and functions of glycerol
Glycerol is a small, simple, ubiquitous, uncharged, hydrophilic molecule, which is a 
naturally occurring 3-carbon alcohol in the human body (Robergs & Griffin. 1998). 
(Figure 10).
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Figure 10 Glycerol structure.
Glyeerol acts as the structural backbone of TAG moleeules and is highly involved in a 
variety of important physiological processes. Glyeerol is a preeursor for the synthesis 
of TAG and of PL in the liver, adipose tissue and small intestine. After uptake, 
glycerol is irreversibly eonverted by glycerol kinase (GK) to G3P. In mammals, GK 
has mainly been identified in liver, kidney, adipose, muscle tissues and in the intestine 
(Lin 1977; Wuensch & Ray. 1997). Glycerol acts as an intermediate in lipolysis, a 
proeess of lipid breakdown to release fatty aeids. Glycerol is also one of the 
precursors for gluconeogenesis, a process of synthesis of glucose from non­
carbohydrate substrates. Glyeerol formed by lipolysis is phosphorylated and oxidized 
to dihydroxyacetone phosphate (DHAP) which in turn is isomerized to
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glyceraldehyde 3-phosphate (Figure 11). This is an intermediate of both the 
glycolytic and the glueoneogenic pathways. Thus, glycerol can be converted into 
pyruvate or glueose in the liver. The reverse process can occur by the reduction of 
DHAP to G3P. Hydrolysis by a phosphatase produces glycerol. Thus, glyeerol and 
glycolytic intermediates are readily interconvertible (Stryer 1995).
CHzOH CH,OH CH,OH
H O — CH  H O — C — H ---- ^ lÿcW --^  0  = C
I I Phosphate |
CH^ OH CH^ OPOg^  dehydrogenase CH^ OPOg^
Glycerol L-Glycerol Dihydroxyacetone
3-phosphate phosphate
Figure 11 The conversion between glycerol and dihydroxyacetone phosphate (DHAP) 
(Stryer 1995).
The small intestine is now considered a gluconeogenie organ, the main precursors are 
glutamine, and to a lesser extent, glyeerol in the rat (Croset et al. 2001). Glueose-6- 
phosphatase, which catalyses the dephosphorylation of glueose-6-phosphate to 
glucose, is expressed in human and rat small intestine (Rajas et al. 1999).
1.5.2 Transport of glycerol
Two pathways, the paraeellular and transeellular, have been suggested for the 
transport of molecules across the epithelium of the gastrointestinal traet. The 
paraeellular route involves diffusion through the extraeellular spaces between cells; 
and the transeellular route involves erossing the apical and basolateral membranes of 
the epithelial cells (Widmaier et al. 2006; Laforenza et al. 2009).
Based on a series of in vitro studies using the rat jejunum and colon (Sawada et al. 
1991; Tomita et al. 1992), it has hypothesized that passive diffusion via the 
paraeellular route is the principal transport mechanism for the intestinal absorption of
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glycerol. However, more recent data support a role for aquaporins (AQPs) in 
transeellular water and glycerol transport. These enable the rapid and substantial 
movement of water soluble molecules across the epithelium of the gastrointestinal 
tract (Verkman & Mitra. 2000; Fujiyoshi et al. 2002).
1.5.2.1 Aquaporins (AQPs)
Aquaporins (AQPs) are a family of small (~30kDa), hydrophobic, integral membrane 
proteins that funetion as water-permeable ehannels. They are widely distributed in 
plants, unicellular organisms, invertebrates and vertebrates. To date, 13 mammalian 
AQPs have been identified (AQPO-12) (Hibuse et al. 2006). AQP3, 7, 9, and 10 are 
termed aquaglyceroporins as they are potentially involved in the facilitated movement 
of glyeerol as well as water, urea and other small solutes through cell membranes 
(Verkman & Mitra. 2000; Fujiyoshi et al. 2002). However, the physiologieal 
significance and fiinction of AQPs and aquaglyeeroporins is yet not fully understood.
1.5.2.1.1 AQP in the digestive tract
AQPs are expressed in a tissue-specific manner. Reeent findings have shown the 
presence of several types of AQP (AQP3, 4, 6, 7, 8 and 10) in the epithelial cells of 
the gastrointestinal tract, which might suggest a potential contribution of AQPs to the 
water and glycerol movement across the epithelium in the small intestine. The AQPs 
in the gastrointestinal tract and their tissue profile are showed below.
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Table 3 AQPs in the gastrointestinal tract
AQP Location Function
Basolateral membrane of the epithelial
AQP3 cells lining the villus tip of the small intestine and colon in rats (Koyama et 
al. 1999; Ramirez-Lorca et al. 1999).
AQP3-facilitated water and glycerol 
transport (Yang & Verkman 1997; 
Meinild et al. 1998).
Basolateral membrane of basal
AQP4 intestinal crypt gland cells in the small 
intestine of rats (Koyama et al. 1999)
Water and other small solutes transport
Apieal membrane domain of the
AQP6 superficial epithelial cells of the small 
intestine (Laforenza et al. 2009)
Water and other small solutes transport
Apical membrane domain of the
AQP7 superficial cells of the rat gastrointestinal epithelium (Laforenza 
et al. 2005).
Water and glyeerol transport
AQPS Apical membrane of jejunum and colon epithelial cells (Tani et al. 2001). Water and other small solutes transport
AQPIO Apical membrane of the absorptive cells of the human ileum
Small intestine-specific glycerol 
channel; an entry pathway for water, 
glycerol and other small solutes 
(Mobasheri et al. 2004)
Among them, AQP3, 7 and 10 are aquaglyceroporins. Abbreviations: AQP: aquaporins.
It has been postulated that water may pass through the apical membrane of the 
absorptive epithelia mainly by AQP 10 and partly through AQP8, AQP6 or AQP7 and 
the basolateral membrane through AQP3 or AQP4; glyeerol may cross the apical 
membrane of the absorptive epithelia through AQP 10 (human) or AQP7 (rat), and the 
basolateral membrane through AQP3 (Hatakeyama et al.2001; Laforenza et al.2005; 
Laforenza et al.2009).
Thus, a working model for aquaglyceroporins - mediated glyeerol transport has been 
proposed based on this evidenee (Figure 12).
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Figure 12 A working model for aquaglyceroporins - mediated glycerol transport.
It summarizes the known AQPs and the transeellular AQP mediated glycerol movement in 
enterocytes (Figure drawed according to Hatakeyama et al.2001; Laforenza et al.2005; 
Laforenza et al.2009). Abbreviations: AQP: aquaporins.
1.6 The membrane and intracellular proteins involved in intestinal 
fatty acid transport
1.6.1 Membrane proteins
Membrane proteins that have been proposed as potential intestinal fatty acid 
transporters include Fatty Acid Translocase (FAT)/ Cluster of Differentiation 36 
(FAT /CD36), fatty acid transport protein 4 (FATP4) and the plasma membrane fatty 
acid binding protein (FABPpm). These have all been implicated to play an essential 
role in apical membrane uptake of fatty acids and the other lipid products from the 
intestinal lumen into the enterocytes (Trevaskis et al. 2008).
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FAT/CD36 is highly expressed in the intestine and localizes to the apical membrane 
of enterocytes of humans and mice. Its expression is elevated by the presence of 
dietary fat and has been shown to play a crucial role in the uptake of fatty acids and 
intestinal lipid absorption (Chen et al. 2001; Lobo et al. 2001; Poirier et al. 1996). 
Studies in primary enterocytes isolated from the proximal intestine of CD36 null mice 
showed a 50 % reduction in fatty acids uptake as compared to enterocytes from wild 
type mice (Nassir et al. 2007).
The FAT? family represents a group of membrane-associated proteins with a 
molecular weight of 63 kDa. The FATP4 isoform is predominately localized to the 
apical side of enterocytes in human and mice and is essentially involved in fatty acid 
uptake by enterocytes (Ehehalt et al. 2006; Stahl et al. 1999).
FABPpm is a 40 kDa protein found in various organs including the small intestine. 
Immunocytochemical studies have demonstrated that FABPpm is expressed in the 
apical tips of the brush-border villus and crypt of the jejunum and ileum in human and 
in rats (Stremmel et al. 1985; Wang et al. 2005).
1.6.2 Cytoplasmic fatty acid binding proteins (FABPc)
Once fatty acids are inside the cells, they are bound by FABPc, which may aid or 
direct movement through the cytosol.
It is known that there are high concentrations of two types of FABPc in enterocytes— 
liver FABP (L-FABP) and intestinal FABP (I-FABP) (Bass 1985; Shields et al. 1986). 
I-FABP is mainly expressed in the villus tips and targets the delivery of fatty acids 
from the brush-border membrane to specific sites of lipid metabolism, while L-FABP
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is localized more deeply in the crypts in rat (Shields et al. 1986). Both I- FABP and 
L-FABP expression inereases following incubation of fatty acids with Caco2 cells 
(Dube et al. 2001). However, in mice, fat feeding for 7 days increased only L-FABP, 
not I-FABP (Poirier et al. 1997).
Not all fatty acids are re-esterified to form TAG. Those with a shorter chain length 
(below 12-14 carbons) can enter the capillary plasma directly in the form of non- 
esterified fatty acids (NEFA) (Frayn 2010). Most of the dietary fatty acids are long 
chain (16 carbons upwards) and enter the bloodstream as CM-TAG.
The membrane and intraeellular proteins involved in intestinal fatty acids transport 
are showed in Figure 13.
Apical membrane 
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Cytoplasmic 
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Figure 13 The membrane and intracellular proteins involved in intestinal fatty acids 
transport.
A schematic which summarizes the lipid transporters and binding proteins that have been 
implicated in the uptake and transport of fatty acids across intestinal epithelial cells 
(Modified from Trevaskis et al. 2008). Abbreviations: CD36, Cluster of Differentiation 36; 
FATP4, fatty acid transport protein 4; FABPpm, plasma membrane fatty acid binding protein; 
L-FABP, liver fatty acid binding protein; I-FABP, intestinal fatty acid binding protein.
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1.7 Metabolic events of the absorptive and postabsorptive state
1.7.1 General description of metabolic events during the absorptive period 
(postprandial) and postabsorptive (fasting) state
In the absorptive state ingested nutrients enter the blood from the gastrointestinal tract. 
After a meal, synthesis of glycogen, TAG and protein oecurs. The major metabolic 
events during the absorptive period are shown in Figure 14.
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Figure 14 Illustration of major metabolic pathways in the absorptive state.
All arrows between boxes represent transport of metabolites via the blood (Widmaier et al. 
2006). Carbohydrates: Glucose is converted to glycogen (glycogenesis) in liver and skeletal 
muscle for storage. Some glucose is converted to fatty acid and synthesised to TAG in liver, 
which is transported to adipose tissue by lipoproteins. In adipose tissue, glucose is converted 
to TAG for storage. In body cells, glucose undergoes oxidation for energy. Lipid: TAG is 
synthesized from ingested lipids and glucose by adipocytes; TAG synthesized in the liver is 
transported to adipose tissue for storage. Absorbed TAG is transported to adipose tissue by 
CM. Amino acids:In all cells type, amino acids are used for protein synthesis. In liver, some 
amino acids can be converted to keto acids for energy production or TAG synthesis. TAG is 
then transported to adipose tissue by lipoproteins (Gennann & Stanfield. 2005; Gropper et al. 
2008). Abbreviations: VLDL, very low density lipoproteins; CM, chylomicron. Energy=ATP.
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The postabsorptive or fasting state corresponds to the time between meals when 
nutrients are not being absorbed, and the body’s own stores must supply energy 
(Widmaier et al. 2006). In the postabsorptive state, catabolism of glycogen, lipid and 
protein begin to occur. The major metabolic events during the postabsorptive states 
are shown in Figure 15.
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Figure 15 Illustration of major metabolic pathways in the postabsorptive state.
All arrows between boxes represent transport of metabolites via the blood (Widmaier et al. 
2006). Carbohydrates: In liver, glycogen is catabolised to glucose (glycogenolysis) and new 
glucose is formed from non-carbohydrate precursors (gluconeogenesis) from lactate, pyruvate, 
glycerol and amino acids; glucose is then transported into the bloodstream for uptake and 
utilization for other tissues and to help maintain blood glucose level. In muscle, glycogen is 
catabolised to glucose-6-phosphate, which can be used by the muscle cells for energy. Lipid: 
In adipose tissue, TAG is hydrolysed to fatty acids and glycerol (lipolysis), which enters the 
bloodstream. Glycerol travels to the liver, where it is converted to glucose (gluconeogenesis). 
Fatty acids enter the bloodstream and provide the primary energy source for most body cells. 
In liver, fatty acids are converted to ketones. TAG continues to be produced from liver in the 
fasting state. Amino acids: In muscle, some proteins are catabolised to amino acids, which 
are transported to the liver for gluconeogenesis. The brain continues to use glucose but also 
starts using ketones as they build up in the blood (Gennann & Stanfield. 2005; Gropper et al. 
2008).
1.7.2 Regulation of absorptive and postabsorptive metabolism
Insulin and glucagon are two peptide hormones secreted by the pancreatic islets of 
Langerhans and are the two most important factors that control the metabolic
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adjustment between the absorptive and postabsorptive state (Widmaier et al. 2006; 
Germann & Stanfield. 2005). Insulin promotes the anabolic pathways of the 
absorptive state and suppresses the catabolic pathways of the postabsorptive state. 
Contrarily, glucagon secretion decreases during the absorptive state and increases 
during the postabsorptive state (Widmaier et al. 2006; Germann & Stanfield. 2005). 
The metabolic effects of insulin are showed in Table 4.
Table 4 Overview of target tissue responses to an increase or decrease in the plasma
concentration of insulin
Plasma insulin increase Plasma insulin decrease
Muscle
Glucose uptake and utilization 
increase(glycogen synthesis, 
amino acid uptake, protein 
synthesis)
Glucose uptake and utilization 
decrease(glycogen catabolism, protein 
catabolism, amino acid release, fatty acid 
uptake and utilization)
Adipocytes
Glucose uptake and utilization 
increase(TAG synthesis)
LPL activity increases
Glucose uptake and utilization decrease(TAG 
catabolism and release o f glycerol and fatty 
acids)
Liver
Decrease in glucose release 
(glycogen synthesis, TAG 
synthesis, No ketone synthesis)
Glucose release increases due to glycogen 
catabolism and gluconeogenesis; Ketone 
synthesis and release
(Modified from Widmaier et al. 2006; Germann & Stanfield. 2005).
The metabolic effects of insulin are mainly on skeletal muscle, adipose tissue and 
liver. The insulin signalling pathway is shown below (Figure 16).
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Figure 16 Schematic diagrams illustrating the effects of insulin at the cellular level.
Insulin binds to its receptor and activates insulin receptor substrate (IRS)-l by 
phosphorylation of tyrosine residues. This, in turn, activates phosphatidylinositol 3-kinase 
(PI-3K) and protein kinase B (PKB), resulting in translocation of glucose transporter 4 
(GLUT4) to the plasma membrane, increased glucose transport into the cell and inhibition of 
lipolysis (in adipose and muscle). Insulin also can activate the mitogen activated protein 
kinase (MAPK) pathway. These pathways act in a coordinated way to regulate glucose, lipid 
and protein metabolism (Modified from DeFronzo 2006).
1.8 Evidence for the role of fasting and postprandial 
hypertriacylglycerolaemia in atherosclerosis and insulin resistance
1.8.1 Evidence linking fasting and postprandial elevated plasma TAG levels with 
cardiovascular disease
High levels of plasma TAG are associated with an increased risk of cardiovascular 
disease (CVD) (Austin 1998). Hypertriacylglycerolaemia signifies the presence of 
excess TRL, which consist of VLDL and CM. A meta-analysis of 17 prospective 
population-based studies found fasting TAG levels to be an independent risk factor 
for CVD for both men and women in the general population (Hokanson & Austin. 
1996).
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However, humans are in the absorptive (fed) state 16-18 h per day, and there is 
emerging evidence to show that postprandial hypertriacylglycerolaemia may play a 
more important role than fasting hypertriacylglycerolaemia in atherosclerosis. It is 
now 33 years since Zilversmit originally proposed his hypothesis that atherogenesis 
was a “postprandial phenomenon” (Zilversmit 1979). Indeed, in a case-control study, 
Patsch et al. (1992) showed that postprandial levels of TAG posed a significant 
increase in atherogenic risk; the results were consistent with the concept of 
atherosclerosis as a postprandial disorder. In a large-scale, prospective study, Bansal 
et al. (2007) also showed postprandial hypertriacylglycerolaemia was strongly 
associated with an increased risk of future cardiovascular events. The results indicate 
that postprandial TAG levels may be superior to fasting levels for evaluation of 
cardiovascular risk.
Many studies have shown that postprandial hypertriacylglycerolaemia is linked with 
endothelial dysfunction, oxidative stress, foam cell formation and eventually 
atherosclerosis (Ginsberg 2002; Fujioka & Ishikawa.2009; Bansal et al.2007). During 
the postprandial state CM and VLDL compete for LPL-mediated hydrolysis (Cohn et 
al. 1990; Bjôrkegren et al. 1996; Karpe et al. 1997). Delayed clearance of TRL may 
also increase atherosclerosis (Avramoglu et al. 2006; Ginsberg 2002).
1.8.2 The contribution of endogenous TAG and exogenous TAG to the metabolic 
hypertriacylglycerolaemia in insulin resistant states
Insulin resistance, which represents a reduced physiological response of the liver and 
peripheral tissues to the action of the normal levels of insulin, is the prominent feature 
of type 2 diabetes and obesity. Hypertriacylglycerolaemia is the most common lipid 
abnormality in an insulin resistance state. It has been shown that postprandial
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hypertriacylglycerolaemia is more prevalent in individuals with type 2 diabetes, 
obesity, or other conditions characterized by insulin resistance, and contributes to the 
increased risk of atherosclerosis (Chen et al. 1993; Syvânne & Taskinen. 1997; 
Schaefer et al. 2002; Lewis et al. 1990; Rivellese et al. 2004). Both the endogenous 
TAG and exogenous TAG contribute to the postprandial metabolic 
hypertriacylglycerolaemia in insulin resistant states. A pathological increase of TAG 
following a meal in insulin resistant states may be due to the overproduction of 
endogenous or exogenous TRLs, or impaired clearance or a combination of both 
(Figure 17).
Figure 17 Postprandial metabolic hypertriacylglycerolaemia in insulin resistant states 
(Avramoglu et al. 2006).
Insulin resistance causes enhanced lipolysis by adipocytes resulting in increased NEFA flux 
to peripheral tissues including liver and the intestine. The increase in NEFA can further 
attenuate insulin signalling and exacerbate insulin resistance which combined with hepatic 
and intestinal insulin resistance stimulates overproduction of both hepatically- and 
intestinally-derived apoB-eontaining lipoprotein particles which cause fasting and 
postprandial metabolic hypertriacylglycerolaem ia. Impaired clearance of endogenous or 
exogenous TRLs will also contribute to hypertriacylglycerolaem ia in insulin resistant states.
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1.8.2.1 The contribution of endogenous TAG to the metabolic 
hypertriacylglycerolaemia in insulin resistant states
In the liver, insulin inhibits VLDL production and secretion. Overproduction of 
hepatic VLDL is associated with insulin resistance; during which there is a reduced 
sensitivity to the inhibitory action of insulin on apoB synthesis and degradation in 
hepatocytes (Avramoglu et al. 2003). Hepatic lipid abnormalities in the insulin 
resistant state may be partly accounted by an increased flux of NEFA from adipose 
tissue to the liver and increased dietary NEFA transported via CM (Adiels et al. 2008). 
The enhanced flux of NEFA from adipose tissue to other tissues including the liver is 
due to the failure of insulin to suppress hormone sensitive lipase (HSL), the rate- 
limiting enzyme for adipose tissue TAG mobilization (Meshkani & Adeli 2009). It 
has been shown that hepatic production of apoB 100-containing lipoproteins is 
stimulated by a short-term elevation of plasma NEFA in healthy humans (Duez et al. 
2008). Increased NEFA can also activate de novo lipogenesis (DNL, the synthesis of 
new fatty acids and TAG from substrates other than lipids-particularly glucose) 
through activating sterol regulatory element binding protein (SREBP-lc), a key 
lipogenic transcription factor, resulting in overproduction of VLDL (Lewis et al. 
2002).
Furthermore, increased NEFA levels can attenuate insulin signalling and aggravate 
insulin resistance. Impaired hepatic insulin signalling is well documented in insulin 
resistant states, this results in decreased phosphorylation of insulin receptor substrate 
(IRS)-l and IRS-2, as well as Akt and reduced phosphatidylinositol 3-kinase (PI-3K) 
activity; increased protein-tyrosine phosphatase IB (FTP-IB) levels, the main 
negative regulator of insulin signalling and an up-regulation of SREBP-lc (Adeli et al.
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2001; Taghibiglou et al. 2002; Shimomura et al. 2000). In addition, some 
intracellular metabolites of NEFA, ceramides and diacylglycerol also attenuate the 
insulin signalling pathway (Holland et al. 2007).
MTP may play a role in the increased assembly of VLDL in the insulin resistant states. 
The hepatic expression of MTP is increased in the obese and hyperlipidaemic rat 
(Kuriyama et al. 1998), obese diabetic mice (Bartels et al. 2002) and insulin resistant 
hamsters (Taghibiglou et al. 2000).
1.8.2.2 The contribution of exogenous TAG to the metabolic 
hypertriacylglycerolaemia in insulin resistant states
Emerging data from animal and human models have shown that increased intestinal 
apoB48-containing lipoprotein production is closely linked with insulin resistance. 
Haidari and colleagues have demonstrated the overproduction of intestinal apoB48- 
containing lipoproteins in both fasting and fed states in a chronic fructose-induced 
insulin resistant, hypertriacylglycerolaemia model of the Syrian golden hamster. This 
was associated with increased MTP mass and activity and enhanced lipoprotein 
assembly and secretion (Haidari et al. 2002). It has also been shown that intestinal 
apoB48-containing TRL production rate is increased in hyperinsulinaemic, insulin- 
resistant humans (Duez et al. 2006). Treatment of insulin resistant hamsters with 
rosiglitazone, a member of the thiazolidinedione class of insulin sensitizers with 
specific peroxisome proliferator-activated receptor gamma (PPAR- y) agonist activity, 
improved whole body insulin sensitivity and reduced intestinally-derived apoB48- 
containing lipoprotein secretion as well as reducing MTP expression in primary 
cultured enterocytes (Lewis et al. 2005; Leung et al. 2004).
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A recent study in the fructose-fed Syrian golden hamster model of insulin resistance 
has shown that these hamsters are unresponsive to the inhibitory effects of insulin on 
apoB48-containing lipoproteins. Freshly isolated enterocytes from the insulin- 
resistant hamster have aberrant intestinal insulin signalling, that is, decreased IRS-1 
and Akt phosphorylation, increased FTP-IB protein and activation of extracellular 
signal-related kinase-1/2 (ERK-1/2) (member of the MAPK signalling) (Federico et al. 
2006). Psammomys obesus is a rodent models of nutritionally-induced insulin 
resistance that oversecrets CMs. This rodent has increased rates of de novo 
lipogenesis, apoB48 biogenesis, MGAT and DGAT activity (Zoltowska et al. 2003). 
Insulin resistance is associated with elevated NEFA flux from adipose tissue which 
might lead to stimulation of intestinal derived lipoproteins. Metabolic studies have 
shown that intestinal lipoprotein production is markedly stimulated by an acute 
elevation of plasma fatty acids in insulin-sensitive hamsters (Lewis et al. 2004) as 
well as in healthy humans (Duez et al. 2008).
1.9 Measurement of endogenous and exogenous TAG kinetics in the 
fed state
1.9.1 General tracer theory and practice in the study of TAG kinetics
The term ‘tracee’ is defined as the substance of interest, for example glycerol, to be 
traced kinetically. A ‘tracer’ is a labelled substance, for example stable isotopically 
labelled glycerol, introduced into the ‘system’ (i.e. the body) to infer information 
about the kinetics of the tracee (Chan et al. 2004). Ideally, a tracer should have the 
same physical, chemical and biological properties as the tracee and should be 
uniformly mixed with the tracee. The tracer can exactly reflect the tracee’s 
movements in vivo, but should not perturb the state of the system (Pont et al. 1998).
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Isotopically labelled glycerol or fatty acid can be administered (typically by injecting 
or infusing intravenously, or giving orally) to trace the metabolism of TAG. The 
glycerol or fatty acid serves as a precursor for the synthesis of TAG molecules which 
become integrated into lipoprotein particles. By taking repeated blood samples over 
many hours after administration of the tracer and measuring the glycerol or fatty acid 
enrichment of the TAG isolated from lipoproteins, the production and clearance rates 
of TAG in TRL can be calculated (Sun et al. 2007).
Mass spectrometry (MS) can separate and measure compounds according to 
molecular mass and so can detect and quantify stable isotope tracers. These are 
measured as a tracer-to-tracee ratio (TTR), which is also referred to as the enrichment 
of the compound (Pont et al. 1998).
1.9.2 Previous studies of endogenous and exogenous TAG kinetics
Stable isotopically labelled tracers are widely used to study the kinetics of lipids and 
lipoproteins in humans, and can provide a quantitative understanding of the dynamics 
of these metabolic processes in vivo (Magkos & Mittendorfer. 2009; Marsh et al. 
2003).
The methodological determination of VLDL kinetics using isotopes is well described. 
Kinetic studies have mostly focused on apoBlOO, an integral constituent of the 
lipoprotein that remains with the particle during secretion to its clearance from plasma 
(Hugh & Barrett. 1998). ApoB48 also remains an integral component of CM particles 
from biosynthesis until clearance. It is believed to reflect the metabolism of intestinal 
lipoproteins and it is a suitable maker for CMs and their remnants in plasma (Welty et 
al. 1999). However, these methods measure particle kinetics rather than TAG kinetics.
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1.9.2.1 Measurement of TAG kinetics in the fasted state
In the fasting state, plasma TAG is principally within endogenously derived TRL, the 
VLDL. Lemieux et al. (1999) compared VLDL TAG kinetics measured with the 
stable isotope [^Hs] glycerol to the radioactive isotope [^Hs] glycerol and 
demonstrated that [^Hs] glycerol given as a bolus is a safer, more convenient method 
which required a short duration to measure VLDL TAG kinetics. Subsequently, 
Patterson et al. (2002) compared an intravenous bolus of [^Hg] glycerol to an 
intravenous bolus of either [1-^^C] palmitate or [2, 2 -^H2 ] palmitate as well as a 
constant infusion of [2, 2-^H2] palmitate tracer. This study showed that a bolus 
injection of [^Hs] glycerol has several advantages over the other tracer techniques. 
There is less recycling of palmitate than glycerol. Thus, an intravenous bolus of [^Hs] 
glycerol is considered to be the most convenient, precise and safest method which can 
be used to measure VLDL-TAG kinetics in the fasted state in humans (Lemieux et al. 
1999; Patterson et al. 2002; Adiels et al. 2005a; Adiels et al. 2005b).
1.9.2.2 Achieving steady state TAG concentrations in the fed state
A difficulty which has hampered TAG kinetic measurements in the fed state is that it 
is not a steady state condition. For isotopic quantitative measurements, a steady state 
is required (Chan et al. 2004; Sun et al. 2007). A variety of meal protocols have been 
therefore developed in an attempt to achieve postprandial steady state TAG levels.
Duvillard et al. (2005) fed subjects every 2 h, with meals (containing 55 % 
carbohydrate, 39 % fat and 7 % protein, 1,700 kcal/ day) divided into small portions. 
Meals were given 6 h prior to the tracer infusion and up to the end of the 16 h study. 
Welty et al. (Welty et al. 1999; Welty et al. 2004; Lichtenstein et al. 1992) used an 
hourly feeding procedure, in which subjects received 20 identical small hourly meals,
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each equivalent to 1/20 th of their daily food intake with 15 % of calories given as 
protein, 49 % carbohydrates, 36 % fat (15 % saturated, 15 % monounsaturated, 6 % 
polyunsaturated), and 180 mg cholesterol/1000 kcal, but a steady-state was difficult to 
achieve in all subjects. Hogue et al. (2008) achieved a TAG steady state by half- 
hourly feeding for 15 hours, each meal consisting of 1/30 th of subject’s daily caloric 
intake with 15 % of calories as protein, 45 % carbohydrate, and 40 % fat (7 % 
saturated, 26 % monounsaturated, 7 % polyunsaturated), and 85 mg of cholesterol 
/lOOO kcal.
The feeding protocols described were all used in combination with an infusion of 
labelled amino acids to measure the kinetics of the proteins associated with either 
endogenous or exogenous particles. Although these approaches provide a measure of 
particle kinetics, they do not provide a measure of the TAG kinetics within the 
particle as the kinetics of TAG was not measured (Sun et al. 2007).
1.9.2.3 An immunoaffînity chromatography method for the separation of 
endogenous TRL from exogenous TRL
Another difficulty which has hampered TAG kinetic measurements in the fed state is 
that TRLs represent a mixture of exogenously and endogenously derived particles. 
Postprandial lipoproteins have been separated by immunoaffînity chromatography 
(Cohn et al. 1993; Karpe & Hamsten. 1994; Bjôrkegren et al. 1997; Jackson et al. 
2006; Heath et al. 2007). This technique is based on an antibody-antigen reaction. 
ApoB48 is identical to the N-terminal 48 % of apoBlOO, but shares no homology with 
the C-terminal end of apoBlOO. ApoBlOO specific monoclonal antibodies (4G3, 
5E11), which are directed against the C-terminal portion of apoBlOO and do not 
cross-react with apoB48, have therefore been used to separate apoB 100-containing
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lipoproteins from apoB48-containing lipoproteins. The antibodies are coupled to a 
solid phase. This approach results in a bound fraction which has lipoproteins 
containing apoBlOO and an unbound fraction which has lipoproteins containing 
apoB48 (Sun 2008). Therefore, the endogenous lipoproteins and exogenous 
lipoproteins are separated.
1.9.2.4 Simultaneous measurement of endogenous and exogenous TAG kinetics 
in the fed state
In the liver, intravenously administered [^Hs] glycerol can be used as a substrate for 
TAG synthesis which can then be incorporated into VLDL. Sun (2008) have shown 
that intravenously administered [^Hs] glycerol can also be incorporated into 
exogenously derived CM TAG in humans and was able to measure glycerol 
enrichment in the apoB48-containing derived fractions separated from apoBlOO 
fractions by immunoaffînity chromatography. This suggests endogenously derived 
glycerol can be used in the synthesis of TAG in the enterocytes during the 
postprandial period. This was an unexpected finding as the supply of exogenous 
glycerol would be very high during the postprandial period. This would also imply 
the glycerol tracer was able to cross the basolateral membrane of enterocytes and mix 
with the exogenous glycerol pool to form TAG which then becomes incorporated into 
secreted CM lipoprotein particles.
1.10 Caco2 cell line
Caco2 is a human colon adenocarcinoma cell line that was established by Fogh et al 
(1977). The Caco2 cell line is morphologically and physiologically similar to the 
human intestinal enterocytes and is commonly accepted as a suitable model for the 
study of intestinal lipid metabolism. In a study of twenty human colon tumor cell
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lines, Caco2 alone showed the ability to undergo spontaneous differentiation to 
develop a number of characteristics commonly associated with small intestinal 
enterocytes (Chantret et al. 1988; Schnabl et al. 2009).
During differentiation, enterocytes develop microvilli on their apical surface and form 
tight junctions (TJ) between the neighbouring cells. Differentiated Caco2 cells 
develop brush-border microvilli, polarized monolayers with TJ, and express the small 
intestine-specific enzymes such as sucrase and alkaline phosphatase (Trotter & Storch. 
1991). Caco2 cells have also been shown to synthesize and secrete lipoproteins in a 
polarized manner (Traber et al. 1987). Caco2 cells are capable of apoB mRNA 
editing of apoBlOO to apoB48 resulting in secretion of both CM (apoB48) 
(Luchoomun & Hussain 1999) and VLDL (apoBlOO) (Traber et al. 1987). In addition, 
mRNA for apoA-I, apoA- TV, apoC-III, and apoE have been detected (Hughes et al. 
1987; Reisher et al. 1993).
However, it must be recognized that there are some differences between mature 
human enterocytes and Caco2 cells.
Caco2 cells produce both apoB48 and apoBlOO, whereas mature human enterocytes 
only produce apoB48 (Bateman et al. 2007). Caco2 cells also have no mucus layer 
and “tighter” TJ compared to the small intestine (Hidalgo et al. 1989; Legen et al. 
2005). Importantly, there is a difference in the TAG synthesis pathway that 
predominates in Caco2 cells and enterocytes. As mentioned above, the MAG 
pathway is characteristic of enterocytes, and is especially important in the 
postprandial state. However, the G3P pathway is the major pathway for TAG
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synthesis in Caco2 cells under both basal and lipid stimulated conditions. It has been 
shown that Caco2 cells have lower MGAT activity, a key enzyme involved in MAG 
synthesis pathway, compared to G3P acyltransferase activity, the main synthesis route 
via G3P pathway (Trotter & Storch. 1993b). When compared with levels obtained in 
rat jejunal samples, the MGAT activity in Caco2 cells was less than 1/10th of that in 
rat jejunal cells (Trotter & Storch. 1993b). In addition. Levin et al. (1992) showed 
pre-incubation of Caco2 cells with MAG did not increase the MAGT activity and 
TAG synthesis, which also suggests the MAG pathway has low activity in these cells. 
The MGAT evidence is only from studies in rats so far, and may not reflect MGAT 
activity in human enterocytes.
1.11 Proposed work
Emerging evidence suggests that the small intestine is not merely an absorptive organ 
but also plays a dynamic role in lipid homeostasis in human. The process of 
utilization of glycerol for TAG metabolism has been widely investigated in adipose, 
skeletal muscle and hepatic tissue, but there is little information related to intestinal 
utilization for TAG synthesis. Accumulating evidence suggests this process may also 
be severely perturbed in the intestinal enterocytes especially in 
hypertriacylglycerolaemia or insulin resistant states. This project will focus on this 
area through two separate research questions.
Research Question 1: Can endogenous glycerol be used to produce exogenous 
TAG by intestinal cells?
This project was to determine the contribution of endogenous glycerol to TAG 
synthesis in human subjects and in a Caco2 cell model system. In human subjects two 
different glycerol tracers were administered simultaneously, one intravenously (^Hg-
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glycerol) and one orally (^^Cg-glycerol) to determine the contribution of endogenous 
and exogenous glycerol to intestinal TAG synthesis.
The % 5 -glycerol tracer was used to calculate endogenous and exogenous kinetics. In 
addition, in vitro experiments was to determine the conditions under which intestinal 
cells can synthesise TAG from basolaterally derived glycerol so as to provide a 
further understanding of intestinal TAG metabolism. This was tested by performing 
cell culture experiments to determine TAG synthesis and secretion after providing the 
cells with apical or basolateral glycerol to provide further evidence for the in vivo 
human model.
Since the metabolic fate of glycerol may be regulated by the manner in which 
substrates are presented to the enterocytes, phospholipids synthesis and secretion was 
also investigated in the present study.
Research Question 2: How does glucose and insulin concentration impact on the 
use of glycerol for TAG and PL metabolism in intestinal cells?
The modulation of intestinal lipid metabolism is not fully understood, especially by 
hormonal factors and metabolite concentrations. This was investigated by examining 
the effect of high and low glucose concentrations and the effect of insulin on glycerol 
incorporation into TAG and PL in a Caco2 cell model system.
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1.12 Aims
1. To perform human postprandial metabolic kinetic studies using two 
isotopically labelled glycerol tracers and thereby analyse the contribution of 
exogenous and endogenous triacylglycerol-rich lipoproteins to postprandial 
hypertriacylglycerolaemia in healthy subjects.
2. To determine the effects of the site of entry of isotopically labelled glycerol 
(apical versus basolateral) for lipoprotein production following the incubation 
of polarized Caco2 cells under varying conditions of glucose and insulin 
concentration.
1.13 Hypothesis
1. In humans, an intravenously administered glycerol tracer can label exogenous 
TAG in a similar manner to glycerol tracer administered orally.
2. In Caco2 cells, glycerol will be taken-up on both the apical and basolateral 
surfaces and used in the synthesis of TAG and PL.
3. In Caco2 cells, high glucose concentration will increase the synthesis of TAG, 
while insulin will inhibit the synthesis of TAG.
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Chapter 2 Analytical methods
2.1 Materials 
Chemicals and consumables
Labelled glycerol (^Hs-glycerol, 99 atom %) and tripalmitin (Glycerol-^^Cs, 99 
atom %) for the in vivo human study were purchased from Cambridge Isotopes (USA). 
The ^Hs-glycerol was prepared in saline and sterilised by the department of Pharmacy, 
Guy’s and St Thomas’ Hospital Trust (London, UK). Chloroform (HPLC grade), 
hexane (HPLC grade), diethyl ether (HPLC grade), pyridine and hydrochloric acid 
were purchased from Fisher Scientific (UK). Methanol (HPLC grade) and acetic 
anhydride were obtained from Agros Organics (UK). Silica thin-layer 
chromatography (TLC) plates were purchased from VWR (UK). Cation resin100-200 
mesh, AG50W-X8 and Anion resin 100-200 mesh, AG1-X8 were purchased from 
Bio-rad (UK). Ion exchange chromatography columns were obtained from 
Bioconnections (UK). Polyallmer OptiSeal Ultracentrifuge tubes were purchased 
from Beckman (USA). Protein G Sepharose™ 4 Fast Flow was obtained from 
Amersham (UK). Monoclonal antibodies 4G3, 5E11 and Bsoll6 were obtained from 
the Heart Institute, University of Ottawa (Canada). The Bi-Cinchoninic acid (BCA) 
kits were purchased from Pierce (UK). Sulphosalicylic acid was obtained from VWR 
(UK). Plasma triglycerides and cholesterol measurement reagent were obtained from 
Horiba (ABX, UK). NEFA measurement reagent and phospholipids kits were 
obtained from WAKO (Alpha Laboratories Ltd, UK).
Nunc-brand tissue culture flasks (T 25 and T 75) and multi-well plates were obtained 
from Thermo Fisher Scientific (Leicestershire, UK). Support Transwell TC sterile
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packaged inserts were ordered from Coming (Fisher Scientific, UK). General cell 
culture reagents such as Dulbecco's Modified Eagle Medium (DMEM), Foetal bovine 
semm (FBS), non essential amino acid (NE A A), penicillin/streptomycin (Pen-Strep) 
solution, trypsin-ethylene diamine tetraacetic acid (trypsin/EDTA) and trypan blue 
solution were obtained from Invitrogen Life Technologies (Paisley, UK). TAG 
concentrations in the in vitro studies were measured using a Triglyceride 
Quantification Kit (BioVision, USA). Unless otherwise noted, all other reagents were 
purchased from Sigma-Aldrich (UK).
2.2 Methods used in the human study
2.2.1 A summary of the sample preparation methods used in the human study
The schematic below summarizes the sequential steps that were undertaken in the 
preparation of samples from human studies (Figure 18).
Plasma
Lipid isolation
TAG separationTLC
Lipid extraction
Ultracentrifugation
Glycerol purificationIon-exchange
chromatography
GC-MS
GC-IRMS
Immunoaffmity
chromatography
Determination of glycerol enriclrment
To obtain fractions of lipoprotein by density
To separate endogenous and exogenous lipoproteins
Figure 18 Schematic of the sequential steps in the preparation of samples in the human 
study.
Abbreviations: TLC, thin-layer chromatography; TAG, triacylglycerol; GC-MS, gas 
chromatography-mass spectrometry; GC-IRMS, gas chromatography-isotope ratio mass 
spectrometry.
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2.2.2 Ultracentrifugation for separation of lipoprotein fractions
Ultracentrifugation was undertaken in order to separate different lipoprotein fractions 
from plasma. Plasma was separated from blood samples collected at regular time 
points by centrifugation at 3000 rpm for 10 minutes at 4°C (Heraeus Labofuge 400R 
Centrifuge, Thermo Scientific UK). Lipoproteins were separated by sequential 
flotation ultracentrifugation so as to isolate two fractions representing large TAG 
enriched VLDLl and CMl lipoproteins with a Svedbberg flotation rate (Sf) >60 and a 
relatively smaller and denser VLDL2 and CM2 fraction, Sf 20-60 (Havel et al. 1955). 
Ultracentrifugation was undertaken using a LE80-K ultracentrifuge (Type 50.4 Ti 
rotor, Beckman Instruments, Palo Alto, CA, USA). Three ml of plasma was 
transferred to a 4.7 ml polyallmer OptiSeal ultracentrifuge tube which was pre-coated 
with polyvinyl alcohol (PVA). Next, 1.5 ml of saline at a density of 1.006 g/ml 
containing 0.1 % ethylenediaminetetraacetic acid (EDTA) was carefully overlaid on 
the top of the plasma; the total volume of plasma and saline in each tube was 4.5 ml. 
Samples were centrifuged at 45,000 rpm for 66 minutes to isolate the Sf>60 (VLDLl 
and CMl) particles. The top of the tube was then cut and 1 ml of the fraction 
transferred to a volumetric flask and made up to 2 ml by washing the cut tops with a 
further 1 ml 1.006 g/ml saline. This Sf>60 (VLDLl and CMl) fraction was stored at 
4 °C. The infranatant (lower phase) of the sample was then transferred to a fresh 
ultracentrifugation tube and overlaid with 1.006 g/ml saline to the volume of 4.5 ml. 
The samples were then centrifuged at 37,000 rpm for a minimum of 16 hours to 
separate the Sf 20-60 (VLDL2 and CM2) fractions. The tube slicing procedure was 
repeated to collect the Sf 20-60 (VLDL2 and CM2) fractions. After measuring the 
TAG concentration in the Sf>60 and Sf<20-60 lipoprotein fraction samples, the
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lipoprotein fractions were stored at 4 °C and used for immunoaffînity chromatography 
within 24 hours of ultracentrifugation.
2.2.3 Immunoaffinity chromatography with protein G matrix coupled to 
apoBlOO antibodies (4G3, 5E11, BsoI16) for separation of apoBlOO and apoB48- 
containing lipoproteins
2.2.3.1 Preparation of Protein G Sepharose Matrix coupled to apoBlOO 
antibodies
Protein G Sepharose™ 4 Fast Flow was used as matrix for antibody separation and 
was prepared one day before use. This matrix was bulk prepared and then aliquoted 
into glass vials, ready for the separation of apoBlOO- and apoB48-containing 
lipoprotein fractions. Solid phase (0.05 ml, 2 mg Protein G /ml) was sequentially 
washed with a 10-fold volume of deionised H2 O, 1 mM hydrochloric acid and 20 mM 
sodium phosphate buffer (coupling buffer, pH7.0). Each wash was followed by 
centrifugation (1000 rpm, 10 minutes, 4 °C) and the supernatant was discarded. The 
solid phase was maintained in coupling buffer. Next, monoclonal antibodies 4G3, 
5E11 and Bsoll6 were individually coupled to Protein G Sepharose while being 
gently mixed on a rotator (SB3, Stuart, UK) at 2 rpm, 4 °C overnight. The following 
day, after centrifugation (1000 rpm, 10 minutes, 4 °C), excess supernatant was 
removed. Excess (Unbound) antibodies in the supernatant were measured with a 
BCA protein assay, as described in section 2.2.4. This was used to check binding 
efficiency of all the antibodies. If the concentration of protein in the supernatant was 
less than 0.5 % of total antibody concentration, it was assumed that complete coupling 
had occurred. The matrix was then washed three times with a 10-fold volume of 
coupling buffer and after each centrifugation, the supernatant discarded. Individual
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matrixes in coupling buffers were next transferred into a 3.5 ml glass vials. Thus, 
4G3, 5E11 and Bsoll6 were individually coupled to Protein G Sepharose and termed 
4G3, 5E11 and Bsol 16-matrix. For each matrix, the total volume was made up to 0.5 
ml with coupling buffer (Sun 2008).
2.2.3.2 Separation of the apoBlOO from apoB48-containing lipoproteins by 
immunoaffinity chromatography
This step separated the bound (apoBl 00-containing lipoproteins) from the unbound 
(apoB48-containing lipoproteins) (Figure 19).
Lipoprotein fractions (Sf>60 and S120-60) were individually loaded onto the 4G3- 
matrix and incubated overnight while gently mixing on a rotator (2 rpm, 4 °C). The 
next day, after centrifugation (1000 rpm, 20 minutes, 4 °C), the unbound fraction (the 
supernatant) was transferred from the vials containing the 4G3 antibody to the vials 
containing the 5E11 antibody. The bound phase, remaining in the slurry was then 
washed with 0.5 ml coupling buffer to collect any residual unbound lipoproteins. 
This washing step was repeated twice. The supernatants from each wash were 
combined and then added to the vial containing the 5E11 antibody-matrix. These 
vials were incubated overnight while gently mixing on a rotator (2 rpm, 4 °C).
The remaining bound fraction was stored in the fridge (4 °C). The next day, the 
5E11- matrix was washed three times by centrifugation with 0.5 ml coupling buffer to 
again collect the unbound lipoprotein fractions. The supernatant from each wash was 
combined and loaded onto a Bsol 16-matrix and incubated overnight while gently 
mixing on a rotator (2 rpm, 4 °C). Again, the remaining bound fraction was stored in 
the fiidge (4 °C). The following day, the unbound fraction (apoB48-containing 
lipoproteins) from the final Bsol 16-matrix were collected after centrifugation (1000
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rpm, 20 minutes, 4 °C) and added to a new 7 ml glass vial. The bound fractions in the 
slurries after each separation on the 4G3-, 5E11- and Bsoll6- matrixes were 
combined in a different 7 ml glass vial and then centrifuged to remove the supernatant. 
Coupling buffer - 0.5 ml was twice used to wash the 3.5 ml vials to ensure that all the 
bound fractions were transferred to the 7 ml vial. The washed slurries containing the 
combined 4G3-, 5E11- and Bsol 16-matrixes contained the bound fraction (apoB 100- 
containing lipoproteins) in 0.5 ml coupling buffer (Figure 19). Thus, the bound and 
unbound fractions were separated.
Lipoprotein fraction  
(apoB48,apoB100)
I r
Unbound Unbound Unbound
Bsol16+Prote!n4G3-H»rotein G 5E11+Protein G ^ 3
ApoB48
C ontaining
lipopro teins
ApoBlOO
C ontaining
lipopro teins
Figure 19 Illustration of immunoaffinity chromatography method to separate apoBlOO 
and apoB48-containing lipoproteins using a sequential procedure of protein G sepharose 
coupled with apoBlOO antibodies: 4G3, 5E11 and Bsoll6.
2.2.3.3 Validation of immunoaffinity chromatography method
Sun (2008) validated the immunoaffinity methodology using Sodium dodecyl sulfate- 
polyacrylamide gel electrophoresis (SDS-PAGE) with protein silver staining to 
determine the bound fractions were not contaminated with apoB48 and that the 
unbound fractions were not contaminated with apoBlOO. The results showed the
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absence of apoB48 in the bound fractions and absence of BlOO in the unbound 
fractions by SDS-PAGE in the Sf>60 and Sf 20-60 fractions (Figure 20).
< -A poB 100
V  >  f .i
< -A poB 48
TRL LDLstds VLDLl VLDLl CM CM
Figure 20 SDS-PAGE with protein silver staining showing the efficiency of the 
immunoaffinity method at separating hepatic and intestinal lipoproteins.
Proteins were extracted from a postprandial Sf>60 TRL sample and Sf20-60 postprandial 
samples separated by the immunoaffmity technique into bound (VLDLl) and unbound (CM l) 
samples. A purified LDL sample was used to locate the position of apoBlOO bands on SDS- 
PAGE. All samples were run on the same gel but not all lanes are shown. The places where 
the image has been cut are clearly shown.
In the current study western blot was also performed to verify the absence of apoBlOO 
in the unbound fractions. The absence of BlOO in the unbound fractions was also 
verified by western blotting (Figure 21).
<-A poB 100
<-A poB 48
ApoB48 CM2 CMl TRL
Figure 21 Western blot of unbound Sf>60 (CMl) and Sf 20-60 (CM2) postprandial 
samples.
Lane 1 shows the apoB48 standard. All samples were run on the same gel but not all lanes are 
shown. The position where the image has been cut is clearly shown.
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2.2.4 Bi-Cinchoninic Acid (BCA) Protein Assay
The BCA protein assay was performed following the instructions from Pierce (UK). 
The working range of protein concentrations used was 5-250 pg/ml. The standards 
were diluted with the sample buffer (20 mM sodium phosphate buffer, pH 7.0). 
Bovine serum albumin (BSA) was used as a standard and prepared by sequential 
dilution.
Samples (25 pi) and standard (25 pi each) were added in duplicate to a 96-well 
microplate and 200 pi of working reagent (Pierce, UK) was added to each well. The 
plate was covered and incubated at 37 °C for 30 minutes. After cooling down to room 
temperature, the plate was placed into a microplate reader (Opsys MR, DYNBX 
Technologies UK) and the absorbance measured at 540 nm (DYNEX software. 
Version 2.0).
2.2.5 Lipid extraction from lipoprotein fraction
Lipid extraction was based on the procedure of Folch (Folch et al. 1957). After 
separation by immunoaffinity chromatography (Section 2.2.3), lipids from the 
apoB 100-containing lipoproteins (Bound) and apoB48-contaning lipoproteins 
(Unbound) were extracted overnight (4 °C) with a 4-fold volume of chloroform- 
methanol (2:1) solution (% v/v). The samples were then centriftiged at 2500 rpm for 
30 minutes (4 °C). The infranatant (lower phase) was transferred to a clean, labelled 
vial using a glass Pasteur pipette. The supernatant (upper phase) was re-extracted 
with a further 2-fold volume of chloroform-methanol (2:1) solution (% v/v) at 4 °C for 
at least 1 hour. Then the samples were centrifuged for a further 30 minutes at 
2500 rpm at 4 °C. The infranatant samples were combined and a potassium chloride 
(KCl) (0.88 % w/v) added using 25 % of the total volume of the solvent extracts.
71
Samples were mixed and centrifuged (2500 rpm, 4° C, 30 minutes). The aqueous 
layer was discarded and 100 pi ethanol was added to each vial. Then the samples 
were placed under a gentle stream of oxygen-free nitrogen (OFN) (NitroFlow® Lab, 
Parker Filtration & Separation B.V. Netherlands) to remove solvent. Samples were 
then reconstituted in 100 pi chloroform for thin-layer chromatography (TLC).
2.2.6 Thin Layer Chromatography of extracted lipoprotein lipids
A glass chamber containing hexane-diethyl ether-acetic acid (70:30:2, % v/v) as the 
mobile phase was used to separate the different lipid classes in the samples. Each 
sample of extracted lipid was applied as a band measuring approximately 2 cm in 
length, 2.5 cm from the bottom of the TLC plate (20x20cm aluminium sheets. Silica 
Gel 60). The separated lipids were visualised by iodination. Once the lipid bands 
could be identified, they were lightly circled with a pencil and the silica carefully 
scraped off the silica-coated aluminium TLC plate with a scalpel.
2.2.7 Hydrolysis of TAG and PL samples for the isolation of glycerol
The silica scrapings from the TLC plates were hydrolysed in a solution of toluene 
(1 ml) and 3 % hydrochloric acid in methanol (v %), 2 ml at 50 °C overnight. The 
next day, after allowing the samples to cool to room temperature, 2 ml of 5 % sodium 
chloride in H2 O (% v/v) and 3 ml of hexane as added. After vortexing, the samples 
were left at 4 °C for 30 minutes. The samples were then centrifuged at 2500 rpm, for 
30 minutes at 4 °C. The solvent phase was discarded. The remaining aqueous phase 
contained the glycerol.
2.2.8 Purification of glycerol by Ion-Exchange Chromatography
Ion exchange chromatography columns were packed with 1 cm^- volume of AG50W- 
X8 cation resin 100-200 mesh and 1 cm  ^ - volume of AG1-X8 anion resin 100-200
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mesh and washed 3 times with 3 ml deionised H2 O. Samples were then applied to a 
column using a clean glass Pasteur pipette. Glycerol was eluted from the columns 
with 3 ml deionised H2 O. The samples were then dried overnight by lyophilisation 
(Thermo Electron Corporation, UK).
2.2.9 Measurement of glycerol enrichment by gas chromatography-mass 
spectrometry (GC-MS) and gas chromatography-isotope ratio mass 
spectrometry (GC-IRMS)
2.2.9.1 Glycerol Derivatisation for GC-MS
Samples were derivatised to their triacetate derivative as described by Ackermans et 
al. (1998). Briefly, 100 jxl pyridine: acetic anhydride (1:1, v %) was added to each 
glycerol sample. The samples were allowed to incubate at room temperature at 30 
minutes, dried under a stream of oxygen free nitrogen (approximately 25 minutes). 
Samples were reconstituted in 100 pi of ethyl acetate, and then transferred to 
autosampler vials for GC-MS analysis.
2.2.9.2 Measurement of glycerol enrichment by GC-MS
All gas chromatography-mass spectrometry (GC-MS) analysis was performed on an 
Agilent 5973 network mass selective detector (Agilent Technologies, UK). The 
system was equipped with a 6890N GC fitted with 30 m, 0.25 mm id, 0.25 pm film 
RTX SMS capillary column (5 %-phenyl-methylpolysiloxane) (Thames Restek, UK) 
and the carrier gas used was helium (1 ml/min).
The mass spectrometer was operated in the positive chemical ionization (PCI) mode, 
in which the reagent gas (methane) ions undergo reactions with sample molecules to
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form sample ions. Ions were monitored at m/z 159, m/zl62 (M+3) and at m/z 164 
(M+5) for glycerol, ^^Cs-glycerol and ^Hs-glycerol, respectively.
The interface temperature was 240 °C. The ion source temperature was 175 °C and 
the quadrupole temperature was 150 °C. Two pi of each sample were injected by 
splitless injection; the temperature of the injector was 250 °C. The GC oven 
temperature was held of 70 °C for 1 minute and increased at 20 °C/min to 220 °C. 
The retention time for glycerol was 7 minutes and total run time was 12 minutes.
2.2.9.2.1 Calculation of glycerol enrichment
The ratio of labelled to unlabelled glycerol was calculated using the following 
equation:
Ratio=Area obtained for labelled glycerol /Area obtained for unlabelled glycerol 
The ratio was converted into tracer-to-tracee ratio (TTR):
TTR=R,-Rb
Where R^  is the m/z peak area ratio for the enriched samples at time t and Rb is the 
baseline reading.
2.2.9.2.2 GC-MS standard curve
Prior to performing any analysis of samples by GC-MS, it was first confirmed that 
GC-MS measurements for glycerol were accurate and stable. This was achieved by 
routinely running a standard curve.
Glycerol standard curves were prepared using ^Hs-labelled glycerol, ^^Cs-labelled 
glycerol and non-isotopically labelled glycerol (referred to as D$, ^^ C glycerol or Do) 
as shown in Table 5 and Table 6.
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Table 5 ^Hs-glycerol standards
No Ds(pg) D5 (pmol) Do(pg) Do(pmol)
D 5/D 0
ratio(pmol)
1 0 0 8.4 0.091 0
2 0.330 0.003 8.4 0.091 0.037
3 0.660 0.007 8.4 0.091 0.075
4 1.155 0 . 0 1 2 8.4 0.091 0.130
5 1.650 0.017 8.4 0.091 0.186
Table 6 ’^Cg-glycerol standards
No (hg)
"Cg
(jimol) ''C(pg) '^C(pmol) ratio(pmol)
1 0 0 1 0 0.109 0
2 0 . 1 0 . 0 0 1 1 0 0.109 0 . 0 1 0
3 0 . 2 0 . 0 0 2 1 0 0.109 0.019
4 0.4 0.004 1 0 0.109 0.039
5 0.5 0.005 1 0 0.109 0.048
A typical set of calibration curves are shown in Figure 22 and Figure 23. For the 
glycerol standard curve, the slope of the theoretical ratio versus the measured ratio 
was 1.0037 and the r^  value was 0.9990 (Figure 22). For the glycerol standard 
curve, the slope of the theoretical ratio versus the measured ratio was 1.0056 and the 
r^  value was 0.9998 (Figure 23). These results demonstrated the machine was 
performing well. A standard curve was run before and after each batch of samples to 
ensure consisteney in results.
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Figure 22 Calibration curve of the ^Hs-glycerol standard curve with monitoring of m/z 
of 159 and 164 (The theoretical ratio vs the measured ratio) (n=3) (mean±SEM).
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Figure 23 Calibration curve of the ^^Cs-glycerol standard curve with monitoring of m/z 
of 159 and 162 (The theoretical ratio vs the measured ratio) (n=3) (mean±SEM).
2.2.9.3 Measurement of glycerol enrichment by GC-IRMS
All gas chromatography-isotope ratio mass spectrometry (GC-IRMS) analysis was 
performed on a Delta Plus XP (Thermo Fisher Scientific) coupled to a Tracer Ultra 
GC. The GC was equipped with a RTX 5ms, 30 m, 0.25 mm id, 0.25 pm capillary 
columns. Five pi samples were injected by splitless injection; the temperature of the 
injector was 250 °C. The GC oven temperature was held of 70 °C for 1 minute and 
then increased at 15 °C/min to 250 °C. The total run time was 18 minutes.
This method only measures ^^ C and cannot detect and was therefore used to 
measure ^^ Cg -glycerol in the apoBlOO and apoB48-containing TAG (i.e only 
exogenously derived glycerol).
2.2.9.3.1 Standard curve preparation
A standard curve containing ^^Cg-glycerol and non- isotopically labelled glycerol
(referred as ^^ C glycerol) was prepared as shown in Table 7.
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Table 7 ^^Cg-glycerol standards (IRMS)
No ''C(pg) ''C(pg)
"c/'^c
ratio TTR
1 0 1000 0 0
2 10 1000 0.010 0.010
3 20 1000 0.020 0.019
4 30 1000 0.030 0.029
5 40 1000 0.040 0.039
2.2.9.3.2 Measurement of glycerol standard enrichment
With GC-IRMS analysis, samples and standards are oxidised to CO2 and H2 O in a 
combustion furnace held at 940 °C. The ratio of in the CO2 is expressed as a
‘delta value’ (the permil deviation of the sample relative to a reference gas) was 
converted to TTR as follows:
Rb = (d "C/'^C vs. PDB / 1000 +1) x 0.0112372 TTR = (Rb-Ro) % 9/3
Where Ry is the atom percentage of the enriched samples at the given time, Ro is the 
baseline value; the value 9 represents the number of carbon atoms in the derivatised 
molecule and 3 represents the number of enriched carbons in the tracer used. 
Again a set of standards were run before and after each batch of samples. A typical 
calibration curve is shown in Figure 24. The slope of the theoretical TTR versus the 
observed TTR was 0.9967 and the r^  value was 1 (Figure 24).
0.05
0.04 y= 0.9967X + 2E-05
t  0.03
i  0,02
0.01
0
0.020 0.01 0.03 0.04 0.05
T heoretical TTR
Figure 24 Calibration curve of the ^^ Cg- glycerol standard curve used in GC-IRMS 
calibration (The theoretical TTR versus the observed TTR) (n=3) (mean±SEM).
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2.2.10 Measurement of free plasma glycerol enrichment
Samples were collected in chilled tubes containing 6.8IU lithium heparin (BD, UK) 
and separated by centrifugation (2000 rpm, 15 minutes, 4 °C) immediately after 
collection. Then the plasma samples were stored at -20°C.
Plasma samples (500 pi) were deproteinised with 1 ml of 3.5 % (w/v) sulphosalicylic 
acid in H2 O for 30 minutes at 4 °C. The supernatant was collected after centriftigation 
(2000 rpm, for 20 minutes at 4 °C) and then purified by ion-exchange chromatography 
as described in section 2.2.8 and derivatised as described in section 2.2.9.1 and 
analysed by GC-MS as described in 2.2.9.2.
2.2.11 Measurement of metabolite concentration in the plasma
Plasma samples were collected in pre-chilled EDTA tubes and separated by 
centrifugation at 3000 rpm for 10 minutes at 4 °C. The concentration of TAG, total 
cholesterol and NEFA were measured using an automatic MIRA analyzer (ABX 
Diagnostics, France) using an enzymatic assay. TAG concentration in total fractions 
and unbound fractions was also measured by an automatic MIRA analyzer. The 
unbound fractions were concentrated 7-fold prior to measurement. The bound 
concentration was calculated as the difference between the total and unbound fraction 
concentration. Plasma glucose concentration was measured by a glucose analyzer 
(YSl 2300 STAT Plus. Analytical ©technologies, UK).
2.2.12 Measurement of plasma insulin concentration
Samples for insulin measurement were collected in pre-chilled tubes and serum was 
separated by centrifugation at 3000 rpm for 30 minutes at 4°C. Insulin was measured 
by a double antibody radioimmunoassay (Sonksen 1976).
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Briefly, aliquots of serum (50 pi) were incubated at room temperature overnight with 
the first antibody, guinea pig anti-insulin serum (GP 8) with the tracer ^^ I^-A^ -^tyr- 
monoiodo-insulin (Amersham Pharmacia Biotech, UK) in a total volume of 500 pi. 
Then 100 pi of a second antibody, a solid phase sheep-anti-guinea pig serum antibody 
(Pharmacia Decanting Suspension, UK), was added and the samples incubated for 2 
hours. Following this, 1 ml of H2 O was added to the samples, and the samples 
centrifuged at 1500 rpm for 45 minutes at 4 °C. The supernatant was decanted 
immediately and the precipitate counted on a gamma counter (Wallac Wizard 1470, 
UK).
2.2.13 Calculation of Homeostasis Model Assessment (HOMA) and Glycerol 
tracer concentration
The Homeostasis Model Assessment (HOMA) was calculated using the H0MA2 
calculator of University of Oxford 
(http://www.dtu.ox.ac.uk/homacalculator/index.php).
Glycerol tracer concentration was calculated using the following equation:
Tracer concentration = TTR*total glycerol concentration.
The Area Under the Curve (AUC) was calculated using the trapezoidal rule.
2.2.14 Calculation of Fractional catabolic rate (FCR), production rate (PR) and 
pool size (PS)
^Hs-glycerol enrichment from the endogenous and exogenous TRLs in the Sf>60 and 
Sf20-60 fractions were described by a multi-compartmental model (SAAM program, 
SAAM Institute, Seattle, WA) developed by Dr Hovorka (University of Cambridge, 
UK) (Figures 25 and 26).
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The models represent the kinetics of the TTR profiles which change as labelled 
glycerol is removed from plasma and incorporated into the TAG fractions. The 
models assume a steady state of native (unlabelled) glycerol throughout the 
experimental period, i.e. a constant appearance, disappearance, and incorporation of 
native glycerol into the TAG fractions. The incorporation of glycerol into VLDL by 
the liver and into CM in the intestine is subject to a delay and two delay pathways 
were represented.
VLDL 1-TAG and VLDL2-TAG production rate (PR) were calculated as the product 
of VLDL 1-TAG and VLDL2-TAG fractional catabolic rate (FCR) and their 
respective TAG pool size (PS). VLDLl and VLDL2-TAG PS were calculated from 
VLDLl and VLDL2-TAG concentration and plasma volume which were determined 
by the method of Pearson et al (1995).
CMl-TAG and CM2-TAG PR were calculated as the product of CM 1-TAG and 
CM2-TAG FCR and their respective TAG PS. CMl and CM2-TAG PS were 
calculated from CMl and CM2-TAG concentration and plasma volume.
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Figure 25 The model structure for VLDL.
The model for VLDL included a compartment for VLDLl-TAG and a compartment for 
VLDL2-TAG with an input into both compartments from the glycerol precursor pool, a loss 
from each compartment and a transfer from the VLDLl-TAG compartment to the VLDL2- 
TAG compartment. Abbreviations: VLDL, very low density lipoproteins.
Masma
lycerol CLIl
delay
Figure 26 The model structure for CM.
The model for CM included a compartment for CMl-TAG and a compartment for CM2-TAG 
with an input into both compartments from the glycerol precursor pool, a loss from each 
compartment and a transfer from the CMl-TAG compartment to the CM2-TAG compartment. 
Abbreviations: CM, chylomicron.
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2.3 Methods used in the Cell culture experiment
2.3.1 A summary for the methods used in the cell culture study
The schematic outlines the sequential steps that were undertaken in preparation, 
separation, and purification of samples from cell culture experiments.
Lipid isolation
GC-MS
TLC
Lipid extraction
Glycerol purification
Cells or basolateral media
TAG and phospholipids separation
Ion-exchange
chromatography
Determination of glycerol enrichment
Figure 27 Schematic of the sequential steps in the preparation of samples in the cell 
culture experiment.
Abbreviations: TLC, thin-layer chromatography; TAG, triacylglycerol; GC-MS, gas 
chromatography-mass spectrometry.
2.3.2 Culturing of Caco2 cells
Caco2 cells (HTB37) were obtained from the American Type Culture Collection 
(ATCC; VA, USA). The cells were cultured in 25 cm^ plastic flasks at 37 °C in an 
incubator with 5 % carbon dioxide (CO2 ), 95 % air atmosphere at constant 95 % 
relative humidity. The culture medium consisted of DMEM (glucose 4.5 g/L with L- 
Glutamine) supplemented with 1 % NEAA, 1 % (v/v) of antibiotics (penicillin- 
streptomycin) and 20 % (v/v) heat-inactivated FBS. The cells were split at 90 % 
confluence. The culture media was aspirated and discarded. Then approximately 3 
ml of pre-warmed trypsin-EDTA (PET) solution was added to the flask. The flask 
was put in the incubator (37 °C) until the cells detached (approximate 5-6 minutes). 
The cells would become rounder when they detached. This can be observed under an
8 2
inverted microscope. When the cells began to detach, the PET solution was removed 
and approximately 1 0  ml of pre-warmed fresh culture media was added to the flask. 
Then the cells were dispersed gently by pipetting up and down a few times until 
homogeneous, as monitored under a microscope. For sub-culturing, 3 ml of the 
homogenous cell suspension was transferred to a 75 cm^ flask containing 13 ml of 
complete medium (1/5 dilution). The cell culture media was changed 24 hours after 
plating and then every 2  days.
2.3.3 Preparation of frozen cell culture stocks
Cells were grown in 75 cm^ culture flasks until 90 % confluent. The cells were 
detached with approximate 7 ml PET solution per flask. After cells had detached, 
8 - 1 0  ml of culture medium was added and mixed to get a homogenous suspension (a 
2 0  pi sample of the homogenous suspension was collected for counting of cells using 
a haemocytometer). The cell suspension was centrifuged at 1300 rpm (Sigma 6K10 
centrifuge) for 10 minutes at room temperature. Then the cell pellet was re-suspended 
in freezing medium containing 90 % FBS, 10 % Dimethyl Sulfoxide (DMSO) (v/v) to 
a concentration approximate 4x10^ cells/ml and 1 ml samples transferred quickly to 
cryovials for storage (each vial was clearly labelled with date, passage number, cell 
type, name and laboratory number). The vials were placed in a -80 °C freezer (16-24 
hours) before being transferred to liquid nitrogen vessel for long-term storage.
2.3.4 Plating of frozen cells
An ampoule containing 1 ml frozen cells in freezing medium was thawed rapidly in a 
37 °C water bath. Then the cell suspension was quickly transferred to 10 ml culture 
medium (37 °C) and centrifuged at 1300 rpm (Sigma 6K10 centrifuge) for 10 minutes 
at room temperature. The cell pellet was re-suspended in 5 ml pre-warmed culture
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medium and transferred to a 25 cm^ plastic flask, and cultured under standard 
conditions, as described in section 2.3.2. Cell attachment was assessed by 
microscopy. The following day, the media was removed and fresh media was added 
to remove any trace of DMSO.
2.3.5 Sample collection and analysis
2.3.5.1 Transepithelial electrical resistance measurements to ensure the integrity 
of cell monolayes
The tight junctions (TJ) are always described as ‘gates’ or ‘fence’; as they separates 
apical from basolateral domains. This ensures cell adhesion, polarization and 
monolayers integrity (Lugo- Martinez et al. 2009). There are many ways to evaluate 
the integrity of cell monolayers on membrane supports. The most common is the 
measurement of Transepithelial electrical resistance measurements (TEER). TEER 
values in this study were determined with a Millicell-ERS (Electrical Resistance 
System) apparatus (Millipore Corp., MA, USA). This provided a practical, quick and 
reliable method for assessing monolayer confluence and TJ formation (Lugo- 
Martinez et al. 2009).
TEER measurements were performed following the manufacturer’s instructions.
Data were expressed as Qxcm^. The TEER of a cell layer was calculated according to 
the following equation: TEER = (R monolayer-R blank) xA (Qx cm^), where R monolayer is 
the resistance measured, R blank is resistance of blank inserts without cells (but 
containing media), and A is the surface area of the transwell insert (4.67 cm^). Values 
lower than 200 - 250 flxcm^ indicate poor integrity of TJ; these monolayers were 
discarded (Ohashi et al. 2009).
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2.3.S.2 Treatment conditions
Caco2 cells between passages 38 to 72 were seeded at 5x10^ cells/ml (at a density of 
160x10^ cells/cm^) onto 6  well Trans well filter supports (0.4 pm pore size, 4.67 cm^, 
insert membrane growth area, 24 mm insert diameter). This allows separate access to 
apical and basolateral surfaces (Figure 28). Cells reached confluenee approximately 
14 days after seeding and experiments were initiated 21 days following seeding, 
ensuring monolayer TJ formation by a measurement of TEER. The prepared 
monolayers were only used for the experiments when TEER was >250 ohms * cm^ 
(Bateman et al. 2007).
Transwell insert
Culture media
0 0 0 0 0 0 0 0 0
10.4|jm
Apical compartment
-Caco-2 cells monolayer
Basolateral compartment
Figure 28 A schematic diagram of Caco2 cells seeding in the transwell plates for 
metabolic studies.
Prior to any treatment, the cells were cultured in serum free DMEM for 24 hours. 
Cells cultured under conditions of high glucose concentration were cultured in media 
containing 25 mM glucose. Those cultured under conditions of low glucose 
concentration were cultured in media containing 5 mM glucose.
Cells were incubated under conditions of high or low glucose serum-free media and 
stable isotopieally labelled ^^Cs-glycerol (60 pM) added in the presenee or absence 
albumin bound oleie acid (OA, Sigma, 0.5 mM) or insulin (INS, 10 nM) (Table 8 ).
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Table 8 General treatment culture conditions
Treatment condition Surface added to
Media
glucose
^^Cs-glycerol only (-0A)
Either apical or 
basolateral
High and 
Low
^^Cs-glycerol and insulin*(+INS)
Either apical or 
basolateral
High and 
Low
^^Cs-glycerol and OA (+0A)
Either apical or 
basolateral
High and 
Low
^^Cs-glycerofGA and Insulin*(+OA+INS)
Either apical or 
basolateral
High and 
Low
* Insulin always in the basolateral compartment
High glucose, 25 mM glucose in both compartments; Low glucose, 5 mM glucose in both 
compartments. Abbreviations: OA, oleic acid; INS, insulin.
After incubation for periods up to 24 hours, the media was collected and cells were 
scraped-off from their support using a cell scraper, rinsed in ice-cold phosphate 
buffered saline (PBS) and sonicated for 15 minutes. All samples were immediately 
frozen at -20°C until further analysis.
2.3.S.3 Isolation of lipids and glycerol from cells and culture media
Total lipids from the cells and basolateral media were extracted with 
chloroform/methanol (2:1, v: v) and individual classes separated by TLC using 
hexane/diethyl ether/acetic acid (70:30:2, by vol.). Lipids were visualized by iodine 
vapour and the bands containing TAG and PL scraped off and hydrolysed in a 
solution of 3 % hydrochloric acid in methanol to release glycerol and fatty acids as 
previously described in sections 2.2.5-2.2.S. The ^^C-enrichment of TAG and PL in 
the cells and basolateral media was analysed by GC-MS (Agilent 5973 network MSD, 
Agilent Technologies, UK) as previously described. Glycerol enrichment was 
determined following derivatisation to glycerol triacetate and analysed by PCI by GC- 
MS (section 2.2.9.2). Mass spectrometry results are presented as TTR as described in 
section 2.2.9.2.I.
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2.3.5.4 TAG concentration determination
To determine intraeellular TAG concentrations, cells were first homogenized in 5 % 
Triton-XlOO (1 ml). TAG concentration was measured using a TAG Quantification 
Kit. The TAG concentration of the basolateral media was calculated after correction 
for a media-only blank. The intra assay CVs for this measurement was 7 %.
2.3.5.5 PL concentration determination
PL concentration in the basolateral media was measured using PL kits according to 
instruction manual of WAKO. The intra assay CVs for this measurement was 8  %.
2.4 Statistical analysis
Conventional methods were used for the calculation of means, standard deviations 
(SD), standard error of the mean (SEM). Data was analysed using GraphPad Prism 5 
software. Analysis of TAG concentrations during postprandial steady state was by 
repeated measures ANOVA. Non-parametric data e.g. the FCR was logarithmically 
transformed before statistical analysis. Associations between the log transformed data 
and parametric data were determined by calculation of Pearson correlation coefficient. 
The parametric tests were applied if the log transformation was successful in 
normalising the distribution of data. Difference of TAG FCR, PR and PS among 
lipoprotein fractions (VLDLl, VLDL2, CMl and CM2) was compared by one way 
ANOVA. Analysis of TAG and PL concentrations and enrichment in cells and 
basolateral media was by one-way ANOVA. Comparisons of TAG and PL 
enrichment in cells and basolateral media in high and low glucose media was by two- 
way ANOVA to identify significant differences between the groups. Comparisons of 
AUC/dose of ^ ^Cg-glycerol and ^Hs-glycerol labelled CMl TAG was determined by t- 
test. A P  value lower than 0.05 was considered to be statistically significant.
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Chapter 3 An in vivo investigation o f  intestinal glycerol 
utilization in healthy subjects
3.1 Background
TAG synthesis in the human small intestine has primarily been assumed to be a 
unidirectional process, with glycerol absorbed from the gut lumen being re­
synthesised into TAG within the enterocytes. This is followed by secretion from the 
basolateral membrane into the lymphatic circulation (Frayn 2010). However, a 
question remains as to the contribution of circulatory (endogenous) derived glycerol, 
taken up by enterocytes, in relation to glycerol incorporation into CM TAG during the 
postprandial period.
Stable isotope techniques utilizing ^Hs-glycerol in the fasting or post-absorptive state 
have been widely used to investigate the in vivo kinetics of fasting TAG metabolism, 
yet there is paucity of data relating to the quantification of exogenous TAG kinetics in 
the fed state. This is a vital area of study as abnormalities in postprandial TAG 
metabolism have been associated with the development of atherosclerosis (Zilversmit 
1979; Patsch et al. 1992; Bansal et al. 2007). In the postprandial state, TRL consist of 
a mixture of exogenously-derived particles secreted by the small intestine, that 
compete for clearance fi-om the plasma with endogenous lipoprotein particles which 
are continuously secreted fi*om the liver.
Sun (2008) demonstrated that intravenously administered ^Hs-glycerol also seemed to 
label intestinal as well as liver-derived TAG in the postprandial state. This suggests
that endogenously derived glycerol also becomes incorporated into exogenous 
particles that contain dietary-derived TAG.
This study aims to gain more of an insight into glycerol utilization by the small 
intestine by simultaneously administering an oral glyceride tracer (^^Cs- glycerol 
tripalmitin provided in a meal) in combination with an intravenous ^Hg-glycerol tracer. 
This protocol enables a direct comparison of the incorporation of systemic 
(endogenous) glycerol with oral (exogenous) glycerol in the synthesis of CMs in the 
intestine and enables the determination of the significance, if any, of this observation. 
In addition, the measurement of ^^Cs- glycerol (exogenous) in VLDL provided a 
measure of the efficiency of the immunoaffinity chromatography method used to 
separate CMs and VLDL.
3.2 Methods
3.2.1 Experimental protocol
3.2.1.1 Subjects
Five healthy, lean Caucasian male subjects, age 50-65, body mass index (BMI) 21-24 
were recruited for this study. The study was approved by East Kent Ethics 
Committee and the University of Surrey Ethics Committee. All volunteers were 
informed of the purpose, nature and potential risks of the study and provided informed 
consent.
3.2.1.2 Clinical Protocols
Subjects were asked to avoid any alcohol and physical activity for three days prior to 
the study and were provided with a low fat meal to be consumed before 1 0  pm the
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evening before the study. Subjects were asked to remain fasted and only consume 
water until the start of the study.
The clinical protocol is illustrated in Figure 29. After taking a baseline blood sample 
at approximately 8.00 am (-240 minutes), subjects were given six identical high fat 
meals every 2  hours for a period of 1 1  hours to produce a constant elevated level of 
plasma TAG. Each meal was made up of 125 ml fresh Thick Chocolate Milk Shake 
(Tesco, UK) with an additional 20 ml double cream, 15 ml olive oil and 20 ml 
sunflower oil. The proportion of the different fats in the meal was chosen to reflect 
the mean fat composition of the UK diet. Each meal provided 497 kcal of energy as
12.2 % carbohydrate, 4.5 % protein and 83.3 % fat. All meals were consumed within 
five minutes of being given to each subject. At 12.00 pm (0 minute), a bolus of ^ Hs- 
glyeerol (75 pmol/kg) (30 mg/ml, 2.5 ml per vial, Pharmacy, Guy’s and St Thomas’ 
Hospital Trust, UK) was administered intravenously. The third meal (also given at 0 
hours) contained tripalmitin (^^Cs-glycerol) (10 mg/kg body weight) which was taken 
orally. The labelled tripalmitin was emulsified into the meal by gently heating the 
tracer at 84 °C with 15 ml olive oil and 20 ml sunflower oil until dissolved and then 
mixing with 125 ml milk shake and 20 ml double cream. The 240 minutes delay in 
administration of both isotopes was to allow for a postprandial steady state to be 
achieved (Sun 2008). Blood samples were taken for the measurement of exogenous 
and endogenous TRL glycerol enrichment at 0, 30, 60, 90,120, 150, 180, 240, 300 and 
420 minutes. Samples for plasma glycerol enrichment measurement were taken at 5, 
15, 30,45, 60, 90, 120, 150, 180, 240, 300 and 420 minutes.
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Figure 29 Cinical study protocol.
The subjects were given high fat meals every 2 hours for 11 hours, the third meal (provided 4 
h after the start of the study contained tripalmitin (^^Cs-glycerol). An intravenous bolus of 
^Hs-glycerol (75pmol/kg) was also administered at this time. The black arrows indicate blood 
sampling time for lipoprotein analysis, the purple arrows indicate time of the meals, the bold 
yellow arrow indicates the administration of ^H^-glycerol z.v. at 0 time point and the bold 
purple arrow indicates the administration of ^^Cg-glycerol in the meal at 0 time point.
3.2.2 Analytical protocol
Lipoprotein fractions were isolated from plasma by sequential, flotation 
ultracentrifugation. For each time point, consecutive spins were used to float CMs 
(CMl) and VLDLl (Sf >60), smaller CMs (CM2) and VLDL2 (Sf 20-60) as 
described in Section 2.2.2.
Immediately after ultracentrifugation, apoBlOO and apoB48-containing particles in 
the Sf>60 and Sf 20-60 fractions were separated by affinity chromatography 
purification using three monoclonal antibodies (4G3, 5E11 and BS0 II 6 ), specific for 
apoBlOO, coupled to Protein G (Sepharose 4 fast flow, GE Healthcare) (as described 
in Section 2.2.3). Samples were mixed with solid-phase bound antibodies (Protein G) 
and incubated on a rotary mixer at 4 °C overnight. The bound particles, containing 
apoBlOO, consisted of a fraction containing the endogenously derived particles. The
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unbound particles consisted of CMs and their remnants which contain apoB48 
(Section 2.2.3). This protocol has been validated by Sun (2008).
For the measurement of TAG glycerol enrichment, total lipid from the apoBlOO and 
apoB48-containing lipoproteins was extracted with chloroform-methanol (2:1) 
(Section 2.2.5) and TAG isolated by TLC (Section 2.2.6). TAG was hydrolysed as 
described in Section 2.2.7 and then glycerol purified by ion exchange chromatography 
(Section 2.2.8). Glycerol was processed to its glycerol triacetate derivative and 
enrichment measured by GC-MS and GC-IRMS. Mass spectrometry results are 
presented as TTR as described in Section 2.2.9. Free plasma glycerol enrichment was 
measured as described in section 2 .2 .1 0 , and used as a measure of a precursor for 
TAG synthesis to enable mathematical modelling of lipoprotein TAG.
HOMA was calculated using the H0MA2 calculator of University of Oxford as 
described in Section 2.2.13. ApoE genotype was measured in the Department of 
Clinical Chemistry, Royal Surrey County Hospital. Plasma TAG, cholesterol, NEFA 
concentration and TAG concentration in the bound and unbound fractions were 
measured enzymatically as described in Section 2.2.11. Plasma glucose concentration 
was measured by YSI as described in Section 2.2.11. Insulin was measured by a 
double antibody radioimmunoassay as described in Section 2.2.12. Tracer 
concentration was calculated using the equation as described in Section 2.2.13. AUC 
was calculated using the trapezoidal rule as described in Section 2.2.13. Calculation 
of FCR, PR and PS was described by a multi-compartmental model as described in 
Section 2.2.14. Data were expressed as means±standard error of the means 
(MeaniSEM).
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3.3 Results
3.3.1 Subjects characteristics
The mean BMI of the subjects was 22.7 ± 0.4 (kg/m^) with an mean age of 59.2 ± 2.7 
years (Table 9). All subjects were healthy, with no history of diabetes, hypertension, 
impaired fasting glucose, cardiovascular or endocrine disease, hepatic, renal disorders 
or any other severe disease. All subjects were homozygous for the E3 allele (E3/E3 
genotype). Mean fasting plasma TAG concentration was 0.89 ±0.1 mmol/L and 
mean total plasma cholesterol level was 5.3 ± 0.4 mmoEL (Table 9).
Age BMI TAG Cholesterol Glucose HOMA
Subject (y) (kg/m )^ (mmol/L) (mmol/L) (mmol/L)
N1 64 21.7 0.83 5.9 3.3 0.4
N2 60 21.9 1 5.2 5.7 0.6
N3 65 22.8 0.93 5.3 5.1 0.8
N4 57 24.2 1.14 6.2 5.5 0.6
N5 50 22.8 0.57 3.8 4.8 0.5
Mean±SEM 59.20±2.71 22.68±0.44 0.89±0.10 5.28±0.41 4.88±0.42 0.59±0.16
3.3.2 Postprandial plasma TAG concentrations
Plasma TAG concentrations showed a rise following the consumption of the first meal. 
TAG levels remained elevated throughout the time course of the study (Figure 30). 
The mean TAG concentration in the steady state period (0-420 minutes) was 1.94 ± 
0.07 mmoI/L, with a mean increase of 64.08 ± 0.06 % above the baseline (-240 
minutes) level (P<0.05). There was no statistically significant difference between 
TAG concentration at 0 and 420 minutes by repeated measures ANOVA although 
there was a tendency for total plasma TAG to decline towards the end of study 
(P>0.05).
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Figure 30 Plasma TAG values remained elevated throughout the time course of the 
study following the consumption of the meal (n=5) (Mean±SEM).
Purple arrows represent the meal time.
3.3.3 Plasma cholesterol concentrations
Plasma cholesterol eoneentrations remained at a constant level during the study period 
(0-420 minutes) with a mean of 4.27 ± 0.03 mmol/L (Figure 31). There was no 
statistieally significant difference between any time point by repeated measures 
ANOVA (P>0.05).
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Figure 31 Plasma cholesterol concentration (n=5) (Mean±SEM).
Purple arrows represent the meal time.
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3.3.4 Plasma NEFA concentrations
Following the consumption of the first meal, plasma NEFA concentrations showed a 
non-significant rise from baseline levels (following 4 hours). The mean of NEFA 
concentration was 0.64 ± 0.03 mmol/L over 0-420 minutes. There was no statistically 
significant difference between any time point by repeated measures ANOVA (P>0.05) 
(Figure 32).
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Figure 32 Plasma non essential fatty acid (NEFA) concentration (n=5) (Mean±SEM).
Purple arrows represent the meal time.
3.3.5 Plasma insulin concentrations
The mean insulin concentration following the consumption of the meals is shown in 
Figure 33. There was a statistically significant difference between the 0 and 420 time 
point by repeated measures ANOVA (P<0.05). There was no significant difference 
between the other time points.
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Figure 33 Insulin concentration following the high fat, low carbohydrate, low protein 
meal with 2 hourly feeding intervals (n=5) (Mean ± SEM).
Purple arrows represent the meal time. (?<0.05 0 minute vs 420 minutes).
3.3.6 Plasma glucose concentrations
Glucose concentrations following the consumption of meal are shown in Figure 34. 
Plasma glucose concentrations remained at a constant level during the study period 
(0-420 minutes) with a mean of 5.13 ± 0.10 mmol/L (Figure 34). There was no 
statistically significant difference between any time point by repeated measures 
ANOVA (P>0.05).
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Figure 34 Glucose concentration following the high fat, low carbohydrate, low protein 
meal with 2 hourly feeding intervals (n=5) (Mean ± SEM).
Purple arrows represent the meal time.
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3.3.7 Lipoprotein subclass concentrations
TAG concentration in Sf>60 lipoprotein fractions increased after the meal and 
remained elevated over the study period (0-420 minutes) (Figure 35). The TAG 
concentration in the Sf 20-60 lipoprotein fractions remained low during the period of 
the study (0-420 minutes) (Figure 36). There was no statistically significant 
difference between TAG concentration at 0 and 420 minutes by repeated measures 
ANOVA (P>0.05) either in the Sf>60 or Sf20-60 fractions.
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Figure 35 TAG concentration in Sf>60 lipoprotein fraction (n=5) (Mean±SEM).
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Figure 36 TAG concentration in Sf 20-60 lipoprotein fraction (n=5) (Mean±SEM).
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3.3.8 Glycerol enrichment
3.3.8.1 Plasma glycerol enrichment
Plasma glycerol enrichment represents the systemic glycerol precursor pool for both 
endogenous and exogenous lipoprotein TAG.
Deuterium-labelled (^Hs) plasma glycerol peaked at 5 minutes and then decreased 
rapidly with the isotopic ratio (m+5/m) returning to baseline values at 120 minutes. 
There was only a baseline level of enrichment of labelled-glycerol (m+3/m) 
detected indicating the oral glycerol tracer or any recycled ^H$-glycerol tracer was not 
detectable in plasma (Figure 37).
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Figure 37 Plasma glycerol enrichment.
^Hs-labelled glycerol (blue line) and -labelled glycerol (pink line) (n=5).
3.3.8.2 TAG enrichment with ^Hs-glycerol
Figure 38 shows the GC-MS data for ^H$-glycerol enriched TAG in the large TRL 
fractions (ST>60) and Figure 39 shows data for the small TRL fractions (Sf20-60). 
Both graphs show the enrichment of the immunoaffinity chromatography separated 
bound (apoBlOO-containing) VLDL TAG and unbound (apoB48-containing) CM
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TAG. Glycerol enrichment in the VLDLl TAG (Sf>60 fraction) peaked at 90 
minutes after administering the intravenous ^H^-glycerol (intravenous) (Figure 38). 
Glycerol enrichment (deuterium) was also measured in the CMl TAG (Sf>60 fraction) 
(Figure 38); this also peaked at 90 minutes.
Glycerol enrichment in VLDL2 TAG (Sf20-60 fraction) (Figure 39) increased more 
slowly than that in the VLDLl TAG (Sf>60 fraction) and peaked at 180 minutes after 
administering the deuterium label (Figure 39, blue line). Glycerol enrichment was 
also measured in the exogenously-derived CM2 TAG (Sf20-60 fraction), which also 
peaked at 180 minutes (Figure 39, pink line).
The enrichment of -labelled glycerol (intravenously administered) was much 
higher in the endogenous (bound: VLDL TAG) than in the exogenous (unbound: CM 
TAG) lipoprotein fractions (Figure 38 and Figure 39).
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Figure 38 GC-MS data for deuterium labelled glycerol in Sf>60 TAG following the 
separation of endogenous (bound: VLDL TAG) and exogenous (unbound: CM TAG) 
fractions by immunoaffinity chromatography (n=5).
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Figure 39 GC-MS data for deuterium labelled glycerol in Sf20-60 TAG following the 
separation of endogenous (bound: VLDL TAG) and exogenous (unbound: CM TAG) 
fractions by immunoaffinity chromatography (n=5 for VLDL2 TAG; n=3 for 90,120 
and 420 minutes of CM2 TAG.
3.3.S.3 Measurement of carbon enrichment following oral administration of ^^ €3 - 
glycerol
Figure 40 shows the enrichment of CMl TAG (Sf>60) and VLDLl TAG (Sf>60) 
with ^^Cs-labelled glycerol following the separation of exogenous (unbound; apoB48) 
and endogenous (bound; apoBlOO) samples by immunoaffinity chromatography. 
Enrichment was measured by GC-combustion-IRMS, a technique which only 
measures carbon isotopes, there being no contribution to enrichment levels by the 
tracer (Section 2.2.9.3). The result shows enrichment peaking at around 180 minutes 
in the CMl TAG (Sf>60) fractions (blue line). There was a very low level of 
enrichment of -glycerol in the endogenous (Sf>60 VLDLl TAG) fraction. This 
result shows the antibody method could indeed successfully separate the endogenous 
and exogenous lipoproteins as only the exogenous lipoproteins showed any measure 
of enrichment (only the meal contains the ^^Cg-glyeerol label which was not detected 
in the endogenously separated particles). There was a small rise in the VLDLl TAG 
towards the end of the study which may have been due to recycling of CMl TAG
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glycerol into VLDLl TAG. At 180 minutes (the peak enrichment for CMl TAG), the 
enriehment of VLDLl TAG was 4 % that of CMl TAG.
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Figure 40 GC-IRMS data for ^^ Cg labelled glycerol (diet derived label) in Sf>60 and 
Sf20-60 TAG following the separation of exogenous (unbound: CM TAG) and 
endogenous (bound: VLDL TAG) fractions by immunoaffinity chromatography.
This technique only measures '^C glycerol (n=5).
The enrichment of the Sf 20-60 fraction could not be measured accurately beeause the 
coneentration of glyeerol was below the limits of detection for the GC-IRMS.
Figure 41 shows the tracer concentration of ^^ Cg- labelled glycerol and ^H$- labelled 
glycerol in the antibody separated CMl TAG fractions (Sf>60). Comparison of tracer 
coneentration of ^^Cg-glycerol and ^Hs-glycerol labelled CMl TAG fractions shows 
that CMl TAG is labelled with -glycerol within 30 minutes (Figure 41). There 
was a longer lag phase before CMl TAG was labelled with ^^Cg-glycerol, probably 
related to gut transit time of the label, with the profiles of both curves being similar.
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Figure 41 The concentration of '^Cs-glycerol and ^Hs-glycerol in CMl TAG (Sf>60) 
(n=5).
Since the dose of labelled glycerol and labelled glycerol were different, the 
tracer concentrations were corrected for the dose. Table 10 shows the results of AUG 
glycerol tracer concentration/dose (total dose of tracer given) of ^^Cg-glycerol and 
^Hs-glycerol labelled CMl TAG. There was no significant difference between 
glycerol labelling and ^Hs-glycerol labelling in the CMl fraction (P = 0.42) (While 
the AUC/dose was similar for the 2 tracers in 3 subjects, it was very different in 2 
subjects). The percentage of ^^Cg-glycerol and ^H$-glycerol that was administered 
that appeared in the systemic circulation over the time course of the study was 5.6 % 
and 2 . 2  %, respectively.
Table 10 The results of AUC/dose of ^^Cg-glycerol and ^Hs-glycerol labelled CMl TAG
Subject
'^Cs-glycerol
AUC/dose
^Hs-glycerol
AUC/dose
N1 0.014 0.017
N2 0.010 0.010
N3 0.004 0.021
N4 0.216 0.045
N5 0.020 0.014
Mean 0.053 0.021
SEM 0.041 0.006
P value 0.42
Abbreviations: AUG, area under curve.
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3.3.8.4 Measurement of endogenous and exogenous TAG kinetics using H5 - 
glyceroltracer
The FCR - the fraction of tracee irreversibly removed from a pool per unit time (e.g. 
pools/day) and the PR - the TAG that enters the pool (Chan et al. 2004) were 
determined by a mathematical model (Section 2.2.14). The PS - the mass of tracee in 
a specific pool was determined as the product of plasma volume and tracee 
concentration (Section 2.2.14). A typical curve fit by the model for VLDLl and 
VLDL2 is shown in Figure 42. A typical curve fit by the model for CMl and CM2 is 
shown in Figure 43.
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Figure 42 A typical curve fit by the model for VLDLl and VLDL2.
SI is the curve fit to VLDLl and S2 is the curve fit to VLDL2. VLDLl and VLDL2 are the 
measured data.
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Figure 43 A typical curve fit by the model for CMl and CM2.
SI is the curve fit to CMl and 82 is the curve fit to CM2. CMl and CM2 are the measured 
data.
The FCR, PR and PS of TAG in endogenous (ST>60, VLDLl and Sf20-60, VLDL2) 
lipoproteins for each subject are shown in Table 11 and represent the kinetics of these 
particles in the postprandial period. The FCR, PR and PS for the exogenous (ST>60, 
CMl and Sf20-60, CM2) lipoproteins for each subject are shown in Table 12.
Table 11 Fractional catabolic rate (FCR, pools/day), Production rate (PR, mg/kg/d) and
FCR(poolsZd)
VLDLl TAG 
(Sf>60)
PR(mg/kg/d) PS(mg) FCR(pools/d)
VLDL2 TAG 
(Sf20-60)
PR(mg/kg/d) PS(mg)
N1 12.63 - - 14.95 - -
N2 14.78 315.54 1449.91 16.33 25T3 104.49
N3 7.06 128.49 1286.30 6 jd 18.88 195.90
N4 12.14 275.71 1685.07 16.55 24.74 110.92
N5 13.82 174.34 996.52 10.27 26J6 203.02
Mean 12.09 223.52 1354.45 12.98 23.83 153.58
SEM 1.34 43.44 144.68 1.91 1.69 2&56
The PR and PS of VLDLl and VLDL2 in N1 could not be calculated due to lack of fraction 
TAG concentration.
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Table 12 Fractional catabolic rate (FCR, pools/day), Production rate (PR, mg/kg/d) and
FCR(pools/d)
CMl TAG 
(Sf>60)
PR(mg/kg/d) PS(mg) FCR(pools/d)
CM2 TAG 
(Sf20-60)
PR(mg/kg/d) PS(mg)
N1 2^89 - - 7.75 - -
N2 23.22 130.60 381.95 - - 36.90
N3 18.55 166.28 633.87 19.94 14.07 49.90
N4 9.35 209.53 1662.05 21.89 5.71 19.35
N5 16.69 84.56 400.26 7.22 328 35.81
Mean 19.54 147.74 769.53 14.20 7.69 35.49
SEM 3.42 26.53 302.98 3.90 3.27 626
The PR and PS of CMl, and CM2 could not be calculated due to lack of fraction TAG 
concentration. The CM2 FCR and PR could not be calculated in N2 due to lack of 
enrichment data.
There was no significant difference between VLDLl and CMl TAG FCR in the 
Sf>60 fraction (P =0.09), although there was a trend towards higher FCR for CMl 
TAG. There was also no significant difference between VLDL2 and CM2 TAG FCR 
(P=0.68). The results also showed VLDLl (Sf^60) and VLDL2 (Sf 20-60) TAG FCR 
were not significantly different (P=0.54) and that the FCRs for CMl (Sf>60) and 
CM2 (Sf 20-60) TAG were not significantly different (P=0.59).
VLDLl TAG PR was significantly higher than VLDL2 TAG PR (P=0.02); CMl 
TAG PR was significantly higher than CM2 TAG PR (P=0.05). There was no 
significant difference between VLDLl and CMl TAG PR (P=0.19) and no significant 
difference between VLDL2 PR and CM2 TAG PR (P=0.11).
VLDLl TAG PS was significantly higher than VLDL2 TAG PS (P=0.006); CMl 
TAG PS was significantly higher than CM2 TAG PS (P=0.05); VLDLl TAG PS was 
not significantly different from CMl TAG PS (P=0.07); VLDL2 TAG PS was 
significantly higher than CM2 TAG PS (P=0.01).
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The FCR of CMl TAG was significantly negatively correlated with BMI (r=-0.97, 
P=0.02) (Figure 44), but not age (P=0.35), fasting TAG concentration (P=0.68), 
plasma volume (P=0.13) or HOMA (P= 0.45). The FCR of CM2 TAG (P=0.42), 
VLDLl TAG (P=0.45) and VLDL2 TAG (P=0.78) showed no significant correlations.
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Figure 44 Correlation of BMI with CM (Sf>60) TAG FCR.
3.4 Discussion
This in vivo study describes the use of two different labelled glycerol tracers to 
measure TAG metabolism in the postprandial period. The differently labelled 
glycerols were introduced intravenously (^H^-glycerol) and orally (^^Cs-glycerol) to 
follow both endogenous and exogenous lipoprotein metabolism. Endogenous (liver- 
derived) and exogenous (diet- derived) lipoproteins were separated using a previously 
validated immunoaffinity chromatography technique. The current study provided a 
measure of the kinetics of TAG substrate within the particles rather than the kinetics 
of the proteins associated with the particles (Duvillard et al. 2005; Hogue et al. 2008; 
Welty et al. 1999; Welty et al. 2004; Lichtenstein et al. 1992).
The results from this study showed that intravenously administered tracer (^H$-
glycerol) was detected in both endogenously (hepatic, i.e. VLDL) as well as
exogenously (intestinal, i.e. CM) derived TAG. This data suggests endogenous
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glycerol (circulation sourced) can be incorporated into TAG in the enterocytes and 
secreted in CMs during the postprandial period. The orally administered label (^ ^Cg - 
glycerol; diet-derived label) was, as expected, found to be almost completely 
associated with the exogenous fraction of lipoproteins (CMl) with less than 4 % 
appearing in VLDLl. The appearance of ^^Cg-glycerol in VLDLl only occurred 
towards the end of the study and suggests this may be due to recycling of CM TAG 
into VLDL TAG in the liver. This provided a validation that the immunoaffinity 
chromatography method was efficiently separating CM and VLDL.
In the present study, a continuous feeding protocol was used to achieve a relatively 
steady plasma TAG concentration in the postprandial period. TAG levels remained 
elevated throughout the time course of the study although there was a small decline 
towards the end of the study (Figure 30). This when compared to other studies 
resulted in a much higher rise plasma TAG in the postprandial period. Other studies 
have used continuous feeding protocols generally show much lower rises in plasma 
TAG or do not report TAG levels (Duvillard et al. 2005; Hogue et al. 2008; Welty et 
al. 1999; Welty et al. 2004; Lichtenstein et al. 1992).
Following the consumption of the meal, plasma insulin concentration showed a rise 
from baseline levels towards the end of the study. There was a statistically significant 
difference between the 0 and 420 time point by repeated measures ANOVA (P<0.05) 
(Figure 33). The feeding protocol in the present study contained meals with high fat, 
low carbohydrate and low protein content. NEFA concentrations did not decrease 
with multiple meals as might be expected; this might be due to the low carbohydrate 
meal, which resulted in a low insulin release, and this might hamper the inhibition
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effect of insulin on HSL. This could also have been due to increased fatty acid 
‘spillover’ into the systemic plasma during the extended postprandial period. This 
may contribute up to 40-50 % of the total plasma NEFA pool in the postprandial 
period (McQuaid et al. 2011; Karpe et al. 2011). Another possible explanation might 
be the hourly samples measurement in current study, thus the expected patterns may 
have been missed which happened quickly.
3.4.1 TAG kinetics in endogenous and exogenous lipoproteins
3.4.1.1 TAG kinetics in endogenous lipoproteins
A number of studies have utilized ^Hs-glycerol to measure total VLDL TAG kinetics 
in vivo (Lemieux et al. 1999; Patterson et al.2002; Adiels et al.2005; Adiels et al.2006; 
Mittendorfer et al. 2003; Sun 2008). However, all but one of these studies was 
performed in the postprandial state.
Adiels et al. (2005b) performed the only study that differentiated between VLDLl 
and VLDL2 TAG rather than measuring total VLDL TAG. They measured fasting 
VLDLl and VLDL2 TAG kinetics in 17 healthy subjects (age, 49 ± 9; BMI, 26.4 ± 
2.4) after giving each individual a bolus dose of ^ Hg-glycerol (500 mg).
VLDLl TAG FCR (15.2 pools/d) and VLDL2 TAG FCR (14.0 pools/d) in the study 
of Adiels et al. (2005b) were similar but approximately 15% higher than those 
reported in the present postprandial study (12.09 and 12.98 pools/d respectively). 
This may suggest that in the postprandial state, VLDL FCR may be lower due to 
competition with CM particles for LPL. The authors also reported that the FCRs for
108
VLDLl and VLDL2 were very similar. This was consistent with the present study 
findings.
Adiels et al. (2005b) reported that mean VLDLl and VLDL2 TAG PR was 218 and
27.2 mg/kg/d, respectively. This was very similar to the results obtained in the 
present study (223.52 and 23.83 mg/kg/d, respectively). Although the current study 
was a postprandial study, the mean plasma TAG concentrations (1.94mmol/L) were 
not much higher (1.54 mmol/L) than in the fasting study undertaken by Adiel (2005b). 
These individuals had much higher fasting TAG levels than those in the current study 
(0.89 mmol/L).
Sun (2008) measured fasting and fed VLDLl and VLDL2 TAG in 6  healthy subjects 
with an intravenous bolus of ^ Hs-glycerol. The feeding protocol and methodology for 
separating VLDL and CMs was identical to that used in the current study and showed 
VLDLl and VLDL2 TAG FCR were not different in the fed and fasted state. 
However, postprandial VLDLl and VLDL2 TAG FCR were much higher in this 
study (52.2 pools/d; 20.4 pools/d) than those obtained in the current study. This may 
be due to the age of the subjects, which was higher in the current study (59.2±2.7 v^ . 
36.8±3.9 years).
Several studies, have measured VLDL kinetics in the postprandial state, by labelling 
apoB 100. For example, Cohn et al. (1990) measured VLDL (a mixture of VLDLl 
and VLDL2) apoB 100 production in six male subjects in the fasted and fed state 
using a constant i.v infusion of deuterated leucine. The study showed VLDL apoB 
100 PS and PR were greater in the fed than fasted state. The results also showed
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VLDL apoBlOO FCR was lower in the fed state than fasted state, which suggests a 
slower removal of VLDL. It is known that in the postprandial state, CM will compete 
with VLDL for lipolysis by LPL and that CM TAG has been shown to be the 
preferred substrate for LPL (Cohn et al. 1990; Bjôrkegren et al. 1996; Karpe et 
al. 1997).
3.4.1.2 TAG kinetics in exogenous lipoproteins
Sun (2008) described the measurement of the metabolism of both endogenous and 
exogenous CM TAG in vivo in both a fasted and fed state using a bolus of intravenous 
^Hs-glycerol administration after separation of the endogenous and exogenous 
lipoproteins by immunoaffinity chromatography. In the fed state, the subjects (2 
males, 4 females; age 24-55) consumed meals (486 kcal per meal, 11 % of 
carbohydrate, 1 % protein and 8 8  % fats) every 2 hours for 13 hours. The only 
difference in her protocol was that ^^Cg-glycerol was not included in the meal. The 
present study additionally incorporated ^^Cg-glycerol in the third meal. Sun (2008) 
showed that CMl FCR was significantly higher than CM2 FCR; however, this trend 
was not demonstrated in the current study.
Both studies showed CMl TAG FCR was significantly negatively correlated to BMI, 
but not age or fasting TAG concentration. In the fed state, insulin sensitivity may 
affect the response to the feeding protocol. For example, insulin sensitivity may be 
related to the release of LPL which is a major factor controlling the clearance of TAG 
in plasma. Rattarasam et al. (2003) reported insulin sensitivity was inversely 
correlated with BMI in healthy men. Higher BMI might reduce LPL insulin 
sensitivity which results in a decrease in CMl TAG FCR.
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All other studies have measured apoB48 particle kinetics rather than TAG kinetics. 
These studies have therefore utilized an infusion of a labelled amino acid to measure 
the kinetics of the proteins (apoBlOO and apoB48) which are specifically associated 
with either endogenous or exogenous particles (Hogue et al.2008; Zheng et al.2006). 
This provides a measure of particle kinetics rather than a measurement of the kinetics 
of TAG within the particle.
No previous studies have used oral ^^Cg-glycerol to trace exogenous TAG 
metabolism, although [U^^C]-palmitic acid has been given orally with an intravenous 
administration of ^H2 -palmitate to trace exogenous and endogenous VLDL-TAG, 
respectively (Heath et al.2003). Immunoaffinity chromatography using specific 
monoclonal antibodies was also used to separate CM and VLDL. A study of healthy 
men by Bickerton et al. (2007) measured the incorporation of oral [U^^C]-palmitic 
acid into the CM fraction. The authors found the peak of ^^C-Labelled CM occurred 
180 minutes after giving the oral dose, a similar time to that which occurred in the 
present study. A limitation of the study was that they used a non-steady-state 
condition. In the present study, continuous feeding was used in order to achieve a 
steady state. Both studies utilising the fatty acid tracers investigated the contribution 
of dietary fatty acids to VLDL TAG, so there was little information about CM-TAG 
kinetics (Heath et al.2003; Bickerton et al. 2007). Their results suggested that during 
early time points newly released CMs are available for hydrolysis by LPL and that at 
later time points, plasma TAG-[U^^C]-palmitic acid was no longer confined to CMs, 
and represented newly synthesised VLDL-TAG(Heath et al.2003; Bickerton et al. 
2007).
I l l
The previous studies (Cohn et al. 1990; Hogue et al.2008; Zheng et al.2006) provided 
a measure of particle kinetics, they did not provide a measure of the TAG kinetics 
within the particle. The present study managed to measure VLDL TAG and CM 
TAG kinetics and managed to trace apoB48-containing lipoproteins and apoBlOO- 
containing lipoprotein in a postprandial steady state.
In the current study, an oral tracer (^^Cg- glycerol) in combination with intravenous 
tracer (^Hg-glycerol) was simultaneously administered. The results showed that the 
percentage of the ^^Cg-glycerol of CMl fraction (Sf>60) that appeared in the systemic 
circulation was 5.3 %, whereas the ^Hg-glycerol of CMl fraction (Sf>60) appearing in 
the systemic circulation was 2.1 % (Table 10). This difference was not significant 
and suggests similar use of the oral glycerol tracer for CMl TAG synthesis as the 
intravenous tracer. The study confirms that plasma glycerol can be used in the 
enterocytes to synthesise of CM TAG in the postprandial state and that this glycerol is 
utilised in a similar way to exogenous TAG. However, it is still not clear if 
endogenous glycerol and exogenous glycerol are mixed in one TAG assembly pool or 
separated into different pools. This can be further investigated using an in vitro cell 
culture model.
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Chapter 4 Incorporation o f  ^^Cs-labelled glycerol into 
triacylglycerol and phospholipids by Caco2 cells
4.1 Background
Enterocytes are polarized absorptive cells responsible for the movement of nutrients 
across the intestinal epithelium from the gut lumen to the bloodstream (Frayn 2010). 
Glycerol as a product of the digestion of dietary TAG, either in the form of free 
glycerol or MAG is taken up by enterocytes and re-synthesised back into TAG, 
packaged into CM particles and secreted into the circulation. Glycerol as a substrate 
is often neglected in discussions of metabolic pathways but plays a vital role in 
physiological and pathophysiological processes (Brisson et al. 2001). Its utilization 
for the synthesis of TAG in the small intestine has not been fully described.
Evidence shows that fatty acids and MAG, all hydrolysis products of dietary TAG can 
be taken up into enterocytes across both the apical and basolateral plasma membranes 
(Trotter & Storch, 1991; Trotter et al. 1996; Ho & Storch 2001; Ho et al. 2002; Storch 
et al. 2008). However, there appears to be no evidence to suggest that glycerol taken 
up from the basolateral surface of enterocytes, i.e. on the “opposite side to gut lumen” 
can be used for the re-synthesis of TAG in enterocytes, especially during the 
postprandial state. The purpose of this investigation was to determine whether 
enterocytes, grown as a polarized monolayer in cell culture, can synthesise TAG and 
PL from basolaterally-(endogenously) supplied glycerol as well as apically-derived 
glycerol.
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This study utilized polarized Caco2 cells grown on Transwell® plates, allowing for 
the separation of apical and basolateral compartments. OA was reported to be the 
most potent stimulator of lipoprotein secretion by Caco2 cells than the other fatty 
acids (van Greevenbroek et al. 2000). Therefore OA is employed as the main lipid 
stimulator in the current study. TAG and PL metabolism was measured following the 
addition of a trace quantity (60 pM) of stable isotopically-labelled ^^Cg-glycerol. This 
was added to either apical or basolateral surfaces in the presence or absence of OA. 
The enrichment of ^^Cg-labelled glycerol measured in TAG and PL pools isolated 
from the basolateral media and Caco2 cells (i.e. intracellular) was determined by GC- 
MS. It has been shown that different glucose media concentrations affected TRL 
assembly and secretion (Pauquai et al. 2006). The latter author reported that Caco2 
cells secreted more TRLs when cultured in low glucose media (0 and 5 mM glucose 
in the apical and basal compartments respectively) than in high glucose media (25 
mM glucose in both compartments) following incubation with lipid micelles. 
Therefore the effect of incubating Caco2 cells in high (25 mM) and low (5 mM) 
glucose media was also investigated in the current study.
4.2 Methods
Cell culture methods including culture conditions, sample collection and analysis are 
described in Section 2.3.
Confluent Caco2 cell monolayers were supplemented with labelled ^^Cg-glycerol (60 
pM) in the presence or absence of OA (0.5 mM) in either the apical or basolateral 
compartments. Incorporation of glycerol into TAG and PL was measured when cells 
were cultured under conditions of high (25 mM) and low glucose (5 mM) for a period
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of 24 h (Table 13). All the experiments were performed in replicates (n=3) in the 
present study.
Table 13 Different treatment conditions under which Caco2 cells were cultured
Treatment Surface Media glucose_____________________Measurements____________________
TAG enriclmaent and concentration PL enrichment PL concentration
No OA Apical H i^ Cdk-rBL media Cells+BL media BL media
No OA Apical Low CeHs-rBL media CeUs-rBL media BL media
40A Apical High CeUs-rBL media Ceïïs-rBL media BL media
tOA Apical Low Cdls-^BL media Ceüs-î-BL media BL media
No OA BL High Cdls-rBL media Cefls-rBL media BL media
No OA BL Low Cells+BL media CeUs-rBL media BL media
4-OA BL High CeHs4-BL media Cdls+BL media BL media
-Î-OA BL Low CeUsi-BL media CeUs-rBL media BL media
High glucose, 25 mM glucose in both compartments; Low glucose, 5 mM glucose in both 
compartments. Abbreviations: OA, oleic acid; TAG, triacylglycerol; PL, phospholipids; BL, 
basolateral.
4.3 Results
4.3.1 Transepithelial electrical resistance (TEER) measurements for assessing the 
integrity of Caco2 cell monolayers
The formation of tight junctions (TJ), assessed by TEER, can be used to confirm 
monolayer integrity, adhesion to a matrix and polarization (Lugo- Martinez et al. 
2009). After reaching confluence, monolayer TEER was measured daily. As 
indicated in Figure 45, TEER values increased as Caco2 cells were cultured over time. 
The TEER values showed that at least 21 days was required for culture after seeding 
to enable the formation of intact monolayers. All subsequent studies where cells were 
utilized for experiments were carried out at day 21 post confluence (Ohashi et al. 
2009; Bateman et al. 2007).
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Figure 45 Electrical resistance across the cells on the micropore membrane was 
measured by a Millicell-ERS electrical meter.
TEER was measured using a membrane culture area of 4.67 cm^ and showed maximum 
resistance at day 21. The data represents 4 independent cell culture experiments (mean ± SD) 
(*P<0.05 day 10 V5 day 0; **P<0.01 day 15, 20, 25 V5 day 0).
4.3.2 TAG metabolism measured with ^^Cg-glycerol tracer in the apical or 
basolateral compartment with and without OA incubated under different media 
glucose concentrations in Caco2 cells
4.3.2.1 TAG concentration in cells and basolateral media following incubation 
with ^^Cg-glycerol tracer with and without OA in the apical or basolateral 
compartment under conditions of either high or low glucose media
4.3.2.1.1 Apical incubation of ^^Cs-glycerol tracer with and without OA
In the absence of OA in the apical compartment, cellular TAG concentration (Figure 
46) and TAG concentration in the basolateral media (Figure 47) was low when cells 
were incubated in either high or low glucose media. The addition of OA to the apical 
surface induced a significant increase in intracellular TAG concentration (2.2 and 2.6- 
fold, high and low glucose respectively; P<0.001; Figure 46) and a significant 
increase in TAG concentration in the basolateral media (2.6 and 3.0-fold, high and 
low glucose respectively; P<0.001; Figure 47). There was no significant difference in
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the concentrations of cellular and media TAG when cells were cultured in either high 
or low glucose media (P>0.05) (Figure 46 and Figure 47).
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Figure 46 Concentration of cellular TAG following incubation with ^^ Ca-glycerol (60 i^M) 
with or without OA (0.5 mM) in the apical compartment cultured under conditions of 
high glucose media (open bars) or low glucose media (hatched bars) for 24 h.
Data are expressed as mean ± SD for n=3 independent experiments. ***P< 0.001. 
Abbreviations: OA, oleic acid; ns, no significant difference.
_  0.08-
p T  p r
=  High glucose Ezzi Low glucose
Figure 47 Concentration of TAG in the basolateral media following incubation with 
^^ Ca-glycerol (60 pM) with or without OA (0.5 mM) in the apical compartment cultured 
under conditions of high glucose media (open bars) or low glucose media (hatched bars) 
for 24 h.
Data are expressed as mean ± SD for n=3 independent experiments. ***P< 0.001. 
Abbreviations: OA, oleic acid; ns, no significant difference.
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4.3.2.1.2 Basolateral incubation of ^^Cs-glycerol tracer with and without OA
In the absence of OA in the basolateral compartment, cellular TAG concentration 
(Figure 48) and TAG concentration in the basolateral media (Figure 49) was low 
when cells were incubated in either high or glucose media. The addition of OA to the 
basolateral surface induced a significant increase in intracellular TAG concentration 
(2.9-fold, both in high and low glucose; P<0.001; Figure 48) and a significant 
increase in TAG concentration in the basolateral media (0.9 and 1.6-fold, high and 
low glucose respectively; P<0.01 and P< 0.001 respectively; Figure 49). There were 
no significant differences in the concentration of cellular TAG or basolateral media 
TAG when cells were incubated under conditions of either high glucose or low 
glucose (Figure 48 and 49).
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Figure 48 Concentration of cellular TAG following incubation with ^^C3-glycerol(60pM) 
and OA(0.5mM) in the basolateral compartment, serum free media in the apical 
compartment cultured in high glucose media(open bars) or low glucose media(hatched 
bars) for 24h.
Data are expressed as mean ± SD for n=3 independent experiments. ***? < 0.001. 
Abbreviations: OA, oleie acid; ns, no significant difference.
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Figure 49Concentration of TAG in the basolateral media following incubation with ^^ €3- 
glycerol(6 G^ iM) and OA(0.5mM) in the basolateral compartment, serum free media in 
the apical compartment cultured in high glucose media or low glucose media for 24h.
Data are expressed as mean ± SD for n=3 independent experiments. **P < 0.01,
***? < 0.001. Abbreviations; OA, oleic acid; ns, no significant difference.
In summary, this data shows that cellular and basolateral media TAG concentrations 
increased when OA was added either to the apical or basolateral compartment (Figure 
46-49). There was no significant difference in the concentration of cellular TAG and 
TAG concentration in the basolateral media when culturing under conditions of either 
high glucose or low glucose (Figure 46-49).
4.3.2.2 Enrichment of TAG with ^^Cs-glycerol in cells and basolateral media 
following incubation with ^^Cg-glycerol tracer with and without OA in the apical 
or basolateral compartment under conditions of either high or low glucose media
4.3.2.2.1 Apical incubation of ^ ^Cs-glycerol tracer with and without OA
In the absence of OA (^^Cs-glycerol only in the apical compartment), the level of 
cellular TAG enrichment was relatively low under high glucose culture conditions 
(Figure 50). The addition of OA induced a significant increase in intracellular TAG 
enrichment (2.6-fold; P<0.001) and a significant increase in TAG enrichment in 
basolateral media (7.3-fold; P<0.001) when compared to the absence of OA (Figure
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50). TTR was higher in the basolateral media than in the cells following addition of 
OA (Figure 50).
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Figure 50 Enrichment of cellular TAG and TAG in the basolateral media following 
incubation with ^^Ca-glycerol (60 i^M) and OA (0.5 mM) in the apical compartment 
cultured under conditions of high glucose media for 24 h.
Data are expressed as mean ± SD for n=3 independent experiments. ***p < 0.001. 
Abbreviations: OA, oleic acid; TTR: tracer to tracee ratio.
Similarly, when incubated in low glucose media, the level of cellular TAG enrichment 
was low without the addition of OA (^^Cs-glycerol only in the apical compartment). 
The addition of OA induced a significant increase in intracellular TAG TTR (4.6-fold; 
P<0.001) and a significant increase in TAG enrichment in the basolateral media (3.0- 
fold; P<0.001) (Figure 51). Again, the TTR was higher in the basolateral media than 
in the cells following the addition of OA (Figure 51).
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Figure SlEnrichment of cellular TAG and TAG In the basolateral media following 
Incubation with ^^ Cs-glycerol (60 ^M) and OA (0.5 mM) In the apical compartment 
cultured under conditions of low glucose media for 24 b.
Data are expressed as mean ± SD for n=3 independent experiments. ***P < 0.001. 
Abbreviations: OA, oleic acid; TTR: tracer to tracee ratio.
Higher levels of TAG enrichment in the basolateral media were observed in the 
absence of OA and following the addition of OA when culturing under conditions of 
low glucose media as compared to high glucose media (Figure 52). A greater 
increase in the enrichment level of cellular TAG following addition of OA was also 
observed when culturing under conditions of low glucose when compared to high 
glucose media (Figure 52).
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Figure 52 Comparison of intracellular TAG enrichment and enrichment of TAG in the 
basolateral media following incubation with ^^ Cs-glycerol (60pM) and OA (O.SmM) in 
the apical compartment cultured in high glucose media vs in low glucose media for 24h. 
***P < 0.001. Abbreviations: OA, oleic acid; TTR: tracer to tracee ratio.
In summary, in the absence of OA, very little tracer was incorporated into TAG; TTR 
was higher in the basolateral media than in the cells after the addition of OA apically, 
indicating the tracer incorporated into TAG in the cells was diluted in a larger TAG 
pool. More tracer was incorporated into TAG under culture conditions of low glucose 
media.
4.3.2.2.2 Basolateral incubation of ^^Cg-glycerol tracer with and without OA
In the absence of OA (^^Cg-glycerol only in the basolateral compartment), 
incorporation of the glycerol tracer into TAG was low in the cells and basolateral 
media when cells were cultured in high glucose media (Figure 53). In the presence of 
OA, glycerol enrichment was significantly increased in the cells (1.5-fold; P<0.001) 
and basolateral media (3.7-fold; P<0.001) (Figure 53). TTR was higher in basolateral 
media than cells (P<0.05) (Figure 53).
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Figure 53 Enrichment of cellular TAG and TAG in the basolateral media following 
incubation with ^^ Cg-glycerol (60 jiM) and OA (0.5 mM) in the basolateral compartment 
cultured under conditions of high glucose media for 24 h.
Data are expressed as mean ± SD for n=3 independent experiments. *P < 0.05, ***P < 0.001. 
Abbreviations: OA, oleic acid; TTR: tracer to tracee ratio.
Similarly, when cultured in low glucose media, in the absence of OA (^^Cg-glycerol 
only in the basolateral compartment), incorporation of the glycerol tracer into TAG 
was low in the cells and basolateral media (Figure 54). In the presence of OA, 
glycerol enrichment was significantly increased in the cells (1.0-fold; P<0.001) and 
basolateral media (2.1-fold; P<0.001; Figure 54). TTR was higher in basolaeral 
media than cells (P<0.05) (Figure 54).
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Figure 54Enrichment of cellular TAG and TAG in the basolateral media following 
incubation with ^^ Cs-glycerol (60 ^M) and OA (0.5 mM) in the basolateral compartment 
cultured under conditions of low glucose media for 24 h.
Data are expressed as mean ± SD for n=3 independent experiments. *P < 0.05, ***P < 0.001. 
Abbreviations: OA, oleic acid; TTR: tracer to tracee ratio.
As was the case for glycerol and OA during apical supplementation, incubation in low 
glucose media resulted in higher enrichment than the corresponding treatment in high 
glucose media (Figure 55).
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Figure SSComparison of intracellular enrichment and enrichment of TAG in the 
basolateral media following incubation with ^^Cg-glycerol(60pM) and OA(0.5 mM) in 
the basolateral compartment cultured in high glucose media vs cultured in low glucose 
media for 24h.
* * * P  < 0.001. Abbreviations: OA, oleic acid; TTR: tracer to tracee ratio.
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In summary, in the absence of OA, very little tracer was incorporated into TAG and 
TTR was higher in the basolateral media than in the cells after the addition of OA. 
This indicated the tracer incorporated into TAG in the cells was being diluted by a 
larger TAG pool, as was the case for glycerol and OA following apical 
supplementation. More tracer was incorporated into TAG in the presence of low 
glucose.
4.3.3 PL metabolism measured with ^^Cs-glycerol tracer in the apical or 
basolateral compartment with and without OA incubated under different media 
glucose concentrations in Caco2  cells
4.3.3.1 PL concentration in the basolateral media following incubation with 
glycerol tracer with and without OA in the apical or basolateral compartment 
under conditions of either high or low glucose media
4.3.3.1.1 Apical incubation of ^^Cs-glycerol tracer with and without OA
There was no significant difference in the concentration of PL in the basolateral 
media when culturing under conditions of either high or low glucose media with or 
without OA (Figure 56). Cellular PL concentrations were not determined in the 
current study.
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Figure 56 Concentration of PL in the basolateral media following incubation with *^ €3- 
glycerol (60 |uM) and OA (0.5 mM) in the apical compartment cultured in high glucose 
media(open bars) or low glucose media(batcbed bars) for 24 b.
Data are expressed as mean ± SD for n=3 independent experiments. Abbreviations: OA, oleic 
acid. There was no significant difference between conditions.
4.3.3.1.2 Basolateral incubation of ^ ^Cs-glycerol tracer with and without OA
There was also no significant difference in PL concentration in the basolateral media 
when cultured under conditions of either high or low glucose (Figure 57).
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Figure 57 Concentration of PL in the basolateral media following incubation with ^^ Cg- 
glycerol (60 pM) and OA (0.5 mM) in the basolateral compartment cultured in high 
glucose media (open bars) or low glucose media (batched bars) for 24 b.
Data are expressed as mean ± SD for n=3 independent experiments. Abbreviations: OA, oleic 
acid. There was no significant difference between conditions.
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4.3.3.2 Enrichment of PL with ^^Cs-glycerol in ceils and basolateral media 
following incubation with ^^Cs-glycerol tracer with and without OA in the apical 
or basolateral compartment under conditions of either high or low glucose media
4.3.3.2.1 Apical incubation of ^^Cg-glycerol tracer with and without OA
There were no significant differences observed in the enrichment of PL in the 
basolateral media when cells were treated with or without OA (Figure 58 and 59). 
The addition of OA induced an increase in the cellular enrichment of PL (P<0.05) 
(Figure 58). This increase in cellular enrichment with OA was higher when culturing 
under conditions of low glucose media (P<0.001) (Figure 59). As was the case with 
TAG, TTR was higher in the media than in the cells in the absence and in the 
presence of OA (Figure 58 and Figure 59).
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Figure 58 Enrichment of cellular PL and PL in the basolateral media following 
incubation with ^^ Cs-glycerol (60 pM) and OA (0.5 mM) in the apical compartment 
cultured under conditions of high glucose media for 24 h.
Data are expressed as mean ± SD for n=3 independent experiments. *P < 0.05, ***P < 0.001. 
Abbreviations: OA, oleic acid; TTR: tracer to tracee ratio.
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Figure 59 Enrichment of cellular PL and PL in the basolateral media following 
incubation with ^^ Cs-glycerol (60 fiM) and OA (0.5 mM) in the apical compartment 
cultured under conditions of low glucose media for 24 h.
Data are expressed as mean ± SD for n=3 independent experiments. ***? < 0.001. 
Abbreviations: OA, oleic acid; TTR: tracer to tracee ratio.
Enrichment levels of PL in the cells and basolateral media were higher when eultured 
under eonditions of low glucose eompared to high glucose (Figure 60).
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Figure 60Comparison of intracellular PL enrichment and enrichment of PL in the 
basolateral media following incubation with *^C3-glycerol(60pM) and OA(0.5mM) in the 
apical compartment cultured in high glucose media vs cultured in low glucose media for 
24h.
*P < 0.05, ***P < 0.001. Abbreviations: OA, oleic acid; TTR: tracer to tracee ratio.
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In summary, unlike TAG, OA had no effect on the concentration or TTR of PL in the 
basolateral media. Incubation in low glucose media increased PL TTR but had no 
effect on PL concentration and was contrary to that which was shown for TAG. The 
addition of OA also increased cellular PL TTR.
4.3.3.2.2 Basolateral incubation of ^^Ca-glycerol tracer with and without OA
There was no significant difference in the enrichment of cellular or basolateral media 
PL under conditions of high glucose with or without the presence of OA (Figure 61). 
TTR was higher in the media than in cells with or without the presence of OA (Figure 
61).
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Figure 61 Enrichment of cellular PL and PL in the basolateral media following 
incubation with ^^ Cs-glycerol (60 pM) and OA (0.5 mM) in the basolateral compartment 
cultured under conditions of high glucose media for 24 h.
Data are expressed as mean ± SD for n=3 independent experiments. ***? < 0.001. 
Abbreviations: OA, oleic acid; TTR: tracer to tracee ratio.
However, when cultured under conditions of low glucose media, a significant increase 
in enrichment level of basolateral media PL was measured when OA was added to the 
cells (Figure 62 and Figure 63). TTR was higher in media than in cells with or 
without the presence of OA (Figure 62).
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Figure 62 Enrichment of cellular PL and PL in the basolateral media following 
incubation with ^^Cs-glycerol (60 i^M) and OA (0.5 mM) in the basolateral compartment 
cultured under conditions of low glucose media for 24 h.
Data are expressed as mean ± SD for n=3 independent experiments. ***P < 0.001. 
Abbreviations: OA, oleic acid; TTR: tracer to tracee ratio.
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Figure 63Comparison of intracellular enrichment and enrichment of PL in the 
basolateral media following incubation with ^^Cs-glycerol (60pM) and OA (O.SmM) in 
the basolateral compartment cultured in high glucose media vs cultured in low glucose 
media for 24h.
***P < 0.001. Abbreviations: OA, oleic acid; TTR: tracer to tracee ratio.
In summary, the addition of OA had no effect on concentration of PL released into the 
media. OA had no effect on TTR of cellular PL when the cells were cultured under 
conditions of either high or low glucose media. However, TTR of PL in the 
basolateral media increased significantly after the addition of OA to the basolateral
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compartment when the cells were incubated under conditions of low glucose media. 
Incubating in low glucose media increased PL TTR in the basolateral media but had 
no effect on PL media concentration. TTR was higher in media than cells in the 
absence and presence of OA, indicating labelled PL in cells was being diluted by a 
larger pool of intracellular PL. In the current study, a PL pool refers to all 
intracellular PL and does not represent a storage depot of available PL.
4.3.4 Comparison of the effect of ^ ^Ca-glycerol and OA apical versus basolateral 
supplementation on Caco2 cells
This data clearly demonstrates Caco2 cells can utilize glycerol from both the apical 
and basolateral media and incorporate this molecule into TAG and PL in the presence 
or absence of OA.
4.3.4.1 Comparison of TAG concentration in cells and basolateral media (apical 
versus basolateral supplementation)
Under conditions of high glucose media, there was no significant difference in 
cellular TAG concentration when ^^Cs-glycerol and OA was added to either the apical 
or basolateral surface (P>0.05) (Figure 64). However, the concentration of TAG in 
the basolateral media was lower when ^^Cs-glycerol and OA were loaded 
basolaterally (P<0.01) (Figure 65).
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Figure 64 Comparison of intracellular TAG concentration when ^^ Ca-glyccrol (60 pM) 
and OA (0.5 mM) was added to the apical compartment (open bars) vs the basolateral 
compartment (hatched bars) cultured in high glucose media.
TAG concentration in cells was measured following incubation with ^^Cg-glycerol (60 pM) 
and OA (0.5 mM) in the apical compartment (open bars) and the basolateral compartment 
(hatched bars) cultured in high glucose media for 24 h. Data are mean ± SD for n = 3 
independent experiments. Abbreviations: OA, oleic acid.
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Figure 65 Comparison of TAG concentration in the basolateral media when^^Cg-glycerol 
(60 pM) and OA (0.5 mM) was added to the apical compartment (open bars) V5  the 
basolateral compartment (hatched bars) cultured in high glucose media.
TAG concentration in basolateral media was measured following incubation with '^ Cg- 
glycerol (60 pM) and OA (0.5 mM) in the apical compartment (open bars) and the basolateral 
compartment (hatched bars) cultured in high glucose media for 24 h. Data are mean ± SD for 
n = 3 independent experiments. **P < 0.01. Abbreviations: OA, oleic acid.
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Similarly, when incubating in low glucose media there was no significant difference 
in cellular TAG concentration when ^^Cg-glycerol and OA was added to either the 
apical or basolateral compartment (P>0.05) (Figure 66). However, the concentration 
of TAG in the basolateral media was lower when ^^Cs-glycerol and OA were loaded 
basolaterally (P<0.001) (Figure 67).
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Figure 6 6  Comparison of intracellular TAG concentration when ^^ Cs-glycerol (60 pM) 
and OA (0.5 mM) was added to the apical compartment (open bars) vs the basolateral 
compartment (hatched bars) cultured in low glucose media.
TAG concentration in cells was measured following incubation with ^^Cs-glycerol (60 pM) 
and OA (0.5 mM) in the apical compartment (open bars) and the basolateral compartment 
(hatched bars) cultured in low glucose media for 24 h. Data are mean ± SD for n = 3 
independent experiments. Abbreviations: OA, oleic acid.
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Figure 67 Comparison of TAG concentration in the basolateral media when^^Cg-glycerol 
(60 pM) and OA (0.5 mM) was added to the apical compartment (open bars) vs the 
basolateral compartment (hatched bars) cultured in low glucose media.
TAG concentration in basolateral media was measured following incubation with ^^ Cg- 
glycerol (60 pM) and OA (0.5 mM) in the apical compartment (open bars) and the basolateral 
compartment (hatched bars) cultured in low glucose media for 24 h. Data are mean ± SD for 
n = 3 independent experiments. ***P < 0.001. Abbreviations: OA, oleic acid.
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4.3.4.2 Comparison of PL concentration in the basolateral media (apical versus 
basolateral supplementation)
There was no significant difference in the basolateral media PL concentration under 
any of the conditions tested, i.e. with or without OA added to the apical or basolateral 
media when cultured under conditions of either high (Figure 68) or low (Figure 69) 
glucose concentration.
0.010
s
— 0.008 H
SL
re 0.006- 
I  0.0044
0.000
[=□ Apical Glycerol and OA EZ3 Basolateral Glycerol and OA
Figure 68 Comparison of PL concentration in the basolateral media when^^Ca-glycerol 
(60 pM) and OA (0.5 mM) was added to the apical compartment (open bars) vs the 
basolateral compartment (hatched bars) cultured in high glucose media.
PL concentration in basolateral media was measured following incubation with ^^ €3-glycerol 
(60 pM) and OA (0.5 mM) in the apical compartment (open bars) and the basolateral 
compartment (hatched bars) cultured in high glucose media for 24 h. Data are mean ± SD for 
n = 3 independent experiments. Abbreviations: OA, oleic acid. There was no significant 
difference between conditions.
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Figure 69 Comparison of PL concentration in the basolateral media when^^Cg-glycerol 
(60 pM) and OA (0.5 mM) was added to the apical compartment (open bars) vs the 
basolateral compartment (hatched bars) cultured in low glucose media.
PL concentration in basolateral media was measured following incubation with ^^Cs-glycerol 
(60 pM) and OA (0.5 mM) in the apical compartment (open bars) and the basolateral 
compartment (hatched bars) cultured in low glucose media for 24 h. Data are mean ± SD for 
n = 3 independent experiments. Abbreviations: OA, oleic acid. There was no significant 
difference between conditions.
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4.3.4.3 Comparison of the effects of apical versus basolateral supplementation of 
glycerol tracer and OA on TAG and PL enrichment in cells and basolateral 
media
When incubating cells in high glucose media, TAG and PL enrichment within cells 
was similar irrespective of whether the tracer or OA were added to the apical or 
basolateral compartment (Figure 70). However, there were higher levels of enriched 
TAG in the media following the addition of OA to the apical side. The opposite was 
found to occur with PL where higher enrichment levels were found following the 
addition of ^^Cs-glycerol and OA to the basolateral side (Figure 70). These 
differences were maintained under conditions of low glucose media where enrichment 
levels were higher than those obtained under conditions of high glucose incubation 
(Figure 71).
Incubating cells in low glucose media, in the absence of OA resulted in higher levels 
of TAG and PL enrichment in the cells when labelled glycerol was added to the 
basolateral side as compared to the apical side (Figure 71).
Taken together, this data shows larger increases in media TAG enrichment when 
adding glycerol and OA to the apical side. On the contrary, larger increases in media 
PL enrichment were measured when loading glycerol and OA to the basolateral 
surface. Increases in the enrichment of cellular and media TAG and media PL were 
always greater when incubating cells under low glucose conditions.
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Figure TOComparison of intracellular enrichment and enrichment of media TAG and 
PL following addition of ^ ^C3-glycerol(60pM) and OA(0.5mM) to the apical 
compartment (open bars) vs the basolateral compartment (hatched bars) cultured in 
high glucose media for 24h.
TAG and PL enrichment in cells and in basolateral media were nieasnred following 
incubation with ^^Cg-glycerol (60 pM) and OA (0.5 mM) in the apical compartment (open 
bars) or the basolateral compartment (hatched bars) cultured in high glucose media for 24 h. 
Data are mean ± SD for n = 3 independent experiments. ***? < 0.001. Abbreviations: OA, 
oleic acid; TTR: tracer to tracee ratio; TAG*^ , intracellular TAG; PL*^ , intracellular PL; TAG™, 
basolateral media TAG; PL™, basolateral media PL.
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Figure TlComparison of intracellular enrichment and enrichment of media TAG and 
PL following addition of ^ ^C3-glycerol(60pM) and OA(0.5mM) to the apical 
compartment (open bars) vs the basolateral compartment (hatched bars) cultured in low 
glucose media for 24h.
TAG and PL enrichment in cells and in basolateral media were measured following 
incubation with ^^Cs-glycerol (60 pM) and OA (0.5 mM) in the apical compartment (open 
bars) or basolateral compartment (hatched bars) cultured in low glucose media for 24 h. Data 
are mean ± SD for n = 3 independent experiments. *P < 0.05, **P<0.01, ***P< 0.001 
versus glycerol apical loading. Abbreviations: OA, oleic acid; TTR: tracer to tracee ratio; 
TAG*^ , intracellular TAG; PL^ , intracellular PL; TAG™, basolateral media TAG; PL™, 
basolateral media PL.
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4.4 Discussion
The present study investigated the incorporation of ^^Cs-labelled glycerol into TAG 
and PL in a Caco2 cell model system following incubation of glycerol tracer with and 
without OA in the apical or basolateral compartment for 24 hours. Glycerol 
enrichment of TAG and PL in cells (measured as TTR inside the cells) and in the 
basolateral media (measured as TTR in the basolateral media) was examined.
Results showed that glycerol enrichment in TAG and PL of cells and basolateral 
media can be measured following apical as well as basolateral supplementation of 
glycerol tracer in both the cells and the basolateral media. This suggests that 
basolateral-derived glycerol (the equivalent of endogenous glycerol) can be converted 
into TAG or PL in Caco2 cells.
Higher basolateral media TAG glycerol enrichment was observed when the glycerol 
tracer and OA were added to the apical compartment compared with addition to the 
basolateral compartment. With PL, there was higher media PL glycerol enrichment 
when the glycerol tracer and OA were added to the basolateral compartment 
compared with addition to the apical compartment. This was found irrespective of 
whether cells were grown in high or low glucose media. In the absence of OA and 
when incubated in low glucose media, glycerol enrichment detected in TAG and PL 
in the cells was higher when labelled glycerol was added to the basolateral side 
compared to when added to the apical side.
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4.4.1 Apical versus basolateral metabolism of glycerol in Caco2 cells
4.4.1.1 The effects of apical ^^Cs-glycerol and OA supplementation on TAG and 
PL synthesis in Caco2 cells
Figure 72 and Figure 73 show schematic diagrams which are a possible interpretation 
of the effects of apical ^^Cg-glycerol and OA supplementation on TAG and PL 
synthesis in Caco2 cells.
In the absence of OA when cultured under conditions with high glucose media, TAG 
concentration in the cells and basolateral media was low; the TTR levels were also 
low in cells and media, suggesting very little tracer was being incorporated into TAG 
(Figure 72,®). In the presence of OA, cell and media TAG concentration and TTR 
increased; The higher levels of TTR in the media in comparison to the cells, indicated 
TAG in cells was being diluted by a pool of TAG whose glycerol component was 
derived from a source other than that supplied by glycerol tracer (i.e. an intracellular 
TAG storage pool) (Figure 72, @). A similar trend was found in low glucose media; 
however, TAG TTR was higher than in high glucose media, which suggests either a 
greater incorporation of -glycerol into TAG or what is more likely less dilution of 
glycerol-3-phosphate by glucose (Figure 72,®). Glucose can also be converted to 
Dihydroxyacetone Phosphate (DHAP) via glycolysis and then form lysophosphatidic 
acid which can enter the TAG synthesis pathway (Frayn 2010). Under low glucose 
media conditions, there may be less TAG synthesis by this pathway or less glucose 
converted into glycerol, resulting in more labelled glycerol being used for TAG 
synthesis. In the presence of OA in low glucose media, even more tracer was
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incorporated into TAG (Figure 72, @). The TAG concentration in cells and media 
was the same in high glucose media and low glucose media (Figure 72).
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In the absence of OA, under conditions of high glucose media, very little glycerol 
tracer was incorporated into PL, TTR was higher in media than in cells, indicating PL 
in cells was being diluted in a larger pool (i.e. total PL pool) (Figure 73, (D). In the 
presence of OA, TTR in the cells increased, but there was no change in the media 
TTR; OA had no effect on media PL concentration (Figure 73, ®). Incubation in low 
glucose media increased TTR but had no effect on media PL concentration (Figure 73, 
(3)). OA has no effect on media PL concentration in low glucose media as well 
(Figure 73, @). TTR was higher in the media than in cells at all conditions (Figure 
73). There was an increase in PL TTR in the cells but not in the media following the 
addition of OA, this suggests there was an increase in the labelling of the PL 
intracellular pool than secretion pool. Unlike TAG, OA has no significant effect on 
media PL concentration, this suggests OA has more of an effect on TAG rather than 
PL; alternatively, the increase of PL concentration was too low to be detected using 
the current technique.
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4.4.1.2 The effect of basolateral ^^Cs-glycerol and OA supplementation on TAG 
and PL synthesis in Caco2 cells
Figure 74 and Figure 75 show a scheme of the effect of basolateral ^^Cs-glycerol and 
OA supplementation on TAG and PL synthesis in Caco2 cells.
In the absence of OA in high glucose media, TAG concentration and TTR was very 
low in cells and media (Figure 74, ®). In the presence of OA, TAG concentration in 
cells and basolateral media increased. TTR increased after the addition of OA and 
again TTR was higher in media than in the cells, indicating TAG in cells was diluted 
in a larger intracellular TAG storage pool (Figure 74, ® ). Incubation in low glucose 
increased TTR, suggesting more labelled glycerol was used for TAG synthesis 
(Figure 74, (D). The addition of OA increased TAG concentration in cells and 
basolateral media (Figure 74, @). TAG concentration in the media was lower than 
the value obtained when glycerol tracer and OA were supplemented apically (Figure 
74, (2)and(4)).
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In the absence of OA, very little tracer was incorporated into PL in high glucose 
media (Figure 75, ®). OA addition had no effect on PL concentration and TTR 
(Figure 75, ®). Incubation in low glucose media increased TTR in cells and media 
(Figure 75, (3)). In the presence of OA in low glucose media, TTR increased in 
media (Figure 75, @). TTR was higher in media than cells in all conditions (Figure 
75). In the low glucose media, TTR in media increased following addition of OA, 
but not in the cells, this suggests the glycerol tracer was labelling the export pool 
more than the intracellular PL pool; alternatively, the level of increase in the cells was 
too low to be detected.
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As the concentration of ^^Cs-glycerol added was a tracer quantity, this will not affect 
the whole system. Therefore TAG concentration did not change following addition of 
^^Cs-glycerol in the current study.
4.4.1.3 Cytosolic pool of lipids in enterocytes
It has been proposed that there are at least two pools of stored TAG inside enterocytes, 
one formed primarily from diet-derived precursors (exogenous), the other derived 
from endogenous sources, taken up via the basolateral membrane (Mansbach & 
Siddiqi 2010; Mansbach & Charles 2009; Mansbach & Parthasarathy 1982; Mansbach 
& Dowell 1992; Mansbach & Nevin 1998).
A model of human enterocytes lipid metabolism as described by Porter s group 
(Porter et al. 2007; Trevaskis et al. 2011), proposed an exogenous (e.g., dietary source) 
TAG pool which is synthesized from fatty acids and MAG. The MAG pathway is the 
major path for TAG synthesis (Breckenridge & Kuksis. 1975; Kayden et al. 1967; 
Phan & Tso. 2001). CM formed by this pathway is secreted into the intestinal 
lymphatic system. This pool of lipids is referred to as the lymph lipid precursor pool 
(alternatively termed the secretion or export pool). This model also proposes there is 
a different cytosolic storage pool inside the enterocytes. This lipid storage pool is 
comprised mostly of excess TAG formed by the G3P pathway, and basolaterally 
sourced endogenous lipids i.e. fatty acids taken up from the intestinal bloodstream. It 
is proposed that the lipids stored in this pool may be hydrolyzed and re-circulated into 
TAG assembly pathways and exported or may be incorporated into PL or oxidized 
within the enterocytes (Porter et al. 2007; Trevaskis et al. 2011).
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Caco2 cells are reported to predominantly use the G3P pathway to synthesise TAG 
(Breckenridge & Kuksis. 1975; Kayden et al. 1967; Phan & Tso. 2001). If the model 
described by Porter s group is applied to the present cell system, addition of glyeerol 
tracer to the apical side would be primarily used for the synthesis of TAG and 
secreted into the basolateral eompartment or alternatively form part of the exogenous 
intracellular storage pool. Glycerol tracer added to the basolateral side could be used 
for the synthesis of TAG, could also be exported, stored, oxidized or incorporated into 
PL (Figure 76).
Apical
membrane Caco2 cells Basolateralmembrane
Circulation
Cytosolic lipid pool 
(storage pool)
Endogenous (Glycerol&OA)
G lycerol
tracer
OA
Glycerol 
tra c e r  i
Exogenous  ^
(Glycerol tracer^ 
&0A)
G3P
pathway
Lymph lipid pool 
(secretion pool) Lymph
Cytoplasm
Figure 76 Proposed routes for intestinal glycerol utilization in the synthesis of lipids 
(TAG and PL) in the present study in Caco2 cells (Modified from Porter et al. 2007; 
Trevaskis et al. 2011).
Enterocytes obtain glycerol and fatty acids from two sources: ‘exogenous’ (dietary, apical 
surface entrance) and ‘endogenous’ (blood eirculation, basolateral surface entrance). There 
are at least two lipid pools inside the enterocytes. One pool has been called the lymph lipid 
precursor pool or lipid secretion and export pool. Exogenously derived ^^Cg-Glycerol and OA 
(loaded apically in the current study) may be used in this pool and be transported to the 
cireulation; alternatively it may go into the other pool, referred to as a cytosolic lipid pool or 
lipid storage pool. Whereas, endogenously derived '^Cg-Glycerol and OA (loaded 
basolaterally in the current study) may preferentially go into the storage pool, or alternatively 
goes into the secretion pool for TAG assembly and secretion, or be either incorporated into 
PL or oxidized within the cells. Abbreviations: OA, oleic acid; G3P, glycerol-3-phosphate; 
PL, phospholipids.
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In the present study, the TTR of TAG was much higher in media than the cells after 
the addition of OA to the glycerol tracer when cells were incubated in both high and 
low glucose media. This suggests TAG in cells was being diluted by being combined 
with another TAG pools (i.e. intracellular TAG storage pools).
4.4.1.4 Different metabolic fate of apical versus basolateral supplementation of 
glycerol tracer and OA
The results showed not only that glycerol could be taken up from the apical and 
basolateral side, but also that the metabolic fate of glycerol in Caco2 cells was 
different depending on whether it was loaded in the apical or basolateral compartment. 
TAG-glycerol enrichment in the basolateral media was higher when labelled glycerol 
was added to the apical side as opposed to adding labelled glycerol to the basolateral 
side (Figure 70 and Figure 71) irrespective of whether or not in the absence or 
presence of OA or in either high or low glucose media. Whereas PL-glycerol 
enrichment in the basolateral media was higher when labelled glycerol was added to 
the basolateral side in the presence of OA in either high or low glucose media (Figure 
70 and Figure 71). This suggests that glycerol which originates from the apical side 
may preferentially label the TAG secretion pool and that when glycerol originates 
from the basolateral surface it may preferentially label the PL secretion pool.
When cultured in low glucose media and in the absence of any OA, glycerol 
enrichment detected in TAG and PL in the cells was higher when labelled glycerol 
was added to the basolateral side compared to when added to the apical side (Figure 
71). This suggests that glycerol which originates from the basolateral side may 
preferentially label the TAG and PL storage pool or because there was insufficient 
substrate to stimulate the secretion pathway under this condition. This pattern was not
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found in the presence of OA, probably because OA stimulated TAG and PL secretion, 
so less appeared in the cells.
Although no previous studies have compared the apical versus basolateral uptake of a 
glycerol tracer into TAG and PL in Caco2 cells, the apical versus basolateral uptake 
of fatty acids and MAG has been previously described. In vitro and in vivo 
experiments have shown that the uptake of fatty acids across the apical membrane is 
greater than uptake across the basolateral membrane and that the increase in the 
incorporation of fatty acids into TAG relative to PL is greater for apically derived as 
opposed to basolaterally loaded fatty acids in rodent intestinal cell and Caco2 cells. 
When fatty acids are taken up by the basolateral surface they are primarily 
incorporated into PL in Caco2 cells (Trotter & Storch, 1991; Trotter et al. 1996) and 
in rodent small intestine (Storch et al. 2008). This has also been demonstrated with 
MAG, produced following the hydrolysis of dietary TAG, MAG follow a similar 
pattern of uptake in enterocytes, being predominantly taken up through the apical 
surface in Caco2 cells (Ho & Storch 2001; Ho et al. 2002) and in rodent small 
intestine (Storch et al. 2008). It therefore appears that glycerol uptake has similar 
characteristics. The current results showed greater basolateral media TAG TTR when 
^^Cs-glycerol and OA was added to the apical surface and greater media PL TTR 
when ^^Cs-glycerol was added to the basolateral surface.
4.4.2 Glycerol and fatty acid transport in the small intestine
It has been proposed that aquaglyceroporins may regulate glycerol metabolism in the 
small intestine (Ma & Verkman. 1999; Ishibashi et al. 2011). Based on the proposed 
working model (Figure 12), in the current study, the apical uptake of glycerol in
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enterocytes would be associated with AQPIO and basolateral uptake associated with 
AQP3.
The data shows the basolateral media TAG concentration was much higher when OA 
was loaded apically (Figure 65, 67). One explanation for this could be that substrates 
including OA would be taken-up much more efficiently by the microvillus apical 
surface than the non-villus basolateral surface as this provides a larger surface area for 
transport. Membrane proteins such as FAT /CD36, FATP4 and FABPpm play an 
essential role in apical membrane uptake of fatty acids and the other lipid products 
from the intestinal lumen into the enterocytes and may increase the efficiency of 
substrates uptake at a particular surface. Another possible explanation might be that 
the basolateral membrane is in contact with neighboring cells and the substratum, and 
may therefore not be readily accessible for fatty acid uptake (Trotter et al. 1996). The 
description of basolateral fatty acids transporters still needs to be investigated.
4.4.3 Comparison of high glucose and low glucose culture condition
In the current study, two culture conditions were employed: high glucose (25 mM 
glucose in both compartments) and low glucose (5 mM glucose in both 
compartments).
TAG concentration in cells and media was not affected by the glucose concentration 
of the incubating medium. This is inconsistent with a recent study reported by 
Pauquai et al (2006). The authors demonstrated that Caco2 cells can adapt to a low 
glucose concentration (0 and 5 mM glucose in the apical and basal compartments 
respectively) by secreting 2.1-fold more TRLs than cells cultured at a high glucose 
concentration (25 mM glucose in both compartments) following incubation with lipid
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micelles including OA, 2-mono-oleoylglycerol and cholesterol. The authors 
suggested the increased TAG secretion by cells adapted to low glucose was not 
accounted for an increase in TAG synthesis nor an increase in MTP activity, rather, 
this resulted from an increase in the TAG available for lipoprotein assembly in the 
endoplasmic reticulum (ER) lumen.
There are some potential explanations for the difference between the current results 
and those of Pauquai's (2006). One difference was that in the current study, the 
culture conditions were high glucose (25 mM glucose in both compartments) and low 
glucose (5 mM glucose in both compartments); however, in Pauquai’s (2006) study, 
the low glucose condition was 0 and 5 mM glucose in the apical and basal 
compartments respectively. The other more obvious difference was the incubation 
time. In the current study, cells were incubated in high (25 mM/25 mM) or low (5 
mM/5 mM) glucose for 24 hours; whereas, in the Pauquai’s (2006) study, the cells 
were maintained in high (25 mM/25 mM) or low (0 mM/5 mM) glucose for a period 
of 2 weeks post-confluence. Another difference was the provision of lipids in the 
media. In Pauquai’s (2006) study, the cells were provided with lipid micelles 
containing sodium taurocholate (2 mM), OA (0.6 mM), L-a-lysophosphatidylcholine 
(0.2 mM) and cholesterol (0.05 mM) with or without 2-mono-oleoylglycerol (0.2 mM) 
or butyl alcohol (0.2 mM). The composition is close to that of the content of the 
human duodenal lumen after a lipid-rich meal; this may be likely to stimulate TAG 
secretion to a greater degree than that obtained in the current study with albumin 
bound OA (0.5 mM).
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Pauquai et al. (2006) showed that MGAT2 mRNA (an enzyme in MAG TAG 
synthesis pathway, Figure 4) level increased with time post-confluence, but it did not 
vary significantly between the two glucose culture conditions, this would exclude the 
possibility that a lower glucose supply might decrease the production of glycerol-3- 
phosphate. This is in agreement with a previous study showing that the MGAT 
activity is low in Caco2 cells (Trotter & Storch. 1993).
4.4.4 Fuel selection in enterocytes
The enrichment levels of TAG and PL in cells and basolateral media were higher 
when cells were cultured in low glucose concentration media. This indicates more 
labelled glycerol was used for TAG synthesis when cultured in low glucose media 
condition.
The gastrointestinal tract is a site of high oxygen uptake and high energy demand, 
amounting to 20-25 % of the whole-body oxygen consumption, even in the post- 
absorptive or fasting state (Vaugelade et al. 1994). This high energy demand of the 
gastrointestinal tract correlates to a rapid turnover rate of epithelial cells and a high 
rate of intracellular protein synthesis.
Glutamine and glucose are the preferred fuels for the human small intestine 
(Langhans 2010). Glutamine is the most important fuel of enterocytes (Newsholme et 
al.2003), accounting for about 77 % and 35 % of CO2  production in the fasted and fed 
states, respectively (Langhans 2010). Enterocytes also have a high capacity for 
glucose utilization (Langhans 2010). Moreover, enterocytes can also oxidize fatty 
acids as a source of fuel (Duée et al. 1995; Fleming et al. 1991; Storch et al.2008).
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Thus, while enterocytes prefer glutamine as metabolic fuel, they can also metabolize 
glucose and fatty acids.
In the present study, the high and low glucose culture media contained glutamine, so 
the cells would be using glutamine and glucose as fuels. Although glutamine levels 
were not measured, the results showed TAG TTR and PL TTR were higher in low 
glucose media than in high glucose media, suggesting that when glucose levels were 
high, more glucose was being used to synthesise glycerol, whereas, when the glucose 
level was low, more labelled glycerol was used for TAG and PL synthesis.
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Chapter 5 The effect o f  insulin on Cs-labelled glycerol 
incorporation into triacylglycerol and phospholipids in Caco2 
cells
5.1 Background
Data from both human isotopic studies and animal models have shown that the 
secretion of intestinally derived apoB48-containing lipoproteins is increased under 
conditions of insulin resistance. This has been demonstrated in a nutritionally- 
induced insulin resistant hyperlipidémie model of the Syrian golden hamster (Haidari 
et al.2002) and in hyperinsulinémie, insulin resistant humans (Duez et al.2006). 
Considering the well-known effects of insulin on lipid metabolism in hepatocytes, 
adipocytes and muscles, it was of interest to examine any potential effects of insulin 
on TAG and PL metabolism in Caco2 cells.
5.2 Methods
The experiments with insulin were set up in an identical manner to those described in 
section 4.2, except that the Caco2 cells were also incubated with insulin (10 nM; 
Table 14). Confluent cell monolayers were supplemented with 60 pM labelled ^^ Cg- 
glycerol in the presence or absence of 0.5 mM OA in the apical or basolateral 
compartments. The basolateral compartment contained 2.6 ml serum free media with 
or without added insulin (10 nM). Cells were cultured under conditions of high 
(25 mM) or low glucose (5 mM) for a period of 24 h to determine the impact of 
insulin on intracellular TAG and PL and on secreted TAG and PL in the basolateral 
media.
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Table 14 Treatment culture conditions (with insulin)
Treatment Surface Media glucose Measurements
TAG enrichment and concentration PL enrichment PL concentration
No OA Apical H i^ Cdls-rBL media CeUsi-BL media BL media
No 0 A ™ S Apical H i^ Ceüs-î-BL media CeUs-rBL media BL media
No OA Apical Low Cdls-^BL media Cdls-rBL media BL media
No OAtINS Apical Low CeHs+BL media Cells^BL media BL media
i-OA Apical High Cefls+BL media Cdls-^BL media BL media
-rOA+INS Apical High CeUs-rBL media CeUs-rBL media BL media
+0A Apical Low CeUs+BL media Cells-rBL media BL media
i-OA'MNS Apical Low CeUsi-BL media Cells-rBL media BL media
NoOA BL High CeUsi-BL media Cdls-i-BL media BL media
No OA^INS BL High CeUs-rBL media CeUs-rBL media BL media
No OA BL Low CeUsi-BL media CeUs-rBL media BL media
No OAi-INS BL Low CeUs+BL media CeUs-rBL media BL media
4-OA BL H i^ Cells+BL media CeBs^BL media BL media
i-OA-^INS BL High Cells+BL media CeBs-rBL media BL media
-hOA BL Low CeUsi-BL media Ceüs-î-BL media BL media
-3-OAi-INS BL Low Ceïïs+BL media CeUs-rBL media BL media
* Insulin always in the basolateral compartment
High glucose, 25 mM glucose in both compartments; Low glucose, 5 mM glucose in both 
compartments. Abbreviations: OA, oleic acid; INS, insulin.
5.3 Results
5.3.1 Effect of insulin on TAG in Caco2 cells with and without OA 
supplementation
5.3.1.1 TAG concentration in cells and basolateral media following incubation 
with insulin, ^^Cg-glycerol tracer with and without OA in the apical or 
basolateral compartment
5.3.1.1.1 Apical incubation of ^ ^Cg-glycerol tracer with and without OA
Insulin had no significant effects on the concentrations of cellular and media TAG 
with and without OA when cells were incubated under conditions of either high or 
low glucose media (Figure 77 and Figure 78).
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Figure 77Concentration of cellular TAG was measured following incubation with ^^ €3- 
glycerol(60fiM) with and without OA(0.5mM) in the apical compartment, +/- insulin 
(INSjlOnM) in the basolateral compartment cultured in high glucose and low glucose 
media for 24h.
Data are expressed as mean ± SD for n=3 independent experiments. Abbreviations: OA, oleic 
acid; INS, insulin; ns, no significant difference. The figure only shows the significant 
differences for with and without insulin; the other differences with and without OA or high 
and low glucose are not shown as they have been shown previously.
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Figure 78Concentration of TAG in the basolateral media was measured following 
incubation with *^C3-glycerol(60pM) with and without OA(0.5mM) in the apical 
compartment, H-/- insulin (lOnM) in the basolateral compartment in high and low 
glucose media for 24h.
Data are expressed as mean ± SD for n=3 independent experiments. Abbreviations: OA, oleic 
acid; INS, insulin; ns, no significant difference. The figure only shows the significant 
differences for with and without insulin; the other differences with and without OA or high 
and low glucose are not shown as they have been shown previously.
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5.3.1.1.2 Basolateral incubation of ^^Cs-glycerol tracer with and without OA
Insulin had no significant effect on the coneentrations of eellular and media TAG 
when cells were incubated with and without OA under conditions of either high or 
low glueose media (Figure 79 and Figure 80).
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Figure 79Concentration of cellular TAG was measured following incubation with 
glycerol (60 i^M) with and without OA(0.5mM), +!- insulin(INS,10nM) in the basolateral 
compartment cultured in high glucose (open bars) and low (hatched bars) glucose media 
for 24h.
Data are expressed as mean ± SD for n=3 independent experiments. Abbreviations: OA, oleie 
aeid; INS, insulin; ns, no significant difference. The figure only shows the significant 
differences for with and without insulin; the other differences with and without OA or high 
and low glucose is not shown as they have been shown previously.
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Figure SOConcentration of media TAG was measured following incubation with ^^ €3- 
glycerol (60 pM) with and without OA(0.5mM), insulin(INS,10nM) in the basolateral 
compartment cultured in high glucose (open bars) and low (hatched bars) glucose media 
for 24h.
Data are expressed as mean ± SD for n=3 independent experiments. Abbreviations: OA, oleic 
acid; INS, insulin; ns, no significant difference. The figure only shows the significant 
differences for with and without insulin; the other differences with and without OA or high 
and low glucose is not shown as they have been shown previously.
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5.3.1.2 Enrichment of TAG with ^^Cs-glycerol in cells and basolateral media 
following incubation with insulin, ^^Cs-glycerol tracer with and without OA in 
the apical or basolateral compartment
5.3.1.2.1 Apical incubation of ^ ^Cg-glycerol tracer with and without OA
The addition of insulin significantly reduced TAG enrichment in the basolateral media 
when cells were incubated with OA and high glucose media (P<0.001; +0A  vs. 
+OA+INS) (Figure 81). There were no differences in intracellular enrichment levels 
of TAG following incubation with insulin either with or without OA (P>0.05) when 
incubating under conditions of high glucose media (Figure 81).
The addition of insulin also reduced TAG enrichment in the basolateral media when 
cells were incubated with OA and low glucose media (P<0.001; +0A  vs. +OA+INS) 
(Figure 82).
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Figure 81 Glycerol enrichment in TAG in cells and basolateral media was measured 
following incubation with ^^C3-glycerol(60pM) with or without OA(0.5mM) in the apical 
compartment, +/- insulin (INS,10nM) in the basolateral compartment in high glucose 
media for24 h.
Data are expressed as mean ± SD for n=3 independent experiments. ***P< 0.001. 
Abbreviations: OA, oleic acid; INS, insulin; TTR: tracer to tracee ratio. The figure only 
shows the significant differences for with and without insulin; the other differences with and 
without OA or high and low glucose are not shown as they have been shown previously.
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Figure 82Glycerol enrichment in TAG in cells and basolateral media was measured 
following incubation with ^^C3-glycerol(60^M) with or without OA(0.5mM) in the apical 
compartment, 4-/- insulin (INS,10nM) in the basolateral compartment in low glucose 
media for 24h.
Data are expressed as mean ± SD for n=3 independent experiments. ***P< 0.001. 
Abbreviations: OA, oleic acid; INS, insulin; TTR: tracer to tracee ratio. The figure only 
shows the significant differences for with and without insulin; the other differences with and 
without OA or high and low glucose are not shown as they have been shown previously.
5.3.1.2.2 Basolateral incubation of ^^Cs-glycerol tracer with and without OA
The addition of insulin significantly reduced TAG enrichment in the basolateral media 
when cells were incubated with OA in high glucose media (P<0.01; +0A  vs. 
-t-QA-MNS) (Figure 83). There were no differences in the intracellular enrichment 
levels of TAG following incubation with insulin either with or without OA (P>0.05) 
(Figure 83).
The addition of insulin also reduced TAG enrichment in the basolateral media when 
cells were incubated with OA in low glucose media (P<0.05; 4-OA v.s. 4-QA4-INS) 
(Figure 84).
160
0.051
0.04-
0.03-
0 .02 -
0.01 -
0.00
C=] Cells TAG {ZZ Media TAG
Figure 83Glycerol enrichment in TAG in cells and basolateral media was measured 
following incubation with ^^Cj-glycerol (60 |uM) with and without OA (0.5 mM), +/- 
insulin (INS, 10 nM) in the basolateral compartment and cultured in high glucose media 
for 24 b.
Data are expressed as mean i  SD for n=3 independent experiments. **P<0.01. 
Abbreviations: OA, oleic acid; INS, insulin; TTR: tracer to tracee ratio. The figure only 
shows the significant differences for with and without insulin; the other differences with and 
without OA or high and low glucose is not shown as they have been shown previously.
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Figure 84Glycerol enrichment in TAG in cells and basolateral media was measured 
following incubation with ^^ Cg-glycerol (60 pM) with and without OA (0.5 mM), -f-/- 
insuUn (INS, 10 nM) in the basolateral compartment and cultured in low glucose media 
for 24 b.
Data are expressed as mean ± SD for n=3 independent experiments. *P < 0.05. 
Abbreviations: OA, oleic acid; INS, insulin; TTR: tracer to tracee ratio. The figure only 
shows the significant differences for with and without insulin; the other differences with and 
without OA or high and low glucose is not shown as they have been shown previously.
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In summary, insulin had no effect on TAG concentration in cells and basolateral 
media under any of the test conditions. Insulin had no effect on cellular TAG TTR 
under any of the test conditions. However, insulin significantly decreased TAG TTR 
in the basolateral media in the presence of OA under conditions of both high and low 
glucose.
5.3.2 Effect of insulin on PL in Caco2 cells with and without OA supplementation
5.3.2.1 PL concentration in the basolateral media following incubation with 
insulin, ^^Cj-glycerol tracer with and without OA in the apical or basolateral 
compartment
5.3.2.1.1 Apical incubation of ^^Cs-glycerol tracer with and without OA
There was no significant difference in the concentration of PL in the basolateral media 
when culturing under conditions of either high or low glucose media with or without 
insulin (Figure 85).
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Figure SSConcentration of PL in the basolateral media was measured following 
incubation with ^^C3-glycerol(60pM) with and without OA(0.5mM) in the apical 
compartment, +/- insulin (INS,10nM) in the basolateral compartment in high and low 
glucose media for 24h.
Data are expressed as mean ± SD for n=3 independent experiments. Abbreviations: OA, oleic 
acid; INS, insulin. There was no significant difference between conditions.
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5.3.2.1.2 Basolateral incubation of ^ ^Ca-glycerol tracer with and without OA
There was no significant difference in the concentration of PL in the basolateral media 
when cells were incubated with or without OA under conditions of either high or low 
glucose media with or without insulin (Figure 86).
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Figure 86Concentration of PL in the basolateral media was measured following 
incubation with ^^ C3-glycerol(60jaM) with and without OA(0.5mM), -f/- insulin 
(INSjlOnM) in the basolateral compartment cultured in high and low glucose media for 
24h.
Data are expressed as mean ± SD for n=3 independent experiments. Abbreviations: OA, oleic 
acid; INS, insulin. There was no significant difference between conditions. The figure only 
shows the significant differences for with and without insulin; the other differences with and 
without OA or high and low glucose are not shown as they have been shown previously.
S.3.2.2 Enrichment of PL with ^^Cs-glycerol in cells and basolateral media 
following incubation with insulin, ^^Cg-glycerol tracer with and without OA in 
the apical or basolateral compartment
5.3.2.2.1 Apical incubation of ^ ^Cs-glycerol tracer with and without OA
The addition of insulin significantly reduced PL enrichment in the basolateral media 
in high glucose media (P<0.05; -i-OA vs. +0A-1-INS) (Figure 87). There were no 
differences in intracellular enrichment levels of PL following incubation with insulin 
either with or without OA (P>0.05) (Figure 87).
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The addition of insulin also reduced PL enrichment in the basolateral media in low 
glucose media (?<0.05; +0A +OA+INS) (Figure 88).
0.05-1
0.04-
0.03-
0.02 -
0 .01 -
0.00
c = l  Cells PL ^ 3  Media PL
Figure STGlycerol enrichment in PL in cells and basolateral media was measured 
following incubation with *^C3-glycerol(60fiM) with and without OA(0.5mM) in the 
apical compartment, +/- insulin (INS,10nM) in the basolateral compartment in high 
glucose media for 24h.
Data are expressed as mean ± SD for n=3 independent experiments. *?<0.05. 
Abbreviations: OA, oleic acid; INS, insulin; TTR: tracer to tracee ratio. The figure only 
shows the significant differences for with and without insulin; the other differences with and 
without OA or high and low glucose are not shown as they have been shown previously.
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Figure SSGlycerol enrichment in PL in cells and basolateral media was measured 
following incubation with ^^C3-glycerol(60pM) with and without OA(0.5mM) in the 
apical compartment, +/- insulin (INS,10nM) in the basolateral compartment in low 
glucose media for 24h.
Data are expressed as mean ± SD for n=3 independent experiments. *P < 0.05. 
Abbreviations: OA, oleic acid; INS, insulin; TTR: tracer to tracee ratio. The figure only 
shows the significant differences for with and without insulin; the other differences with and 
without OA or high and low glucose are not shown as they have been shown previously.
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S.3.2.2.2 Basolateral incubation of '^Cs-glycerol tracer with and without OA
Insulin had no significant effect on cellular PL enrichment in the absence or presence 
of OA with high or low glucose media (Figure 89 and 90). In the absence of OA, 
insulin had no effect on basolateral PL enrichment in high or low glucose media. In 
the presence of OA, insulin reduced PL enrichment in the basolateral media in both 
high (P<0.05, Figure 89) and low (P<0.01, Figure 90) glucose media.
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Figure 89Glycerol enrichment in PL in cells and basolateral media was measured 
following incubation with ^^ Cg-glycerol (60 pM) with and without OA (0.5 mM), +/- 
insulin (INS, 10 nM) in the basolateral compartment and cultured in high glucose media 
for 24 h.
Data are expressed as mean ± SD for n=3 independent experiments. *P < 0.05. 
Abbreviations: OA, oleic acid; INS, insulin; TTR: tracer to tracee ratio. The figure only 
shows the significant differences for with and without insulin; the other differences with and 
without OA or high and low glucose are not shown as they have been shown previously.
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Figure 90Glycerol enrichment in PL in cells and basolateral media was measured 
following incubation with ^^ Cs-glycerol (60 jiM) with and without OA (0.5 mM), +/- 
insubn (INS, 10 nM) in the basolateral compartment and cultured in low glucose media 
for 24 b.
Data are expressed as mean ± SD for n=3 independent experiments. **P<0.01. 
Abbreviations: OA, oleie aeid; INS, insulin; TTR: tracer to tracee ratio. The figure only 
shows the significant differences for with and without insulin; the other differences with and 
without OA or high and low glueose are not shown as they have been shown previously.
In summary, as was the case for TAG, insulin had no effect on PL concentration in 
basolateral media under all test conditions. Insulin had no effect on cellular PL TTR 
under all test conditions. However insulin decreased PL TTR in the basolateral media 
only in the presence of OA under conditions of both high and low glucose.
5.4 Discussion
The data generated from the present study showed insulin had no effect on cellular or 
media TAG and media PL concentration when OA was loaded onto either the apical 
or basolateral sides under conditions of either high or low glucose. This suggests 
insulin had no effect on the synthesis and secretion of TAG and PL. However, insulin 
reduced the amount of tracer incorporated into TAG and PL exported into the 
basolateral media.
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These results are consistent with a previous study where Randell et al. (2001) showed 
that insulin (100 pU/ml, 0.7 nM) had no significant effect on TAG production in 
either unstimulated or oleate-stimulated Caco2 cells. It has also been shown that 
insulin (1 nM, 100 nM,10 pM) decreased the secretion of apoBlOO fi*om hepatic 
HepG2 cells but did not modulate the production or secretion of apoB48 from Caco2 
cells when added to both apical and basolateral surfaces (Allister et al. 2004).
In contrast, Loirdighi et al. (1992) showed that the addition of insulin (30 mU/ml,
208 nM) to the human fetal small intestine (Jejunal explants) did not alter the 
incorporation of oleic acid into TAG, PL and CE in the tissue but it significantly 
decreased the level of TAG in the medium suggesting a decrease in TAG secretion. 
Levy et al. (1996) confirmed and extended the above study in cultured jejunal 
explants from human fetuses (17-20 weeks) with a dose of 3 mU/ml (21 nM) insulin 
and demonstrated that insulin inhibited apoB48 and apoBlOO secretion but did not 
alter their synthesis. In vivo, intestinal lipoprotein production has been found to be 
acutely inhibited by insulin in chow-fed hamsters (Federico et al. 2006). A recent 
human study suggests that acute hyperinsulinaemia reduces intestinal lipoprotein 
secretion in healthy humans, an effect that was described as being both direct and 
indirect through the suppression of free fatty acids (Pavlic et al.2010).
These discrepancies with the current study could be due to the use of different models 
and species or different methods (i.e. human versus rats; insulin concentration used; 
incubation surface for insulin; different culture protocols). The insulin concentration 
used in the above studies was variable. The concentration of insulin in the study of
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Loirdighi's et al. (1992), 208 nM, was justified as being a physiological amount of 
insulin, whereas Allister et al. (2004) used three different insulin concentrations: i.e.
1 nM (which they termed a physiological insulin concentration), 100 nM and 10 pM 
(which they termed as hyperinsulinémie and pharmacological, respectively). The 
authors also showed that the effect of different insulins concentration on apoB 48 
secretion was not dose-dependent. The different insulin concentration used in 
different studies could therefore have cause different results. The insulin 
concentration in the current study was 10 nM, which is considerably less than that 
used by Loirdighi’s et al. (1992) but within the range used by Allister et al. (2004).
In addition, incubation times of insulin were also different. In the study of Loirdighi 
et al. (1992) and Levy et al. (1996), human fetal intestine Jejunal explants were 
incubated for 42 h and insulin significantly decreased TAG secretion. In the present 
study, Caco2 cells were incubated with insulin for 24 h. Allister et al. (2004) also 
incubated Caco2 cells with insulin in the apical and basolateral compartments for 24 h. 
In the current study, insulin was only loaded to the basolateral compartment to mimic 
insulin in the plasma. All these factors may account for the different results.
The intestine is clearly a target tissue for insulin. Insulin receptors have been 
identified on the rat gastrointestinal epithelium (Sodoyez-Goffaux et al. 1985) and 
have been shown to play a responsive role to the quantity and quality of dietary lipid 
(MacDonald & Thornton. 1993). Aberrant intestinal insulin signalling has been 
shown to be apparent in freshly isolated enterocytes taken from an insulin resistant 
hamster model. Decreased lRS-1 and Akt phosphorylation, increased FTP-IB protein
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levels, and activation of extracellular signal-related kinase-1/2 (ERK-1/2) (member of 
the MAPK signalling) were reported (Federico et al. 2006).
The regulation of intestinal cells by insulin occurs not only via a direct effect, but also 
via in-direct mechanisms. AQP3, one of the aquaglyceroporins which facilitates 
glycerol entry, is highly expressed on the basal membrane of epithelial cells in the 
ileum and colon (Koyama et al. 1999; Ramirez-Lorca et al. 1999). There is evidence 
that insulin can regulate glycerol entry into enterocytes through AQP3 (Asai et al. 
2006). These authors demonstrated that insulin significantly suppressed the 
expression of AQP3 mRNA and protein, and suggested that the signalling pathway 
responsible for this could be through P13K and the mammalian target of rapamycin 
(mTOR). However, in the current study, although media TTR for TAG and PL was 
decreased by insulin, the cellular TTR was not suggesting this was not the mechanism 
for reduced media TTR of TAG and PL. The effects of insulin to lower media TAG 
and PL enrichment was observed whether or not glycerol and OA were added to the 
apical compartment or basolateral compartment.
A plausible explanation for the decrease in the enrichment of TAG and PL in the 
media could be that insulin increases the flux of newly synthesised TAG and PL 
(labelled with glycerol) into the cytosolic lipid storage pool. Studies in 
hepatocytes have shown that insulin directs more newly synthesized TAG into the 
cytosolic storage pool rather than the secretion pool (Duerden & Gibbons. 1990; 
Gibbons. 2002). It is not perhaps surprising that the enterocytes appear to respond to 
insulin in a manner similar to the hepatocytes in this aspect. Therefore, in the current 
study, insulin may induce newly synthesised TAG substrates to move down a storage
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pathway; rather than into the secretion pool. Thus, the amount of tracer incorporated 
into the TAG and PL export pool would be lower and therefore the enrichment of 
TAG and PL exported into the basolateral media would decrease. The total cytosolic 
TTR would not be affected just the balance of the enrichment between the storage and 
export pools.
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Chapter 6 General discussion, limitations and future work
Accumulating evidence suggests intestinal lipid metabolism is severely perturbed, 
particularly in the postprandial state, in individuals with obesity, type 2 diabetes and 
atherosclerosis (Rivellese et al. 2004; Avramoglu et al. 2006; Haidari et al. 2002; 
Lewis et al. 2005; Leung et al. 2004). Stable isotopes have been widely used to 
investigate TAG kinetics both in vivo and in vitro. To date very few studies have 
focused directly on glycerol and its role in intestinal TAG metabolism.
The present in vivo study investigated intestinal TAG metabolism in a postprandial 
steady state in healthy subjects and demonstrated that both exogenously and 
endogenously derived glycerol can be incorporated into TAG by enterocytes. With 
the in vitro cell culture study, the Caco2 cell line, which is morphologically and 
physiologically similar to human intestinal enterocytes, was employed to investigate 
differences in the metabolic fate of apical versus basolateral entry of glycerol. The 
results showed glycerol can be taken up by Caco2 cells from both the apical and 
basolateral surface. This corroborates the findings of the in vivo study. These studies 
suggest endogenously supplied glycerol can be incorporated into exogenously derived 
TAG during the postprandial period. The in vitro results showed greater basolateral 
media TAG TTR when ^^Cg-glycerol and OA was added to the apical surface as 
opposed to the basolateral surface and greater media PL TTR when ^^Cg-glycerol was 
added to the basolateral surface as opposed to the apical surface. This suggests the 
pathways by which substrates are utilized by enterocytes are dependent on which 
surface of enterocytes they are absorbed with a preference for export of apically
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derived glycerol TAG and conversion into PL for basolaterally derived glycerol also 
depending on which surface the stimulation of lipids occurs.
6.1 I n  v iv o  and in  v itr o  glycerol utilization by enterocytes
It has been suggested that glycerol may be able to cross the basolateral membrane of 
enterocytes through AQP3 (Hatakeyama et al.2001; Laforenza et al.2005; Laforenza 
et al.2009). However, whether this basolateral derived glycerol mixes with free 
glycerol obtained from hydrolysed dietary lipids or whether the basolateral entry of 
glycerol is separately partitioned into another cytosolic pool inside the enterocytes 
then incorporated into TAG and packed into CM remains to be determined.
For the in vivo study, the TTR profiles for the TAG labelled with oral tracer and 
intravenous tracer were very similar, as was the percentage of oral and i.v tracer used 
for TAG synthesis. This does not provide any evidence for different cytosolic pools 
but suggests the pools can mix freely during the postprandial state. However, only a 
small number of subjects were studied.
The pool theory suggests exogenous (diet-derived) lipids (fatty acids, MAG, glycerol) 
mainly enter the secretion pool (export pool; lymph lipid precursor pool) for export; 
whereas circulation sourced lipids (fatty acids, MAG, glycerol) are used for TAG 
synthesis, storage, PL synthesis or are oxidized (Mansbach & Siddiqi 2010; 
Mansbach & Charles 2009; Mansbach & Parthasarathy 1982; Mansbach & Dowell 
1992; Mansbach & Nevin 1998; Fielding et al. 1996; Jackson et al. 2002; Robertson 
et al. 2003; Porter et al. 2007; Trevaskis et al. 2011). The results generated from the 
current in vitro study suggest there are at least two TAG and PL cytosolic pools inside 
the enterocytes, which are separately located. The intracellular TAG and PL pools are
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predominantly used by glycerol entering basolaterally while the TAG secretion pool is 
predominantly used by glycerol entering via the apical surface.
All these results provide evidence to suggest that enterocytes have the capacity to 
modulate TAG when there are excess substrates available. This may be especially 
important during the postprandial state. It has been suggested that the cytosolic lipid 
storage pool inside the enterocytes may represent a way for enterocytes to regulate 
TRL secretion as a function of time after a meal (Pauquai et al.2006; Chateau et 
al.2005). An increase in this pool may be related to enhanced postprandial 
hypertriacylglycerolaemia seen in metabolic syndrome and type 2 diabetes and which 
is a risk factor in the development of atherosclerosis (Hennig et al. 2001). As well as 
containing exogenous derived lipids, this pool may also be driven by the elevated 
fatty acids levels in the circulation.
The Caco2 cells were cultured in media containing 25 mM glucose for 21 days before 
treatment. This has been shown to generate cytosolic lipid droplets inside the cells 
(Schütz 2004). Thus, these pools would be present when the glycerol tracer and OA 
were added in the experiments.
These results suggest that Caco2 cells can control the balance between CM assembly, 
transport, secretion and cytosolic lipid storage. This process can be affected by the 
availability of substrates on either the apical or basolateral side of the cell.
173
6.2 Limitations
There are several limitations to this study which must be acknowledged.
In the in vivo study, the glycerol enrichment of Sf20-60 exogenous fraction measured 
by GC-IRMS was very low and very variable; this hindered the analysis of exogenous 
TAG kinetics.
Although the in vivo study showed that exogenous TAG can be measured after 
intravenously administering ^Hs-glycerol, it was not clear whether different TAG 
pools to those with the oral tracer were being labelled. This needs further 
investigation.
The continuously fed high fat, low protein and low carbohydrate meal protocol may 
have affected the physiology of digestion and absorption and the mode of 2-hour 
feeding was a potential stress for the subjects.
The first limitation of the in vitro cell culture study is the very labor intensive and 
time consuming, conventional 21-day culture system used with the Caco2 cell line. 
Although in many respects this cell line provides an excellent in vitro model for the 
investigation of intestinal lipid metabolism (tight cells packed in a monolayer, 
polarized secretion of lipoproteins, separate apical and basolateral surface), the system 
does not truly represent the in vivo intestinal epithelium.
Secondly, the OA used in the present study was unlabelled, as was the glucose. This 
prevented the measurement of the quantification of the contribution of fatty acid and
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glucose to TAG and PL synthesis and secretion. Only the contribution of the labelled 
glycerol was quantified.
6.3 Future work
The present in vivo study has demonstrated that it is possible to use z.v. administered 
^Hs-glycerol and orally administered ^^Cs-glycerol to measure the exogenous TAG, 
but ^^Cs-glycerol enrichment in Sf 20-60 was difficult to measure.
GC-IRMS is a more sensitive method for measuring glycerol enrichment but requires 
a larger sample than conventional GC-MS. The ^^Cg-glycerol enrichment in the TAG 
component of Sf 20-60 was very low and variable using this analytical technique 
because of the low concentrations of TAG. A possible way to overcome this 
limitation would be in future analysis to load more lipoprotein fractions onto more 
antibodies, which might improve the detection capability. However the high cost of 
antibody limits the amount of lipoprotein fractions which can be coupled to the 
antibody.
One factor which needs to be considered if carrying out future work would be the
inclusion of more subjects, which would improve the confidence in the results.
Subjects with Metabolic Syndrome or type 2 diabetes could also be examined in
future studies. This would allow comparison of endogenous and exogenous TRL
kinetics between healthy individuals and those with known disturbances in the
processing of lipids by the intestine. This study aimed to determine if there was a
difference between VLDLl (Sf>60) production rate and CMl (Sf>60) production
rate. In this study the SD for VLDLl and CMl production rate was 40%. To detect a
difference between these 2 measurements of 50% with a power of 80% at a two-sided
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5 % level of significance the study would need 11 subjects. To detect a difference of 
25% with a power of 80% the study would need 35 subjects. The study was therefore 
underpowered with 5 subjects.
One important element which should be considered in future in vitro studies would be 
the inclusion of stable isotope labelled fatty acid and glucose. Thus the contribution 
of each substrate can be identified and analysed.
The in vitro study suggests that there might be at least two TAG pools inside the 
enterocytes: a secretion pool, which is more responsive to the apical entry of 
substrates and a storage pool, which is more sensitive to the basolateral entry of 
substrates. Unlike human enterocytes, Caco2 cells can secrete apoB48 as well as 
apoBlOO. It would be interesting to explore whether one of the two separate cytosolic 
pools inside the cells is used for the export of CM and is associated with apoB48 only 
while the other pool is used for the export of VLDL and is associated with apoBlOO.
A possible way to do this would be using Pluronic L81, which specifically inhibits the 
secretion of CM but does not affect VLDL secretion (Hussain 2000).
Future work might investigate what kinds of mechanisms control the balance between 
the storage and secretion pool. In the current study, there were two basic culture 
conditions, high glucose (25 mM) and low glucose (5 mM); levels of glycerol 
enrichment in TAG and PL were much higher when culturing under conditions of low 
glucose media. Different glucose conditions may be one of these mechanisms. A 
fasting and postprandial state may also be another mechanism.
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In order to make the whole cell culture system simple, only OA was used in the 
current study. In future studies it would be of interest to repeat the experiments using 
a fatty acid mixture or lipid micelles.
Many aspects of the mechanisms underlying endogenous glycerol utilization inside 
the small intestine still remain unknown. Further studies need to explore how 
endogenous glycerol is incorporated into TAG. This would include a better 
understanding of glycerol transport into enterocytes and the control of glycerol kinase 
activity.
Another option would be the use of animal models such as the Syrian Golden hamster 
model, in which lipid metabolism closely resembles that of humans. As previously 
described, feeding (high fructose or high-fat) for 3 weeks is known to induce the 
development of whole body insulin resistance in the Syrian golden hamster (Haidari 
et al.2002; Leung et al. 2004). Different labelled substrates could be co-administered 
intravenously or orally. Thus it would be possible to compare the endogenous and 
exogenous contribution from different pathways. Moreover, this hamster model may 
be suitable for investigating human-like dyslipidemia associated with insulin 
resistance.
The present in vitro study has also shown that insulin had no effect on TAG and PL 
synthesis and secretion, but only affected the amount of tracer incorporated into the 
exported (media) TAG and PL. Further studies are needed to elucidate the detailed 
mechanisms of how insulin regulates intestinal TAG metabolism.
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